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Abstract 
The insecticide synergist, piperonyl butoxide (PBO), has been used to reduce resistance 
factors and to characterise metabolic resistance resulting from mixed function oxidases 
(MFOs). Studies have also shown that PBO can interact with resistance-associated esterases.  
 
It is well-documented that the mechanism by which PBO inhibits P450s is the interaction of 
the methylenedioxyphenyl (MDP) moiety of PBO molecule with the haem moiety of the 
enzyme. To investigate the interactions between PBO and esterases, a structure activity 
relationship (SAR) study was carried out using analogues of PBO and E4, a resistance-
associated esterase from the peach-potato aphid Myzus persicae. Results indicate that the 
polyether and the alkyl chain were fundamentally important in this interaction. Removing one 
oxygen atom from the MDP moiety of PBO did not affect the binding affinity, but increased 
affinities resulted from the replacement of the polyether with an alkynyl ether chain or by 
increasing the length of the alkyl chain. 
 
An analogue, EN 16/5-1, that retains the ability to interact with esterases but loses the ability 
to act on P450s, due to a modification to the MDP moiety, was used in conjunction with PBO 
to facilitate characterisation of metabolic resistance in M. persicae and pollen beetle 
Meligethes aeneus. 
 
Selected analogues of PBO containing the alkynyl ether side chain exhibited high synergistic 
effects in vivo and were found to be potent inhibitors of O-deethylation of 7-ethoxycoumarin 
when tested against pyrethroid resistant M. aeneus.  
 
The capability of some of the analogues to act as insecticide synergists was investigated in 
vivo against two M. persicae clones possessing different metabolic resistance profiles.  
 
Finally, the potential of PBO analogues to provide potent and/or specific synergism to 
overcome insecticide resistance and reduce insecticide titre applied to crops is considered. 
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Chapter 1  
Introduction 
 
1.1 Insecticide resistance 
Insects are the largest animal group in the world in terms of number of species (75% of all 
animal species are insects) and are of great ecological and economical importance. In 
agricultural systems insects can either be of beneficial importance, for example honeybees, 
Apis mellifera Linnaeus (Hymenoptera: Apidae) a major pollinator of food plants and 
producer of honey, or be pests, destroying up to 30% of the potential annual harvest 
(Grimmelikhuijzen et al., 2007). Additionally, many insect species are vectors of human and 
animal diseases (Lounibos, 2002).  
 
The use of insecticides plays a major role in controlling populations of insect pests, but 
widespread use of such chemicals has resulted in selection of genotypes which display a 
resistant phenotype and many species have developed mechanisms to resist insecticide 
treatments (Feyereisen, 1995). Indeed, resistance to many classes of insecticides is now 
widespread and is viewed as an extremely serious threat to crop protection and control of 
insect vectors worldwide (Nauen, 2007). 
 
Insecticide resistance is a “pre-adapted” phenomenon and its development depends on the 
genetic variability present in an insect population. In any insect population individual insects 
may have mutations that allow them to survive insecticide treatment (Denholm and Devine, 
2001). This is best demonstrated when considering that the response to a stimulus, such as 
exposure to insecticide, in an insect population will be normally distributed. This means that 
some individual insects will be controlled at a low dose, others will require a somewhat higher 
dose and a few will survive an even higher dose. In the next generation, insects derived from 
the surviving individuals will not significantly shift the response dose of the resulting 
population. These individuals represent the extreme of a normal distributed population and are 
unable to contribute to the resistance development. However, if the population contains 
individuals that carry pre-existing genetic alterations, i.e random mutation which confers the 
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ability to survive exposure to an insecticide, then this genetic trait will be passed on to the next 
generation. Individuals that do not possess the genetic trait will not survive and such a process 
will “select” those individuals which have the “resistance gene”. Therefore, the gene pool is 
enriched with such genes and “selection for resistance” occurs as the level of resistance in the 
population rises (Price, 1991). 
 
Many definitions of insecticide resistance have been proposed and probably that proposed by 
Sawicki (1987) and subsequently modified by Feyereisen (1995) is the most inclusive: 
“Resistance marks a genetic change in response to selection. Individuals carrying genetic traits 
for coping with the chemically hostile environment survive and reproduce, thereby passing on 
these traits to their progeny. Continued selection pressure exerted by the insecticide rapidly 
increases the frequency of the genetic trait (resistance) in the population.” 
 
The intensity, dose rate and timing of applications of an insecticide to control insect 
populations result in the selection of resistant insect forms carrying resistance genes, which 
survive and pass the resistance trait to their offsprings (Nauen, 2007). The rate at which 
resistance develops also depends on the reproduction, the migration and the host range of the 
pest. Insects with short life cycles and high reproductive rates can rapidly build up resistant 
populations (Hemingway and Ranson, 2000). Development of resistance can occur more 
rapidly in greenhouses, where insects have a short generation time, the gene pool remains 
restricted as there is little or no immigration of susceptible individuals and the rate and 
frequency of insecticide applications are high (Comins, 1977). 
 
There are four main mechanisms that enable insects to resist insecticides and these are: 
increased metabolism, changes to the target protein, reduced penetration of insecticides 
through the insect cuticle (not discussed in the present work) and behavioural resistance (not 
discussed in the present work) (Oppenoorth, 1985; Sparks et al., 1989).  
 
1.2 Metabolic Resistance 
A major factor in the development of insecticide resistance is the ability of an insect to 
detoxify the insecticide at a rate to limit the accumulation of the active material at the target 
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site. Insecticide detoxification by insects results from a variety of metabolic processes in 
which the active material is converted into a non-toxic substrate or into a form suitable for 
rapid elimination from the body (Fukuto, 1990; Nebbia, 2001). Three main groups of 
enzymes, esterases, mixed function oxidases (MFOs) and glutathione-S-transferases (GSTs) 
have been reported to confer resistance in several insect species (Oppenoorth, 1985).  
 
1.2.1 Esterases 
Esterases are enzymes that catalyse the hydrolysis of ester-containing compounds to their 
corresponding alcohol and acid (Figure 1.1). A common and widely recognised classification 
proposed by Aldridge groups esterases into three types (A, B and C) based on their interaction 
with organophosphorus insecticides (OPs). A-esterases have an active site cysteine residue 
and hydrolyse OPs; B-esterases hydrolyse OPs and have an active site serine; C-esterases do 
not degrade OPs (Aldridge, 1953). 
 
 
 
 
 
Figure 1.1 Esterase hydrolysis. Esterases hydrolyse an ester via the addition of water to form 
the corresponding alcohol and acid (adapted from Wheelock et al., 2005) 
 
Esterases play an important role in the metabolism and detoxification of many exogenous 
ester-containing compounds such as OP, carbamate and pyrethroid insecticides (Wheelock et 
al., 2005). Metabolic resistance associated with esterases involves hydrolysis of ester bonds 
and/or sequestration of the insecticides (Devonshire and Moores, 1982; Gupta and Dettbarn, 
1993; Casida and Quistad, 2004; Oakeshott et al., 2005; Wheelock et al., 2005). 
Overproduction of esterases (quantitative) and/or qualitative changes in enzyme structure are 
both mechanisms by which esterases are associated with resistance to insecticides (Yan et al., 
2009).  
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Overexpression of esterases associated with metabolic insecticide resistance can occur either 
by amplification of esterase genes or by upregulation, or a combination of both and has been 
documented in numerous insect species (reviewed by Li et al., 2007). The overproduction of a 
specific carboxylesterase, E4 or its closely related variant FE4, by the resistant peach-potato 
aphid Myzus persicae Sulzer (Hemiptera: Aphididae) is perhaps the most extensively studied 
example of insecticide detoxification by gene amplification (Field et al., 1988, 1993; Field and 
Devonshire, 1998). These esterases with broad overlapping substrate specificities can account 
for as much as 1% of the aphid’s total protein and can hydrolyse and/or sequester insecticides 
resulting in high levels of insecticide resistance (Devonshire and Moores, 1982). In highly 
resistant aphids the elevated levels of E4/FE4 enzymes result from the amplified genes, with 
gene copy number rising up to approximately 80 copies (Field et al., 1999). Although 
amplified E4/FE4 are not normally found together in a single aphid or even population, the 
two genes were present together in the progeny of laboratory crosses between E4 and FE4 
clones (Blackman et al., 1996) and the combination has been found in a small number of 
aphids collected from Greece (Blackman et al., 1999). Amplified esterases associated with 
insecticide resistance have also been found in mosquitoes of the Culex genus such as Culex 
pipiens pipiens, C. p. quinquefasciatus and C. tritaeniorhynchus Linnaeus (Diptera: Culicidae) 
(reviewed by Hemingway et al., 2004). For example, it was found that amplified esterase-
based mechanisms in C. p. quinquefasciatus involved the co-amplification of two different 
esterases, both present in 80 copies in the Pel RR strain (Paton et al., 2000). Gene 
amplification of an identical gene to that in insecticide-susceptible insects was also found to 
be the mechanism underlying elevated esterase (Nl-EST1) in OP resistant brown planthoppers 
Nilaparvata lugens Stal (Hemiptera: Delphacidae) (Small and Hemingway, 2000). 
 
Overexpression of carboxylesterases associated with insecticide resistance may also occur via 
upregulation of the corresponding genes. In OP resistant Aphis gossypii Glover (Hemiptera: 
Aphididae) it was found that the relative transcription level and gene copy number of a 
carboxylesterase were 4.54- and 0.97-fold higher respectively, compared to the susceptible 
strain, indicating that the increased expression of the carboxylesterase resulted from increased 
transcription levels rather than gene amplification (Cao et al., 2008). In OP resistant B-biotype 
Bemisia tabaci Gennadius (Hemiptera: Aleyrodidae) it was found that two carboxylesterase 
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genes (coe1 and coe2) were associated with resistance with coe1 being overexpressed 
approximately ~ 4-fold in the OP resistant strain and that the elevated expression was not 
related to gene amplification. It was further suggested that OP resistance in this strain was 
associated with modified transcriptional control (Alon et al., 2008). Overproduction of 
resistance-associated esterases has been also demonstrated in many other important 
agricultural insect pests including the two-spotted spider mite Tetranychus urticae Koch 
(Acari: Tetranychidae) (Van Leeuwen and Tirry, 2007) and the western flower thrip 
Frankliniella occidentalis Pergande (Thysanoptera: Thripidae) (López-Soler et al., 2008). 
 
Metabolic resistance may also result from qualitative changes in esterase activity as 
demonstrated in early studies on OP resistant houseflies, Musca domestica Linnaeus (Diptera: 
Muscidae). In this case, resistant houseflies were shown to be associated with decreased 
esterase activity compared to susceptibles, due to structural changes in the enzyme that 
facilitated the hydrolysis of OP insecticides but prevented or reduced hydrolysis of model 
substrates conventionally used for biochemical characterisation of esterase activity. This 
became known as the ‘‘mutant ali-esterase theory’’ (Oppenoorth and van Asperen, 1960). A 
mutant esterase has also been reported in malathion and diazinon resistant sheep blowfly, 
Lucilia cuprina Wiedemann (Diptera: Calliphoridae) where structural changes in a specific 
esterase, isozyme E3, have a null phenotype on gels stained using standard esterase substrates 
(Campbell et al., 1997). It was shown that the gene encoding E3 in the diazinon resistant 
sheep blowfly differed at five amino acid sites compared to the OP susceptible. One of these 
substitutions, replacement of glycine to aspartate (Gly137Asp) was found to be within the 
active site of the enzyme and alone was responsible for both the loss of carboxylesterase 
activity and the elevated OP hydrolase activity. Modelling of Asp137 in the homologous 
position in acetylcholinesterase suggests that Asp137 may act as a base to orientate a water 
molecule in the appropriate position for hydrolysis of the phosphorylated enzyme intermediate 
(Newcomb et al., 1997). Another mutation, Trp251Leu, was also identified in OP resistant L. 
curpina conferring malathion resistance (Campbell et al., 1998). Both above mutations were 
found in OP resistant M. domestica conferring diazinon and malathion resistance, respectively 
(Claudianos et al., 1999). Additionally, the same tryptophan residue was found to be mutated 
to glycine in the parasitoid wasp Anisopteromalus calandrae Howard (Hymenoptera: 
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Pteromalidae) (Zhu et al., 1999). Qualitative changes in esterase activity have also been 
documented in other OP resistant insect species including the mosquito C. tarsalis (Ziegler et 
al., 1987), the diazinon resistant screwworm Cochliomyia hominivorax Coquerel (Diptera: 
Calliphoridae) (Carvalho et al., 2006, 2009) and the malathion resistant parasitoid 
Habrobracon hebetor Say (Hymenoptera: Braconidae) (Mendoza et al., 2000). 
 
1.2.2 Mixed function oxidases 
Mixed function oxidases (MFOs) are an important family of enzymes involved in the 
detoxification of xenobiotics such as insecticides and plant toxins and for metabolising 
endogenous compounds such as hormones (Agosin, 1985). Cytochrome P450 mono-
oxygenases (P450s) are the most important and extensively studied component of the MFOs 
(reviewed by Werck-Reichhart and Feyereisen, 2000). 
 
The P450s belong to the group of heme-thiolate proteins, which feature a proximal thiolate 
ligand from the amino acid cysteine (Figure 1.2). The P450 enzymes derived their name from 
the formed prominent peak at about 450 nm in the carbon monoxide Soret optical difference 
spectrum (Omura and Sato, 1964). This enzyme catalyses the reaction when one atom of 
molecular oxygen is incorporated into a substrate (e.g. insecticide) and the second atom of 
oxygen is reduced to produce a molecule of water according to the reaction:  
 
Substrate (S) + NADPH + H+ + O2 → SO + NADP+ + H2O 
 
Activation of this reaction requires two electrons provided by the flavoprotein NADPH 
cytochrome P450 reductase although sometimes the second electron is provided by 
cytochrome b5 (Feyereisen, 1999; Murataliev et al., 2008).  
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P450s are found in virtually all aerobic organisms including mammals, birds, insects, plants 
and bacteria. For insects, P450s can be detected in a wide range of tissues such as midgut, fat 
bodies and malpighian tubules (reviewed by Scott, 1999) and the levels and activities can vary 
with different stages of development (Chung et al., 2009). Existence of multiple P450 
isoforms within individual organisms, different expression patterns and wide substrate spectra 
confer high diversity (Scott and Wen, 2001). 
 
Insect P450s are known to play an important role in the metabolism of many insecticides 
including the activation/detoxification of OPs (Hodgson et al., 1995a). Due to the broad 
substrate specificity of P450s, detoxification affects several classes of insecticides and thereby 
can confer cross resistance to unrelated compounds (Hodgson, 1985; Oppenoorth, 1985). 
Insecticide resistance has been associated with enhanced detoxification of insecticides by 
increased levels of P450 activity usually from gene overexpression rather than qualitative 
changes. Genes belonging to the families CYP4, CYP6, CYP9, and CYP12 have all been 
reported to be associated with insecticide detoxification (reviewed by Li et al., 2007). 
 
In many cases the role of P450 in resistance has been implicated by correlation using model 
substrates such as, 7-ethoxycoumarin and 7-methoxycoumarin or molecular techniques or by a 
combination of both methods. Overexpression of P450 activity results, usually, from increased 
transcription rather than gene amplification (reviewed by Li et al., 2007). Enhanced level of 
P450 activity was reported to be correlated with permethrin resistance in the head louse, 
Pediculus humanus capitis De Geer (Anoplura: Pediculidae) (Audino et al., 2005) and in the 
Figure 1.2 P450 porphorin moiety in CYP3A4 
visualised using Pymol, (DeLano, 2002). Oxygen 
atoms are shown in red, nitrogen in blue, sulphur 
in yellow and the iron in orange. Carbon atoms 
are shown in green as bond only and the 
hydrogen atoms have been omitted for clarity.  
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cotton bollworm Helicoverpa armigera Hübner (Lepidoptera: Noctuidae) (Yang et al., 2005). 
In the latter, H. armigera exhibited resistance to various pyrethroid insecticides after selection 
with fenvalerate and phoxim. It was found that the monooxygenase activities in the midguts of 
sixth-instar larvae of the selected strain to various substrates such as p-nitroanisole, 7-
ethoxycoumarin and 7-methoxycoumarin were 3.7-, 4.7- and 10-fold higher respectively, 
compared with that of the unselected strain (Yang et al., 2005). Elevated P450 activity has 
also been reported in combination with high esterase levels in a field resistant strain of T. 
urticae exhibiting resistance to bifenthrin, dicofol and fenbutatin (Van Leeuwen et al., 2005). 
With imidacloprid, correlation between elevated P450 activity and resistance has been 
reported in B-biotype B. tabaci (Rauch and Nauen, 2003; Wang et al., 2009) and recently it 
has been found that overexpression (up to 17-fold) of a single P450 gene, CYP6CM1, was 
correlated with imidacloprid resistance in both B- and Q- biotypes (Karunker et al., 2008, 
2009). Overexpression of P450 activity by co-upregulation of three P450 genes has been 
reported in a permethrin resistant M. domestica strain after continual exposure to this 
insecticide (Zhu et al., 2008). 
 
Elevated P450 activities have also been reported in human disease vectors such as mosquitoes 
(reviewed by Hemingway et al., 2004). Overexpression of P450 activities by upregulation was 
reported in OP and pyrethroid resistant Aedes aegypti Linnaeus (Diptera: Culisidae) in 
combination with a target site mutation (Marcombe et al., 2009). Additionally, it has been 
found that five P450 genes were upregulated (>2.5-fold) in a pyrethroid resistant strain of C. 
quinquefasciatus and the expression ratio for the three highest (CYP9M10, CYP4H34 and 
CYP6Z10) was found to be 264-, 8.3- and 3.9- fold respectively, when compared to the 
susceptible (Komagata et al., 2010). Although overproduction of P450 activity by 
amplification is not common, an amplification has been reported in the malaria vector 
Anopheles funestus Giles (Diptera: Culicidae) where two genes (CYP6P9 and CYP6P4) were 
amplified 25- and 51- times in pyrethroid resistant females (Wondji et al., 2009).  
 
Although metabolic resistance due to a qualitative change in P450 activity is also a rare event 
pyrethroid resistance in a strain of Drosophila melanogaster Meigen (Diptera: Drosophilidae) 
has been identified. This mutant P450, resulting from three amino acid substitutions 
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(Arg335Ser, Leu336Val and Val476Leu) in CYP6A2, was associated with DDT resistance in 
the RDDTR strain, with the recombinant protein showing an enhanced ability to metabolise 
DDT (Amichot et al., 2004). 
 
1.2.3 Glutathione-S-Transferases 
Glutathione-S-transferases (GSTs) are a large family of enzymes found in vertebrates, plants, 
insects, yeast and aerobic bacteria involved in the detoxification of a wide range of 
endogenous and exogenous compounds (Salinas and Wong, 1999).  
 
Generally, GSTs metabolise a wide range of hydrophobic toxic compounds such as 
insecticides and other endogenous substrates, by catalysing the conjugate of endogenous GSH 
to the hydrophilic centre of the toxic substrates. This conjugation process converts the 
products to more water soluble forms, allowing them to be more easily excreted from the cells 
(Dauterman, 1985). 
 
The implication that GSTs could be involved in the metabolism of insecticides was made 
initially by the correlation of enhanced GST activity in insecticide resistant insects compared 
with their susceptible counterparts (reviewed by Enayati et al., 2005). Elevated GST activity 
has been associated with gene amplification or more commonly through increases in 
transcription rather than changes in the enzymes (reviewed by Ranson and Hemingway, 
2005). 
 
Due to the broad substrate specificities of individual GSTs, these enzymes perform a wide 
range of functions including metabolism of different classes of insecticides. High enzyme 
activity was detected in abamectin resistant T. urticae and resistant strains of B. tabaci 
(Konanz and Nauen, 2004; Rauch and Nauen 2004). Involvement of enhanced GST levels in 
OP metabolism has also been reported in M. domestica (Wei et al., 2001; Kristensen, 2005), in 
the chlorfluazuron resistant diamondback moth Plutella xylostella Linnaeus (Lepidoptera: 
Plutellidae) (Sonoda and Tsumuki, 2005) and the malathion resistant tarnished plant bug 
Lygus lineolaris Palisot de Beauvois (Hemiptera: Miridae) (Zhu et al., 2007). Additionally, it 
has been suggested that elevated GSTs in pyrethroid resistant insects may protect the insects 
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by sequestering the insecticide (Kostaropoulos et al., 2001). Insecticide resistance associated 
with enhanced levels of GST has also been reported in various mosquito species (Lumjuan et 
al., 2007; reviewed by Che-Mandoza, et al., 2009). 
 
1.3 Target site resistance 
Target site resistance occurs when genes encoding the proteins on which the insecticides act 
mutate, resulting in insensitive proteins. Modified acetylcholinesterase and knockdown 
resistance (kdr) are two resistance mechanisms which involve modifications to the target site 
of an insecticide and result in insensitivity to that insecticide (Feyereisen 1995). 
Other known target site resistance mechanisms are the “Rdl” mutation(s) in the γ-
aminobytyric acid (GABA) receptor, conferring resistance to cyclodiene insecticides such as 
dieldrin (not discussed in the present work) (ffrench-Constant et al., 1993) and mutation(s) in 
the nicotinic acetylcholine receptor (nAChR), the target for neonicotinoid insecticides (not 
discussed in the present work) (Liu et al., 2005).    
 
1.3.1 Modified acetylcholinesterase 
Acetylcholinesterase (AChE) is the key enzyme of the cholinergic system that terminates 
nerve impulses in the nervous system by catalysing the hydrolysis of the neurotransmitter 
acetylcholine (ACh) (Eldefrawi, 1985). AChE, a serine hydrolase, is the target of carbamate 
and OP insecticides (Casida and Quistad, 2005). Carbamates and OPs exert their toxicity by 
inhibiting AChE, thereby impairing the transmission of nerve impulses across cholinergic 
synapses, resulting in death of the insect (Fournier and Mutero, 1994). 
 
Alterations in the primary structure of AChE reduce sensitivity to OPs and carbamates leading 
to the development of insecticide resistance to these compounds (Fournier, 2005). Initially, 
mutant forms of AChE were characterised, in vitro, by a lack of inhibition in the presence of a 
diagnostic concentration of insecticide. Such mutations usually result in a less active enzyme, 
but insensitive mutations can also result in a more active enzyme (Devonshire and Moores, 
1984; Moores et al., 1996; Byrne and Devonshire, 1997). Sequencing of insensitive AChE 
genes has revealed several point mutations, most of which encode amino acids in the active 
site gorge (Fournier, 2005).  
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In the dipteran order of the Cyclorrhapha (true flies), only one AChE gene is present, ace 
(Huchard et al., 2006). However in many other insect species, it has been shown that there are 
at least two genes, ace-1 and ace-2, encoding AChE1 and AChE2, respectively (Fournier, 
2005). In M. persicae and A. gossypii, it has been shown that although the ace-2 gene has high 
similarity with the ace of D. meganogaster, it is mutations in ace-1 that correlate with 
insensitivity to insecticides (Li and Han, 2002; Andrews et al., 2002, 2004).  
 
Identification and characterisation of AChE in resistant M. domestica strains revealed five 
amino acid substitutions that either singly, or in combination, conferred different spectra of 
insecticide resistance. All mutations were located within the active site of the enzyme, close to 
the catalytic triad (Walsh et al., 2001). Recently, it has been shown that point mutations in the 
AChE gene of T. urticae strains correlate with OP and carbamate resistance (Khajehali et al., 
2010). Mutant AChE correlates with reduced insensitivity to insecticides in several other 
insects including the olive fruit fly Bactrocera oleae Rossi (Diptera: Tephritidae) (Vontas et 
al., 2002), the stored product insect Liposcelis bostrychophila Badonnel (Psocoptera: 
Liposcelididae) (Chai et al., 2007), the oriental fruit fly Bactrocera dorsalis Hendel (Diptera: 
Tephritidae) (Hsu et al., 2006, 2008), the codling moth Cydia pomonella Linnaeus 
(Lepidoptera: Torticidae) (Cassanelli et al., 2006) and vectors of human diseases such as 
mosquitoes (reviewed by Hemingway et al., 2004). 
 
1.3.2 Knockdown resistance  
The voltage-gated sodium channel (VGSC) protein found in nerve-cell membranes plays a 
critical role in the function of the insect nervous system. The VGSC is responsible for the 
conduction of sodium ions (Nα+) across the membrane underlying the propagation of action 
potentials in the neuronal cells. During an action potential, the VGSC undergoes transitions 
between closed-resting, activated and inactivated functional states and the normal function of 
VGSC is essential for normal transmission of nerve impulses (reviewed by Wang and Wang, 
2003). The insect VGSC is a large membrane protein that contains four repeating and 
homologous domains (I-IV) with each domain consisting of six hydrophobic transmembrane 
segments (S1-S6) (reviewed by Catterall, 2000). DDT, its analogues, pyrethrins and 
pyrethroid insecticides act on the VGSC, modifying the gating kinetics and resulting in 
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prolonged opening of individual channels, leading to paralysis and death of the insect 
(Narahashi, 2000).  
 
Resistance to DDT and pyrethroids was first reported in resistant M. domestica by Busvine in 
1951 and this type of resistance was termed “knockdown resistance” (kdr). When the VGSC 
was sequenced from different insects, comparisons between resistant and susceptible insects 
identified a number of amino acid substitutions that were associated with VGSC insensitivity 
(Soderlund and Knipple, 2003; Davies et al., 2007a). Two substitutions in the VGSC, 
Leu1014Phe and Met918Thr were identified in pyrethroid resistant housefly strains and 
originally named as kdr and super kdr resistance (s-kdr), respectively (Williamson, et al., 
1996).  
 
The Leu1014Phe mutation within the IIS6 transmembrane segment of VGSC, has been 
identified in pyrethroid-resistant clones of M. persicae (Martinez-Torres et al., 1999). Later 
the Met918Thr mutation (s-kdr), in the domain between segments IIS4 and IIS5 of the channel 
protein, was also detected together with the Leu1014Phe mutation in some M. persicae clones. 
Presence of both mutations was associated with extreme resistance to different pyrethroids 
relative to aphids lacking the mutations (Anstead et al., 2004; Eleftherianos et al., 2008). 
 
Different alterations in the amino acid sequence of the VGSC protein by inherited mutations 
in the VGSC genes have been identified in several other pyrethroid resistant insect species 
(reviewed by Davies et al., 2007b; reviewed by Soderlund, 2008). For example, changes in the 
VGSC have also been associated with pyrethroid resistance including the whitefly B. tabaci 
(Roditakis et al., 2006), the two spotted mite T. urticae (Tsagkarakou et al., 2009), the onion 
thrip Thrips tabaci Lindeman (Thysanoptera: Thripidae) (Toda and Morishita 2009), the cattle 
tick Rhipicephalus microplus Boophilus (Morgan et al., 2009) and the human head louse 
Pediculus himanus capitis De Geer (Kasai et al., 2009). The genes that confer kdr are 
recessive which means that the trait will only be expressed in homozygous individuals (Daves 
et al., 2008). 
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1.4 Cross resistance and multiple resistance 
Metabolic detoxification, in contrast to target site insensitivity, can often confer resistance to a 
number of different insecticides belonging to different chemical classes and this phenomenon 
is known as ‘cross resistance’. Resistance mechanisms in insects may be present individually 
or in combination. The presence of a number of resistance mechanisms in the same population 
is known as ‘multifactorial’ or ‘multiple resistance’ (Oppenoorth, 1985).  
 
The occurrence of different resistance mechanisms in insect populations has the potential to 
present relatively high levels of resistance to one or more insecticides and thus confer cross 
resistance within or between chemical classes. The presence of such combinations has been 
demonstrated in many insect populations. For example, in M. persicae it has been 
demonstrated that elevated E4 and insensitive AChE can enhance the resistance level to 
pirimicarb by up to 600-fold (Moores et al., 1994). Furthermore, a kdr mutation which on its 
own conferred 35-fold resistance to deltamethrin, was enhanced to 540-fold when present with 
highly elevated E4 (Martinez-Torres et al., 1999). Several different combinations of elevated 
E4 activities and target site mutations (AChE, kdr and s-kdr) were also found in Italian strains 
of M. persicae conferring different levels of resistance to various insecticides (Criniti et al., 
2008).  
 
Elevated P450 and GST activities were also found in an abamectin selected strain of B. tabaci 
conferring cross resistance to abamectin, imidacloprid and emamectin benzoate (Wang and 
Wu, 2007). Additionally, elevated P450 and esterase activity were reported to be correlated 
with resistance to thiamethoxam, imidacloprid, acetamiprid and abamectin in a strain of B. 
tabaci after 36 generations of selection with thiamethoxam (Feng et al., 2010).  
 
1.5 Insecticide synergists  
Metcalf (1967) defined synergists as compounds that are non toxic in the dosage used but 
which serve to enhance the toxicity of a pesticide chemical when they are combined. 
Insecticide synergists act by inhibiting metabolic resistance mechanism(s) that would 
otherwise break down insecticide molecules and thus restore the susceptibility of insects to the 
chemical (Georgiou, 1983; Ishaaya, 1993). Synergists have been used commercially for many 
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years to enhance the efficacy of insecticides and have contributed significantly to improve 
insect control, especially where resistance has occurred (Bernard and Philogène, 1993). 
 
An observation in 1938 that specific compounds enhanced insecticidal activity initiated the 
use of insecticide synergists (Weed, 1938). Many compounds were tested and in 1940 
Eagleson described the use of sesame oil as a synergist when combined with insecticides 
containing pyrethrum or rotenone. Although Eagleson tested a range of different compounds, 
mostly other plant and animal oils, sesame oil was the most effective synergist (Eagleson, 
1942). Later, Haller et al., (1942) fractionated sesame oil and tested the fractions with 
pyrethrum against houseflies, identifying the main components as sesamin and sesamolin, two 
methylenedioxyphenyl (MDP) compounds (Figure 1.3). Since then, many MDP compounds 
have been investigated as insecticide synergists including some compounds with high 
synergistic effects such as sesamex, tropital, isosafrole, safrole, propyl isome and piperonyl 
butoxide (PBO) (Figure 1.3). Of all of these synergists, only PBO was the first truly effective 
and commercially viable synergist (Wachs, 1947; Casida, 1970; Wilkinson, 1976). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Structures of methylenedioxyphenyl compounds 
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1.5.1 Piperonyl butoxide as an insecticide synergist 
Piperonyl butoxide was first synthesised by Wachs in 1947 using the raw material safrole, 
derived from the sassafras tree, which supplied the MDP moiety of the molecule. Nowadays 
PBO is made synthetically. Naturally occurring MDP compounds such as safrole, isosafrole 
and myristicin are found in a wide range of plants including those used as human food, such as 
parsnips, parsley, nutmeg, sesame seeds, pepper etc (Hodgson and Philpot, 1974). 
 
It was initially suggested that PBO inhibited the oxidative metabolism of insecticides based on 
in vivo tests using houseflies (Sun and Johnson, 1960). Subsequent in vitro studies 
demonstrated that PBO and sesamex inhibited the oxidative detoxification of carbamates by 
rat liver microsomes (Hodgson and Casida 1960, 1961). In vitro studies using houseflies and 
rat liver further demonstrated that microsomal oxidation inhibition was due to the direct 
effects of P450 with MDP compounds. These studies demonstrated an apparent reduction in 
P450 levels in microsomes prepared from houseflies and mice treated with PBO (Perry and 
Bucknor, 1970; Matthews et al., 1970).  
 
It was suggested that PBO inhibited P450s by the formation of a complex between the haem 
iron of the P450 and the carbene formed by either direct hydrogen abstraction from the 
methylene carbon or possibly by elimination of water from a hydroxylated methylene carbon 
of the MDP compound (Figure 1.4) (Dahl and Hodgson, 1979). Although the carbene, a short 
lived reactive intermediate, has never been demonstrated directly, this mode of action of the 
MDP compounds upon P450 receives the widest support and no evidence has been put 
forward to shed doubt on its validity (Wilkinson et al., 1984; Correia and Ortiz de Montellano, 
2005).  
 
Although PBO was generally considered to be a specific inhibitor of microsomal oxidases 
(Casida, 1970), it has been shown to inhibit resistance associated-esterases in some 
agriculturally important pests and also enhance insecticide efficacy against insects where 
esterase resistance mechanisms are present (Gunning et al., 1998; Moores et al., 1998; Young 
et al., 2005, 2006). Nevertheless the mechanism(s) by which PBO interacts with resistance-
associated esterases remains unclear. The ability to interact with esterases means that using 
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PBO to identify the presence of metabolic resistance due to oxidases should be viewed with 
caution. 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 The inactivation of P450 enzymes by methylenedioxyphenyl compounds involves 
oxidation of the methylene bridge to a species that forms a tight complex with the haem iron 
atom. As shown, the coordinating species is probably a carbene (adapted from Correia and 
Ortiz de Montellano, 2005). 
 
1.5.2 Use of piperonyl butoxide 
Piperonyl butoxide has been used to enhance the potency of many classes of insecticides 
including pyrethroids, OPs and carbamates (Casida, 1970) and more recently it has been 
shown to exhibit synergistic effects when used with neonicotinoid insecticides (Bingham et 
al., 2008). 
 
The synergistic effects of PBO have been demonstrated in many cases where insecticide 
resistance is present and it has been suggested as a solution to control insect infestations 
including vectors of diseases such as mosquitoes (Kumar et al., 2002; Vijayan et al., 2007; 
Fakoorziba et al., 2009; Yadav, et al., 2009), scabies mites Sarcoptes scabiei De Geer 
(Astigmata: Sarcoptidae) (Pasay et al., 2009), horn fly Haematobia irritans irritans (Diptera: 
Muscidae) (Li et al., 2008) and agricultural insect pests such as B. tabaci and M. persicae  
(Bingham, et al., 2007, 2008). Recently, PBO has been shown to provide synergism with 
pyrethrins against different Liposcelidid psocid species for stored-grain protection and it has 
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been suggested that PBO be recommended for protection and disinfestation in storage (Nayak, 
2010).   
 
In agriculture, PBO has been used as a mixture with pyrethroids to improve their efficacy 
against H. armigera in Australian cotton fields since the early 1990s (McCaffery, 1998; 
Forrester et al., 1993). Young et al., (2005) demonstrated that following topical application 
PBO required around 5 h to inhibit the resistance-associated esterases in H. armigera. After 
this time esterases gradually recovered until full activity was regained after 24 h. In B. tabaci 
similar studies revealed that PBO required around 10 h to inhibit the resistance-associated 
esterases (Young et al., 2006). These findings show that the success of PBO as an insecticide 
synergist can be enhanced by using an appropriate pre-treatment time. Treatment with PBO 
prior to the insecticide application allows time for the metabolic enzymes to be fully inhibited 
before the insecticidal component is applied. Such a technique is known as ‘temporal synergy’ 
(Moores et al., 2005). The ideal pre-treatment time is dependent on the insect species (Young 
et al., 2006). However, pre-spraying crops with PBO several hours before spraying with the 
insecticide is clearly unsuitable for large areas and therefore novel formulations consisting of a 
microencapsulation of PBO and an active ingredient have been designed. These 
microencapsulated formulations give a burst release of PBO several hours before the burst 
release of the insecticidal component such as pyrethroids, carbamates or neonicotinoids. Such 
formulations have been used successfully to overcome metabolic resistance in B. tabaci, H. 
armigera, A. gossypii and M. persicae (Bingham et al., 2007, 2008).  
 
Studies on PBO usage alone showed that PBO exhibits a range of different effects on several 
insect species. The toxicity varies greatly between and within insect and mite species (Devine 
and Denholm, 1998a). In relatively high concentrations (>300 ppm), PBO was found to be 
lethal to all stages of the cattle tick Boophilus microplus Canestrini (Acari: Ixodidae) 
(Schuntner et al., 1974). Furthermore, it has been found that at higher concentrations (>1000 
ppm), PBO had insecticidal effects against all stages of the woolly whitefly Aleurothrixus 
floccosus Maskell (Hemiptera: Aleyrodidae) except eggs (Castener et al., 1989; Garrido et al., 
1990). In laboratory experiments using strains of B. tabaci with different resistant 
backgrounds and in field trials, it was shown that PBO has little lethal effect upon adults at 
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concentrations around 2000 ppm resulting in insufficient control. The slight mortality 
observed was not correlated with the resistance mechanism or enzyme banding patterns 
exhibited by the whitefly strains (Devine and Denholm, 1998b; Devine et al., 1998). However,  
bioassays using a leaf dip method and field trials showed that PBO was an effective 
nymphicide against early instars of susceptible and insecticide-resistance whiteflies (Devine 
and Denholm, 1998b; Devine et al., 1998). In M. domestica, it was found that in artificial diets 
of 100-5000 ppm, PBO increased 11-fold the microsomal oxidase activity in 3rd instar larvae 
and inhibited 15-100% pupation and emergence. Additionally a concentration of 10000 ppm 
PBO caused approximately 50% decrease in egg production (Yu and Terriere, 1974). Field 
and laboratory experiments also demonstrated that treatment with PBO can cause slow growth 
in the mealworm Tenebrio molitor Linnaeus (Coleoptera: Tenebrionidae), the milkweed bug 
Oncopeltus fasciatus Dallas (Hemiptera: Lygaedae) (Bowers, 1968), A. gossypii (Satoh et al., 
1995), L. curpina (Kotze and Sales, 1994) and B. tabaci (Devine and Denholm, 1998b).  
 
It has been shown that an selected insecticide resistant P. xylostella strain developed resistance 
to PBO after larvae were selected with PBO alone or with a mixture of PBO and fenvalerate 
for 5 and 6 generations, respectively (Chen and Sun, 1986; Hung and Sun 1989). In the 
mixture selected strain, the resistance to PBO and to PBO plus fenvalerate was unstable and 
reverted within five generations to those levels prior to selection. In the same report, Chen and 
Sun (1986) suggested that the strain selected with the mixture of PBO and fenvalerate may 
develop cross resistance to other MDP synergists, although the same strain remained sensitive 
to the synergistic action of another microsomal oxidase inhibitor, MGK 264. Considering the 
PBO selected strain, although Hung and Sun (1989) suggested that the resistance to PBO may 
develop due to qualitative or quantitative changes of the microsomal monooxygenases, the 
mechanism(s) were never resolved.  
 
There are a few reports where the toxicity and/or the synergistic effects of PBO against 
beneficial insects have been studied. Contact bioassays with surfaces treated with 10000 ppm 
did not cause mortality to adults of the parasitoid wasp, Diglyphus begini Ashmead 
(Hymenoptera: Eulophidae) (Rathaman et al., 1992). However, a low concentration (1200 
ppm) killed 74% of the pupated parasitoid wasp, Cales noacki Howard (Hymenoptera, 
Chapter 1                                                                                                                                                  Introduction  
37 
 
Aphelinidae) developing in A. floccosus hosts (Castener et al., 1989; Garrido et al., 1990)  
probably as a result of toxicity to the host (Devine and Denholm, 1998a). Synergistic effects 
of PBO with different classes of insecticides have also been reported in other parasitoid wasps 
such as Diaeretiella rapae M’Intosh (Hymenoptera: Aphidiidae) (Wu and Jiang, 2003), 
Pteromalus puparum Linnaeus (Hymenoptera: Pteromalidae) and Diadromus collaris 
Gravenhorst (Hymenoptera: Ichneumonidae) (Wu and Jiang, 2005). There were also high 
synergistic effects of PBO when used with different classes of insecticides (OPs, carbamates, 
pyrethroids), against the P. xylestella parasitoid, Cotesia plutellae Kurdj (Hymenoptera: 
Braconidae), although no synergism was reported when PBO was used with the chitin 
synthesis inhibitor chlorfluazuron (Wu and Jiang, 2004). Investigations of insecticide toxicity 
and synergistic effects of different enzymatic inhibitors including those caused by PBO 
against 18 different species of insects and their natural enemies have shown that PBO 
exhibited the highest synergism. The authors speculated that this resulted from PBO having 
multiple effects on the activity of esterases, GSTs and AChE (Wu and Miyata, 2005; Wu et 
al., 2007). Based on the high levels of synergism seen when PBO was used with various 
insecticides in B. tabaci, a similar assumption was made for the inhibitory effect of PBO on 
esterases and AChE (Kang et al., 2006). Finally, it has been observed that PBO inhibits AChE 
in carbamate resistant H. armigera (Gunning 2002, 2006). 
 
1.5.3 Biphasic response of piperonyl butoxide 
Many studies have shown that MDP compounds and some other xenobiotics can act as 
inducers as well as inhibitors of P450 activity and thus the effect on the enzyme activity is 
biphasic. The time course of these two activities (induction and inhibition) differs, with 
inhibition being relatively rapid and induction being relatively slow. It has been observed, 
mostly in mammalian P450s, that following a single dose of compound there is initially a 
decrease of P450 activity below control levels, followed by an increase above control levels 
with, ultimately, a return to the control level (Hodgson et al., 1995b). Studies have shown that 
MDP compounds including isosafrole and PBO are capable of inducing mammalian P450s 
and that both inhibition and induction may be isozyme-specific and different isozymes may be 
involved in the two activities of the same chemical (Adams et al., 1993; Hodgson et al., 
1995b). Induction of P450 activity by isosafrole in non–mammalian species such as the 
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southern armyworm Spodoptera eridania Stoll (Lepidoptera: Noctuidae) has also been 
demonstrated (Marcus et al., 1986). In another study it was reported that PBO was capable of 
inducing the expression of P450 and GST genes in D. melanogaster (Willoughby et al., 2007). 
More recently, induction of P450 activity in a susceptible strain of T. urticae was investigated 
using a range of known P450 inducers including the MDP compound isosafrole in a series of 
in vivo and in vitro assays. Although many of the tested compounds induced P450 activity, 24 
h treatment of mites with isosafrole did not influence the P450 O-deethylation activity (Van 
Pottelberge et al., 2008). 
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1.6 Aim and objectives of the project 
The overall aim of this project was to investigate the interactions of the insecticide synergist 
PBO and its analogues with metabolic enzymes conferring insecticide resistance in the peach- 
potato aphid M. persicae and the pollen beetle Meligethes aeneus Fabricius (Coleoptera: 
Nitidulidae) by employing a combination of biochemical techniques and in vivo assays. The 
overall objective of the project is to identify more specific and potent insecticide synergists. 
The hypothesis tested is that by altering the chemical moieties of the PBO molecule, more 
specific and potent insecticide synergists can be designed. 
  
The specific objectives of the project were: 
• To investigate the interaction between PBO and esterases. Biochemical assays were 
performed using purified E4, a carboxylesterase derived from M. persicae conferring 
broad spectrum insecticide resistance. In vitro investigations included a structure 
activity relationship (SAR) study using a series of structurally similar compounds to 
PBO (analogues) and the differences in their binding affinities towards E4 were 
assessed (Chapter 3). 
• To characterise the metabolic resistance mechanism(s) in a Greek M. persicae clone 
(clone 5191A) to imidacloprid and the metabolic factors conferring differential 
response to α–cypermethrin in four M. aeneus populations using PBO and the 
analogue, EN 16/5-1. The two insect species were examined in a series of in vitro and 
in vivo assays incorporating the analogue in conjunction with PBO and results 
compared with those from insects with previously characterised resistance mechanisms 
(Chapter 4). 
• To determine the synergistic effects of selected PBO analogues against four M. aeneus 
populations by comparison with PBO in a series of in vivo and in vitro assays (Chapter 
5). 
• To examine the synergistic effects of selected PBO analogues in vivo against two M. 
persicae clones with different resistance mechanism profiles using two different 
classes of insecticides (Chapter 6). 
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Chapter 2  
General Materials and Methods 
 
2.1 Insects 
2.1.1 Myzus persicae rearing 
Aphids for bioassays were reared on Chinese cabbage leaves (Brassica rapa L. var. Pekinensis 
c.v Wong Bok) (Brassicaceae) in small plastic box-cages (Blackman boxes) (Stewart Plastics 
Ltd, Surrey, UK) maintained at 18 ± 2ºC with a 16 h light: 8 h dark photoperiod (Blackman, 
1971). Each box contained two adult aphids placed on a leaf and left for 5 days to produce 
nymphs. After the 5th day the adults were removed and their esterase levels determined to 
ensure that no contamination or loss of esterase expression (reversion) among the different 
clones had occurred during the rearing process (Sawicki et al., 1980; ffrench-Constant et al., 
1988; Field et al., 1989). After approximately 13-15 days adults were used for bioassays.  
 
Myzus persicae clones, 5191A and 794JZ used for esterase purification were reared on 2 
week-old Chinese cabbage plants, as above, in fine-netted cages under conditions described 
above. Cultures in cages were left for 3-4 weeks and then the aphids were collected and frozen 
at -20ºC until required for esterase purification. 
 
2.1.2 Myzus persicae clones 
Five different M. persicae clones were used in this study: 4106A, TIV, 794JZ, 926B and 
5191A. Clone 4106A is a laboratory insecticide-susceptible standard. Clones T1V and 794JZ 
are laboratory standard resistant variants possessing R2 and R3 levels of E4, respectively 
(Foster et al., 2005). Clone 794JZ additionally carries a kdr mutation conferring resistance to 
pyrethroid insecticides (Martinez-Torres et al., 1999). Clone 926B is a highly resistant (R3) 
clone possessing FE4 variant of enhanced esterase (Moores et al., 1994). Clone 5191A was 
collected from tobacco in Greece in 2007. All clones have been established from single 
parthenogenetic females (Foster et al., 2005). All of the parthenogenetic stock cultures were 
provided by the Plant and Invertebrate Ecology Division, Rothamsted Research (for more 
details see Appendix 1.) 
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2.1.3 Meligethes aeneus populations 
Five pollen beetle M. aeneus samples were collected throughout the spring and summer (May 
until July) 2008 from oilseed rape fields. A Swiss population, (Stein), was collected from 
Stein, Switzerland, in May 2008. Three populations originating from different locations in 
Poland (Rogalin, Lebork and Leszno) were kindly supplied by Dr Pawel Wegorek (Institute of 
Plant Protection, National Research Institute, Poland) in July 2008. Polish samples were 
immediately sent to Rothamsted in fine-netted bags for testing. All samples arrived in good 
condition and were tested (in vivo and in vitro) within 2-3 days. The sampling locations were 
regions of intensive rapeseed cultivation and had been sprayed heavily with many classes of 
insecticides, especially pyrethroids (personal communication Dr Pawel Wegorek). A putative 
susceptible population (UK) was collected in July 2008 from Hertfordshire, UK. All 
populations contained adults only and were kept at room temperature (+ 20ºC) prior to assay. 
 
All in vivo and in vitro assays with pollen beetles (non-sexed adults) were carried out at 
Rothamsted Research with the exception of the in vivo assays with the Stein population Stein 
population, which I carried out in the laboratory of Syngenta (Stein, Switzerland).  
 
2.1.4 Musca domestica strain  
A standard susceptible M. domestica strain, (WHO) was obtained from Dr Michael Kristensen 
(Danish Pest Infestation Laboratory, Denmark) and maintained at 28 ± 2ºC with a 16 h light:8 
h dark photoperiod according to Basden, (1947). Housefly heads were supplied by Dr. 
Graham Moores, Rothamsted Research. 
 
2.2 Synergists, insecticides and other chemicals 
Technical PBO (‘Ultra’, 94%) and PBO analogues (>90%) were supplied by Endura SpA, 
Italy. The analogue structures are presented in relevant experimental chapters and in Appendix 
2 (in numerical order). Design of analogue structures were proposed jointly between myself, 
Dr Moores (Rothamsted Research, UK) and Endura SpA (Italy) as an ongoing process 
following preliminary results. Technical imidacloprid (analytical standard 99.7%) was 
obtained from Promochem Ltd, Welwyn Garden City, UK; technical azamethiphos (analytical 
standard 99%) was from Riedel-de Haen, UK and technical α-cypermethrin (analytical 
Chapter 2                                                                                                                    General Materials and Methods                          
42 
 
standard 98%) was from Sigma-Aldrich, UK, as were other chemicals, e.g. 1-naphthyl acetate 
(1-NA), 7-ethoxycoumarin (7-EC), NADPH, EDTA, DTT, PTU, PMSF, DTNB, ATChI and 
Fast Blue RR. Triton X-100 (specially purified for membrane research) was from Roche, UK. 
 
2.3 Biochemical methods 
For the recipes and preparations of buffers, gels and substrates see Appendix 3. 
 
2.3.1 Polyacrylamide gel electrophoresis (PAGE) 
Native gel electrophoresis was carried out as described by Devonshire and Moores (1982). 
Briefly, individual apterous aphids of each M. persicae clone were homogenised in 1.6 % v/v 
Triton X-100, in 0.02 M phosphate buffer, pH 7.0 with sucrose, containing a few grains of 
bromocresol purple as indicator. Following homogenisation, 10 µL samples (from each aphid 
homogenate) were analysed by electrophoresis on a 7.5% polyacrylamide gel using barbitone 
buffer, based on the method described by Williams and Reisfeld (1964). After 1.5 h 
electrophoresis at 150V, gels were rinsed in distilled water, stained in 100 mL 0.2 M 
phosphate buffer, pH 6.0 containing (0.06%) Fast Blue RR, to which 1 mL of 30 mM 1-NA in 
acetone (100% AR) was added and stored in the dark. After 20 min, the esterase banding 
patterns were clearly visible on the gels. The stained gels were then washed with distilled 
water and 7% acetic acid added to stop the reaction. 
 
2.3.2 Enzyme assays 
2.3.2.1 Determination of Myzus persicae total esterase activity 
Aphid esterase activity was measured using a colourimetric assay modified from Grant et al., 
1989.  Briefly, single apterous aphids from each clone were homogenised in a total volume of 
250 µL 0.02 M phosphate buffer, pH 7.0 with 0.1 % v/v Triton X-100 in separate wells of a 
NUNC microplate (Fisher Scientific) using a multiple homogeniser (Burkhard Scientific, 
Middlesexx, UK), (ffrench-Constant and Devonshire, 1988). Aphid homogenate (25 µL) was 
transferred into each well of a new microplate and esterase activity determined by measuring 
the rate of hydrolysis of the model substrate, 1-NA, to 1-naphthol and acetic acid in the 
presence of Fast Blue RR (200 µL/well). Concentrations of substrate and Fast Blue RR before 
addition to the plate were 0.58 mM and 15.46 mM, respectively. The assay was performed 
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using a Tmax kinetic microplate reader (Molecular Devices, Corporation; Menlo Park, 
California) at 450 nm for 10 min, taking readings every 10 sec. The integrated software 
programme Softmax Pro version 4.6 was used to fit linear regressions, the slopes of which 
were summarised as a rate of milli optical density per minute at 450 nm (mOD450 min-1). 
 
Aphid clones were categorised as S/R1 (susceptible), R2 (high level) or R3 (extreme high) 
according to the total esterase activity (personal communication Dr Graham Moores). 
 
2.3.2.2 Direct determination of Myzus persicae esterase inhibition by PBO and analogues 
(conventional spectrophotometric assay) 
Stock solutions of PBO and analogues (10 mM) were prepared in acetone. Aliquots (10 µL) of 
purified E4 diluted in 0.02 M phosphate buffer, pH 7.0 (total volume 35 µL) were incubated 
for 10 minutes with 2-fold serial dilutions of PBO or analogues starting from 0.428 to 
8.36x10-4mM (concentrations before addition of substrate) in a NUNC microplate. Enzyme 
lacking synergist was used as the control in the 11th well of the microplate. Enzyme incubated 
with a serial dilution of acetone was used as an acetone control. Esterase activity was 
measured as described in section 2.3.2.1. 
 
2.3.2.3 Determination of AChE activity 
Musca domestica head homogenate was used as the source of AChE. Approximately 10 
frozen housefly heads were homogenised in a total volume of 1 mL 0.02 M phosphate buffer, 
pH 7.0, in an Eppendorf tube. The homogenate was centrifuged at 10 000 g for 1 min and the 
supernatant used for the assays described below. 
 
Musca domestica AChE activity was measured using a colourimetric assay according to 
Devonshire and Moores, (1984) and Moores et al., (1996) and described initially by Ellman et 
al., (1961). Housefly homogenate (25 µL) was loaded into separate wells of a NUNC 
microplate followed by the addition of 75 µL 0.02 M phosphate buffer, pH 7.0, 100 µL 
dithionitrobenzoate (DTNB) and 100 µL of the model substrate for AChE, acetylthiocholine 
iodide (ATChI). Final concentrations of ATChI and DTNB were 0.5 mM. The product, 2-
nitro-5-thiobenzoate, was determined colourimetrically using a Tmax kinetic microplate 
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reader (Molecular Devices, Corporation; Menlo Park, California) at 405 nm for 10 min, taking 
readings every 10 sec. The integrated software programme Softmax Pro version 4.6 was used 
to fit linear regressions, the slopes of which were summarised as a rate of mOD405 min-1. 
 
2.3.3 Reactivation of Myzus persicae esterase, E4, following inhibition by azamethiphos 
Hydrolysis of azamethiphos by E4 was performed according to Devonshire and Moores 
(1982) with some modifications. Briefly, the kinetic reaction of esterases with OP compounds 
is the same process that occurs when the enzyme catalyses the hydrolysis of its substrate 
(Aldridge and Reiner, 1972) and it is described by the following equations: 
 
  
 
EH +AB        EHAB           EA + BH           
 
EA               EH + AOH  
 
The active enzyme (EH) combines with the organophosphate (AB) to form an enzyme-
substrate complex (EHAB) followed by the rapid formation of the phosphorylated enzyme 
(EA). The final step of the reaction is the hydrolysis of EA and generation of the free enzyme 
EH. The rate constants k1, k2 and k3 describe the rates associated with each step in the catalytic 
process. The rate constant k3 represents the catalytic centre activity (or turnover number) of 
the enzyme for a particular type of substrate or inhibitor. 
 
To calculate k3 for the hydrolysis of azamethiphos the following assay was performed. 
Enzyme, E4, (1 mL) in 0.02 M phosphate buffer, pH 7.0 containing 10 µL of insecticide (10-3 
M) in acetone was incubated at room temperature for 15 min. Enzyme activity before and after 
incubation was measured using the model substrate 1-NA (section 2.3.2.1) and the enzyme 
inhibition (%) was recorded. The excess of unbound azamethiphos was removed by passing 
the sample through a column of Sephadex TM G-25 (Fine) (Amersham Biosciences, 
Buckinghashire, UK) (d:2 x h:10 cm) and eluted using 0.02 M phosphate buffer, pH 7.0. 
Fractions (1 mL) were collected and enzyme reactivation was evaluated by taking 10 µL 
aliquots from each fraction and measuring esterase activity (section 2.3.2.1). Aliquots were 
taken approximately every 5 min, for approximately 1.5 h. A further enzyme sample (1 mL) 
k2 
k-1 
k1 
H2O 
k3 
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incubated under the same conditions with 10 µL of acetone served as a control. The rate 
constant k3 was calculated using a single exponential decay (Grafit 3.0, Leatherbarrow, R.J., 
Erithacus Software). 
 
2.3.4 Enzyme purification 
2.3.4.1 Purification of Myzus persicae esterase, E4 
The resistance-associated esterase, E4, from M. persicae clone 794JZ was purified as 
previously described by Devonshire (1977) with some modifications. Briefly, 5 g aphids 
(stored at -20ºC) were homogenised on ice, in 10 mL 0.02 M phosphate buffer pH 7.0 and 
centrifuged at 20 000 g for 10 min. The supernatants were filtered using cheese-cloth and 
passed through a column of SephadexTM G-25 (Fine) (Amersham Biosciences) (d:4 x h:15 
cm) which separated low molecular weight material. The proteins were eluted using 0.02 M 
Tris/HCl, pH 8.5 buffer. Unretarded fractions were collected and 10 µL aliquots assayed for 
total esterase activity as described in section 2.3.2.1. Fractions with the highest activity were 
pooled and loaded onto an ion exchange column (DEAE SepharoseTM Fast Flow, Amersham 
Biosciences) (d:4 x h:15 cm) and then eluted using a linear 0-0.35 M NaCl gradient in 500 mL 
of 0.02 M Tris/HCl pH 8.5, as described above. Fractions (5 mL) were collected and tested for 
total esterase activity and those fractions with the highest activity were pooled. The samples 
were de-salted, concentrated to approximately 15 mL in a filtration concentrator (Amicon, 
Hertfordshire, UK) and re-chromatographed on the DEAE SepharoseTM ion exchange 
column. Samples were eluted with a linear 0-0.35 M NaCl gradient in 500 mL of 0.02 M 
Tris/HCl, pH 8.5 as described above. The purified E4 was stored at -20ºC after exchanging the 
0.02 M Tris/HCl pH 8.5 buffer for 0.02M phosphate buffer, pH 7.0. 
 
2.3.4.2 Semi-purification of Myzus persicae and Meligethes aeneus esterases  
Esterase from the M. persicae clone 5191A and non-specific esterase(s) from the Lebork M. 
aeneus population were semi-purified using the purification method described in section 
2.3.4.1 with some modifications. Briefly, aphids or pollen beetles (stored at -20ºC) were 
homogenised in 0.02 M phosphate buffer, pH 7.0. Homogenates were centrifuged at 20 000 g 
for 5 min and the supernatants filtered, passed through a SephadexTM G-25 column and the 
proteins eluted using 0.02 M Tris/HCl, pH 8.5 buffer. Unretarded fractions were collected and 
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tested for total esterase activity according to the method described in section 2.3.2.1. Fractions 
with the highest activity were pooled and loaded onto a DEAE ion exchange column. Aphid 
samples were eluted with a linear 0-0.35 M NaCl gradient in 500 ml of 0.02 M Tris/HCl pH 
8.5 as described in section 2.3.4.1. Pollen beetle samples were eluted with a linear 0-1 M NaCl 
gradient in 500 mL of 0.02 M Tris/HCl, pH 8.5. Fractions (5 mL) were collected and tested for 
total esterase activity (section 2.3.2.1) and those fractions with the highest activity were 
pooled and used immediately in the esterase interference assay. 
 
2.3.5 Indirect determination of esterase binding (esterase interference assay)  
The esterase interference assay indirectly measures the binding affinities of inhibitors (e.g 
PBO, analogues and insecticides) to the esterase(s). Esterase(s) was incubated with and 
without the inhibitor and binding affinities monitored by the inhibition of housefly AChE 
using azamethiphos (Khot et al., 2008). 
 
2.3.5.1 Preparation of AChE 
Homogenates of M. domestica heads were prepared according to the method described in 
section 2.3.2.3. 
 
2.3.5.2 Incubation of esterases with synergists and insecticides 
Stock solutions of technical synergists (PBO or analogues) and insecticides (α-cypermethrin 
or imidacloprid) in acetone were pre-incubated in Eppendorf tubes for 16 h at 4ºC with either 
purified esterase from M. persicae clone 794ZJ (E4) or semi-purified esterases from clone 
5191A or semi-purified esterases from M. aeneus (Epb). Esterase(s) incubated in acetone was 
used as control. 
 
2.3.5.3 Indirect determination of esterase binding 
To the wells of a 96-well NUNC microplate, 25 µL 0.02 M phosphate buffer, pH 7.0 was 
added, followed by an additional 22 µL of the same buffer in the first well of each row. A two-
fold serial dilution of azamethiphos (10-6 M, dissolved in acetone) was prepared across the 
plate starting with the addition of 3 µL in the first column. The dilution was made by taking 25 
µL from the first column to the next until the 11th column of the row, from which the 25 µL 
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was discarded. The last column (12th, control) contained 25 µL of phosphate buffer. The rest 
of the microplate contained the following: row A: 50 µL per well of phosphate buffer (‘no 
esterase’); row B: 15 µL per well of esterase pre-incubated overnight with acetone (‘esterase’ 
e.g E4) followed by 35 µL of phosphate buffer; row C and thereafter: 15 µL per well of 
esterase pre-incubated overnight with samples (e.g E4+PBO) as described in section 2.3.5.2 
and 35 µL of phosphate buffer. After 1 h of incubation at room temperature, 25 µL housefly 
head homogenate, as a source of AChE (section 2.3.2.3), was added to each well and the plate 
incubated for a further 15 min at room temperature. Finally 100 µL of DTNB followed by an 
equal volume of ATChI was added to every well to give a final concentration of 0.5 mM. 
AChE activity was then determined by the hydrolysis of ATChI and detection of the released 
thiocholine colourimetrically, at 405 nm, by its reaction with DTNB as described in section 
2.3.2.3. Buffer only (row A) and esterase(s) pre-incubated in acetone (row B) served as the 
negative and the positive controls, respectively. All treatments were performed at least in 
duplicate. 
 
2.3.6 O-deethylation of 7- ethoxycoumarin (ECOD assay) 
2.3.6.1 Enzyme preparations 
Microsomal preparations of rabbit liver and Myzus persicae 
Fresh rabbit liver (1 g) was diced and homogenised on ice, in 1 mL homogenisation buffer 
(0.1 M phosphate buffer, pH 7.6, containing 1 mM EDTA, 1 mM DTT, 1 mM PTU, 1 mM 
PMSF and 1.46 M sucrose) and diluted with the same buffer lacking sucrose to give a final 
10% w/v homogenate. This was centrifuged at 20 000 g for 5 min. The resulting supernatant 
was centrifuged for a further 1 h at 105 000 g and 4ºC. The pellet was resuspended in 
homogenisation buffer without sucrose (1 mL) and used immediately as a microsomal enzyme 
source for O-deethylation assays. 
 
Fresh aphids (0.16 g) derived from M. persicae clone 5191A, were homogenised on ice, in 0.5 
mL homogenisation buffer and diluted in the same buffer to give a final 10% w/v homogenate 
as described above. This was centrifuged at 20 000 g for 5 min. Supernatants were further 
centrifuged at 105 000 g for 1 h at 4ºC. The resulting pellet was resuspended in 300 µL 
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homogenisation buffer and aliquots used directly for the determination of aphid microsomal 
oxidase activity. 
 
Meligethes aeneus homogenisation  
Approximately 55 adult pollen beetles of mixed sexes from each population were 
homogenised on ice in 1 mL 0.1 M sodium phosphate buffer, pH 7.6, containing 1 mM 
EDTA, 1 mM DTT, 1 mM PTU, 1 mM PMSF and centrifuged at 20 000 g for 5 min. The 
resulting supernatant was used directly as the source of pollen beetle oxidase. 
 
2.3.6.2 Determination of O-deethylation activity 
O-deethylation of 7-ethoxycoumarin (7-EC) was measured according to Ullrich and Weber 
(1972) and adapted to the microplate format, as described by DeSousa et al., 1995. Briefly, 7-
EC was dissolved in ethanol (absolute high, 100% AR) to give a 20 mM stock solution and 
diluted by the addition of 0.1 M, sodium phosphate buffer pH 7.8 to give a concentration of 
0.5 mM. Enzyme samples (50 µL final volume) were added to the wells of a microplate 
(OptiPlateTM Perkin Elmer) followed by the addition of 80 µL of 0.5 mM 7-EC to every well. 
The plate was incubated for 5 min at 30°C and the reaction initiated by the addition of 10 µL 
9.6 mM NADPH in 0.1 M sodium phosphate buffer, pH 7.8. Enzyme activity was measured 
using a Victor2 1420 multilabel counter (Wallac, Milton Keynes, UK) for 1 h with readings 
taken every 2 min, using an excitation wavelength of 370 nm and an emission wavelength of 
460 nm. Linear regressions of fluorometric units over time were calculated to provide the rate 
of O-deethylation activity. All treatments were performed in triplicate. 
 
2.3.6.3 Determination of O-deethylation inhibition in Meligethes aeneus homogenate by 
PBO and analogues 
Pollen beetle enzyme (50 µL) was incubated with 3 µL of 10 mM inhibitor (PBO or 
analogues) stock solutions in acetone. Enzyme (50 µL) with 3 µL of acetone was used as a 
control (uninhibited). After 10 min incubation at room temperature, 80 µL of 0.5 mM 7-EC 
was added and oxidase activity monitored as described in section 2.3.6.2. Wells including 
homogenisation buffer, inhibitor diluted in acetone, 7-EC and NADPH were used to measure 
the ‘background’ activity. All treatments were performed in triplicate. 
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2.4 Insect Bioassays 
2.4.1 Full dose response bioassays with Myzus persicae clones 
Apterous aphids were transferred from Blackman boxes (section 2.1.1) to the abaxial surface 
of Chinese cabbage leaf discs (approximately 10 adults per leaf disc) held on 1% agar in 
plastic containers (4 cm in diameter, A.W. Gregory & Co Limited, Kent, UK). The upper edge 
of each container was coated with Fluon® (Whitford Plastics, Cheshire, UK) to prevent aphid 
escape from the leaf surface. Netted lids were added to ensure apterous aphids could not 
escape. After allowing 30 min for the aphids to settle, each was dosed with 0.25 µL of 1g L-1 
synergist dissolved in acetone or acetone only using a Burkard microapplicator (Burkhard 
Scientific, Middx, UK). Synergist concentrations chosen conferred no significant mortality 
compared to the acetone control treatment in preliminary bioassays. Five hours later, aphids 
were further treated with 0.25 µL insecticide (imidacloprid or α-cypermethrin) in acetone at a 
range of concentrations (0.1-3000 ppm, at least 3 replicates per concentration per bioassay). 
Controls were treated with 0.25 µL of acetone or 1g L-1 synergist in acetone and after 5 h with 
a further 0.25 µL of acetone. This 5 h pre-treatment time was found to be optimal for M. 
persicae (Khot, 2009). 
 
Treated aphids were kept at 18 ± 2˚C and 16 h light: 8 h dark photoperiod and scored 72 h 
after treatment. Aphids incapable of co-ordinated movement (after gentle touching with a 
paint brush if necessary) were scored as dead. All bioassays were performed a minimum of 
three times. 
 
2.4.2 Discriminating dose bioassays with Myzus persicae clones  
Topical application bioassays using synergists (1 g L-1 PBO or 1 g L-1 EN 16/5-1) and a single 
diagnostic concentration of an insecticide were carried out against M. persicae clones 5191A 
and 794JZ, as described in section 2.4.1. Insecticide discriminating doses were derived from 
the insecticide full dose response bioassays (section 2.4.1) and were chosen to give low 
mortality (below 25%) in the absence of a synergist. Discriminating dose bioassays were 
performed a minimum of three times. 
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2.4.3 Full dose response bioassays with Meligethes aeneus populations 
The bioassay method for pollen beetle bioassays was based on that recommended by the 
Insecticide Resistance Action Committee (IRAC, method no 11, 2008) and was used to 
investigate responses to α-cypermethrin. Glass vials (d:2.3 x h:5.7 cm) (S Murray & Co, 
Surrey, UK) were coated with 0.5 mL solution of α-cypermethrin dissolved in acetone using a 
blood-roller (Luckham Multimix Major, Denley Instruments Ltd) at room temperature until 
the test solution had completely evaporated. Five to 15 adults of mixed sexes were placed into 
the vials and the top closed loosely with a screw-cap. Three replicates of each insecticide 
concentration (0.01 ppm-100 ppm) were used. Vials treated with acetone only were used as 
controls. 
 
Treated vials were stored at 18 ± 2ºC and 16 h light: 8 h dark photoperiod. All bioassays were 
scored 24 h after exposure to the insecticide. Pollen beetles were considered dead if inactive 
after gentle prodding. 
 
2.4.4 Discriminating dose bioassays with Meligethes aeneus populations 
Due to limited numbers of pollen beetles, no synergist studies were carried out using full dose 
response bioassays. For the single dose response bioassays, glass vials were coated with 0.5 
mL solution of a mixture of a synergist (0.01g L-1) and a single diagnostic concentration of α-
cypermethrin as described in section 2.4.3. Previous studies had shown that, with pollen 
beetle, a synergist pre-treatment had no advantage over application of a mixture (personal 
communication Dr G Moores). Insecticide discriminating doses used in this section were 
derived from the full dose response bioassays (section 2.4.3) and were chosen to give low 
mortality in the absence of a synergist. Vials treated with 0.01g L-1 synergist and acetone only 
were used as controls. Five to 15 replicates were used for each treatment depending on insect 
numbers available. Synergist concentrations chosen conferred no mortality in preliminary 
bioassays. Treated vials including the pollen beetles were stored and scored as described in 
section 2.4.3. 
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2.5 Analysis of data  
2.5.1 Interference assay data 
Concentrations of azamethiphos required to inhibit 50% of the AChE activity, (IC50), were 
calculated by fitting 4-parameter logistic curves (Grafit 3.0, Leatherbarrow, R.J., Erithacus 
Software). Details of the statistical analysis are in the relevant experimental chapters. 
 
2.5.2 O-deethylation of 7-ethoxycoumarin (ECOD assay) 
Oxidase activity was measured by the rate of production of 7-hydroxycoumarin (7-OH) and 
expressed as Fluorometric Units per minute (FUs min-1) following subtraction of ‘background’ 
activity. After stability of the reaction was established, the mean absorbance of three replicates 
at each time point was calculated and a linear regression plotted. Oxidase activity was 
represented by the slopes (rates) of these regression lines. The efficacy of the inhibitors (e.g. 
PBO) was expressed as a percentage of the control slope (enzyme + acetone). Details of the 
statistical analysis are in the relevant experimental chapters. 
 
2.5.3 Full dose response bioassay data 
Pooled raw data from at least three separate bioassays were analysed by probit analysis 
(Busvine, 1951; Finney, 1972) using the statistical programme PC Polo Plus (LeOra, 
Software, Berkeley, USA). Polo Plus programme calculated the concentrations required to kill 
50% of the population (LC50), 95% confidence limits (CL95%), slopes with standard errors 
(SE), chi-square (χ2) and degrees of freedom (df) (see Tables in relevant experimental chapters 
and full data analysis outputs can be found in Appendix 4). Natural response was also 
estimated when control mortality occurred. If no mortality was observed in the controls then 
the natural response was estimated as zero (Robertson et al., 2007). Comparisons using LC50 
values were based on non-overlap of 95% confidence intervals.  
 
The LC50 values were used to generate a ‘Resistance factor’ (RF) and a ‘Synergistic factor’ 
(SF) as follow:  
 
 
Resistance factor (RF) =      _____LC50 for resistant population _________                                  
                                         LC50 for susceptible population 
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The resistance factor (RF) estimates the effect of a certain treatment on a population of insects 
if tested against both resistant and susceptible populations. Generally, RF indicates how much 
more insecticide is required to provide equal control against a resistant population compared 
to a susceptible population. 
 
 
 
The Synergistic factor (SF) estimates the effect of a synergist when used in conjunction with 
an insecticide on a particular insect population (either resistant or susceptible) (Metcalf, 1967). 
The toxicity of the insecticide normally increases with the relative amount of synergist in the 
synergist/insecticide treatment (Brindley and Selim, 1984; Bingham et al., 2007). 
 
2.5.4 Discriminating dose bioassay data 
For discriminating dose response bioassays, a Generalized Linear Model (GLM) was fitted to 
the data calculated as proportions (number of dead aphids out of the total) assuming a 
Binomial distribution for the probability of death and using a logit link function (for model 
equation see Appendix 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Synergistic factor (SF) =      _____LC50 insecticide for population _________                                  
                                         LC50 synergised insecticide for population 
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Chapter 3  
Use of piperonyl butoxide analogues to investigate the interactions between 
piperonyl butoxide and E4, a resistance-associated esterase from the peach -
potato aphid, Myzus persicae Sulzer (Hemiptera: Aphididae) 
 
3.1 Introduction 
 
It has been shown previously that PBO exhibits synergistic effects against insects with phase 1 
metabolic enzyme systems that confer insecticide resistance, namely esterases and oxidases 
(Casida, 1970; Wilkinson et al., 1984; Gunning et al., 1998; Moores et al., 1998; Young et al., 
2005, 2006). Although the mechanism by which PBO inhibits P450s is well-documented 
(Dahl and Hodgson, 1979), the mechanism by which PBO exhibits its inhibitory effects on 
resistance-associated esterases remains unclear. In an attempt to elucidate the mechanism(s) 
involved in these interaction(s), biochemical assays were performed using purified E4, a 
carboxylesterase derived from M. persicae which confers broad spectrum insecticide 
resistance (Devonshire and Moores, 1982).  
 
The carboxylesterase E4, first described in 1977 (Devonshire, 1977) is a classic example of 
the important contribution of this class of metabolic enzymes to insecticide resistance. It has 
been shown that E4 can detoxify a significant proportion of a toxic dose by hydrolysis and 
also by sequestration (Devonshire and Moores, 1982). Despite the critical role that E4 plays in 
insecticide detoxification and the cloning of the gene encoding E4 (Field et al., 1993), the 
crystal structure of the protein is still unknown. This clearly limits understanding of the 
interaction(s) between PBO and E4. However, the structure of E4 can be predicted from other 
closely related serine hydrolases such as other carboxylesterases and AChEs with known 
crystal structures, since they share a similar structural framework (Xie et al., 2002).  
 
To investigate PBO and E4 interactions, a structure activity relationship (SAR) study using a 
series of structurally similar compounds to PBO (analogues) was carried out, measuring the 
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differences in binding affinities to E4 and including theoretical aspects of molecular 
recognition by these molecules. The crucial role of molecular recognition between a protein 
and a ligand was first highlighted by the Dutch chemist, Emil Fischer in 1894 who suggested a 
simple and very comprehensive model that “the enzyme and the substrate must fit together 
like a lock and key” (Fischer, 1894). Although Fisher’s “Lock–and–Key” model is still valid, 
a recent and expanded “hand and a glove” model includes those cases where macromolecule 
enzymes and ligands are flexible and adopt their final shapes during the recognition process 
(Harmat and Naray-Szabi, 2009). These approaches have been used to study possible aspects 
of the interaction between PBO and E4. 
 
In the present work extensive use was made of the esterase interference assay initially 
described by Khot et al., (2008). This indirect assay was developed to overcome the lack of 
observed inhibition of esterase activity in the presence of PBO when using a conventional 
spectrophotometric assay. This biochemical assay was used to study the interactions/binding 
between purified esterase (E4) derived from M. persicae (clone 794JZ) and synergists (PBO 
and its analogues). 
 
The overall aim of this chapter is to give insights into the possible mechanism(s) by which 
PBO interacts with E4 through a series of biochemical assays including a SAR study with 
PBO analogues. Conclusions regarding the potency and possible specificity of the analogues 
are also discussed. 
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3.2 Materials and Methods 
 
3.2.1 Piperonyl butoxide and analogues 
Analogues of PBO with modifications in the MDP moiety, alkyl and polyether side chains 
were synthesised and used (section 2.2). The structures of analogues are given in Appendix 2. 
 
3.2.2 Purification of E4 
Purified E4 derived from M. persicae (clone 794JZ) was used in all biochemical assays. E4 
was purified as described in section 2.3.4.1. 
 
3.2.3 Direct determination of E4 inhibition by PBO and analogues  
Direct determination of E4 inhibition by PBO and analogues was performed as described in 
section 2.3.2.2.  
 
3.2.4 Reactivation of E4 following inhibition by azamethiphos  
Inhibition of E4 activity by azamethiphos and reactivation was performed as described in 
section 2.3.3. 
 
3.2.5 Indirect determination of E4 binding using different concentrations of PBO 
Different stock concentrations (0.3, 3 and 30 mМ) of technical PBO diluted in acetone, were 
pre-incubated in Eppendorf tubes with purified E4 (16 h at 4ºC), to give final concentrations of 
0.003, 0.03 and 0.3 mМ, respectively. Purified E4 incubated with acetone was used as control. 
Indirect determination of esterase activity inhibition was performed as described in section 
2.3.5.3. 
 
3.2.6 Indirect determination of E4 binding using different incubation intervals  
Stock solutions (3 mМ) of technical PBO in acetone were pre-incubated in Eppendorf tubes 
with purified E4 for 1, 2, 4 and 24 h at 4ºC. Purified E4 incubated with acetone at the same 
incubation intervals was used as controls. The assay was performed as described in section 
2.3.5.3. 
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3.2.7 Structure–activity relationship study using the esterase interference assay 
Stock solutions of technical PBO and analogues (3 mМ) in acetone were pre-incubated in 
Eppendorf tubes with purified E4 for 16 h at 4ºC. Purified E4 incubated with acetone was used 
as control. Indirect determination of E4 inhibition by PBO and analogues was performed as 
described in section 2.3.5.3. 
 
3.2.8 Analysis of data  
3.2.8.1 Direct determination of E4 activity inhibition by PBO and analogues 
The mean activity (mOD450min-1) of two replicates was calculated and plotted against inhibitor 
concentrations (concentrations before the addition of the substrate). Slopes were calculated 
using Grafit 3.0 (Leatherbarrow, R.J., Erithacus Software). 
 
3.2.8.2 Indirect determination of E4 binding  
Concentrations of azamethiphos required to inhibit 50% of the AChE activity, (IC50), were 
initially calculated in Grafit 3.0 (section 2.5.1). Then, IC50 values were converted into 
percentages giving the “Index” (I) value. The higher the I value, the lower the binding affinity 
of the compound to the enzyme (E4). Confidence limits (CL) 95% for the I value were also 
calculated and treatments considered significantly different if the CL 95% did not overlap (see 
Appendix 6 for details).  
 
3.2.8.3 Correlation between results obtained from the direct and indirect esterase assays 
for the inhibitory potency of PBO/analogues to E4  
Simple linear regression analysis was used to describe the correlation between the results 
obtained from the direct (conventional spectrophotometric assay) and the indirect (esterase 
interference assay) esterase assays for the inhibitory potency of PBO/analogues to E4 
(GenStat 12th Edition, VSN International).  
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3.3 Results  
 
3.3.1 Direct determination of E4 inhibition by PBO and analogues 
Ten representative analogues of PBO containing alterations in the MDP ring and/or side 
chains were tested for the ability to inhibit E4 activity using the conventional esterase assay. 
Results (change in hydrolysis rate versus inhibitor concentrations-slopes) are given in Figure 
3.1 and Table 3.1. Results showed that analogues gave different responses after incubation 
with the enzyme, but no evidence of inhibition was detected. In fact, EN 14-05 and PBO gave 
highly increased catalytic centre activity of the enzyme for its model substrate (activation). 
Three other analogues, EN 1-179, EN 16/5-1 and EN 1-42, gave an intermediate level of 
increased activity whilst activity with the other analogues did not differ from the control. 
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Figure 3.1 Activity (mOD450min-1) of the aphid esterase (E4) versus inhibitor concentrations. 
Data are means ± SE, n=2. 
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Table 3.1 Slopes (mOD450min-1mM-1) corresponding to PBO and analogues (refer to Figure 
3.1). 
Treatment Slope ± SE 
Control (acetone) 0.45 ± 1.25 
PBO 124 ± 3.08 
EN 16/5-1 68.2 ± 2.03 
EN 1-40 9.28 ± 0.55 
EN 1-42 68.9 ± 1.51 
EN 1-129 1.68 ± 1.91 
EN 25-35 24.0 ± 0.85 
EN 1-183 3.08 ± 2.89 
EN 16-17 0.44 ± 2.26 
EN 25-10 15.5 ± 0.82 
EN 14-05 167 ± 6.95 
EN 1-164 10.5 ± 3.73 
EN 1-179 75.1 ± 3.43 
 
3.3.2 Reactivation of E4 activity following inhibition by azamethiphos  
Incubation of E4 with azamethiphos (10-3M) for 15 min gave ~77% inhibition of activity 
(Table 3.2). 
 
Table 3.2 Activity (mOD450min-1) before and after 15 min incubation of E4 with azamethiphos 
(10-3M). Data are means ± SE, n=2. 
Treatment Activity  ± SE % Remaining activity ± SE 
Before incubation 81.1 ± 2.89 
22.7 ± 0.41 
After incubation 18.4 ± 0.33 
 
Reactivation rate (k3) of E4, after monitoring at intervals for approximately 1.5 h, was found 
to be 1.63 (± 0.16) h-1 indicating that the enzyme had significant phosphatase activity (Figure 
3.2).  
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Figure 3.2 Recovery of E4 activity after 15 min inhibition with azamethiphos (10-3M) 
followed by the removal of excess inhibitor by passing through a G-25 column. Data are mean 
± SE, n=2. 
 
3.3.3 Indirect determination of E4 binding using different concentrations of PBO 
The esterase interference assay depends upon the action of unsequestered azamethiphos 
against housefly AChE, so it was necessary to test if PBO or analogues inhibited housefly 
AChE directly using the standard Ellman assay (Ellman et al., 1961), with ATChI as the 
substrate for AChE. No inhibition was observed (data not shown). 
 
The principle behind the esterase interference assay is that in the absence of esterase, housefly 
AChE activity is inhibited by azamethiphos and this is detected as low AChE activity (in 
Table 3.3 and Figure 3.3 indicated as no E4). In the presence of E4 (E4 only) where 
sequestration may remove the azamethiphos before it reaches the AChE (i.e. E4 ‘protects’ the 
AChE), higher concentrations of azamethiphos are needed to inhibit the AChE. When E4 is 
pre-incubated with PBO prior to exposure to AChE, (E4 + PBO), if there is an interaction 
between the E4 and the PBO, the E4 will no longer ‘protect’ the AChE from the azamethiphos 
and AChE inhibition will be similar to that seen in the absence of E4. Hence this would 
indicate indirectly if E4 has interacted with (blockaded) PBO.  
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The IC50 values of the AChE activity, after incubation of E4 with three different 
concentrations of PBO, are presented in Table 3.3 and Figure 3.3. The I values, represent the 
binding affinity of PBO to E4 as a percentage (Figure 3.4). The lower the I value, the higher 
the binding affinity (where the IC50 value for E4=100% and for no E4=0% see Appendix 6 for 
details). Results showed that binding potencies exhibited by 3 mM PBO and 30 mM PBO 
were very similar, whilst 0.3 mM PBO gave the lowest binding potency. Based on these 
results, 3 mM PBO was the concentration used in the next assays (see sections 3.3.4 and 3.3.5) 
to allow evaluation of the differential binding affinities when a range of PBO analogues were 
tested in the SAR study (section 3.3.5).  
 
Table 3.3 Concentrations of azamethiphos required for 50% inhibition of AChE activity, 
(IC50), after incubation of E4 with different concentrations of PBO with the Index values, (I), 
calculated as described in the text (see also Appendix 6). Data are means ± SE, n=3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3 AChE activity (%) after incubation of E4 with different concentrations of PBO 
(refer to IC50 values from Table 3.3). 
Samples IC50 (ηM) SE ± I (%) 
AChE only (no E4) 0.12 0.004 0 
E4 only 1.93 0.027 100 
E4 + 0.3 mM PBO 0.73 0.032 48.8 
E4 + 3 mM PBO 0.17 0.008 4.14 
E4 + 30 mM PBO 0.15 0.003 2.51 
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Figure 3.4 Graphical representation of Index values of binding affinities of different 
concentrations of PBO to E4 (Index values refer to Table 3.3). 
 
3.3.4 Indirect determination of E4 binding using different incubation times 
The results presented in Figure 3.5 show that the binding of 3 mM PBO to E4 did not change 
when the incubation time was increased from 1 to 24 h. This suggests that PBO acts as a 
reversible inhibitor for the protein. 
 
Figure 3.5 Graphical representation of Index values of binding affinities of PBO to E4 using 
different incubation times. Data are means ± SE, n=3. 
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3.3.5 Structure activity relationship study for the interactions between analogues and E4  
Results from the interference assay were grouped into three categories according to the 
modifications to the structure of the analogues compared to PBO. Data in Table 3.4, Table 3.5 
and Table 3.6 show the structures and the corresponding I values with the lower and the upper 
CL (95%). Analogues, such as PBO, EN 1-126 and EN 1-180 are repeated in Tables and 
Figures for easier comparison. 
 
3.3.5.1 Analogues with general modifications in the alkyl and polyether side chains 
(aromatic ring type A) 
Results in Table 3.4 and Figure 3.6 show significant differences in the analogues’ ability to 
blockade E4. The highest binding affinity of analogues to E4 was observed with an increasing 
length of the alkyl chain. Hence, EN 1-16 containing a hexyl side chain showed the highest 
binding affinity compared to the other analogues. However, the butyl chain in EN 1-14 did not 
increase the binding affinity to E4 compared to PBO. Removal of the propyl side chain in EN 
1-40 resulted in a significantly lower binding than PBO. Introduction of a second polyether 
chain in EN 1-42, restored the ability to bind a significantly higher amount of E4 than EN 1-
40 but less than PBO. Alterations at the end of the polyether chain by the addition of either a 
carboxyl (-COOH) or a sodium carboxylate (-COONa) group, as shown in EN 1-101 and EN 
1-162 respectively, resulted in failure of these analogues to blockade E4. A similar response 
was observed when the long polyether side chain was replaced by a carboxyl group (EN 1-93). 
Replacement of the polyether chain by a dodecyl chain and absence of the propyl alkyl chain 
in EN 1-129, resulted in a significant reduction in binding affinity, although its binding 
affinity was higher than EN 1-101, EN 1-162 and EN 1-93. EN 1-126, where the polyether 
chain was replaced by an alkynyl ether chain, showed a high ability to blockade E4 and 
restored the inhibitory failure of EN 1-101, EN 1-162, EN 1-93 and EN 1-129, although the 
EN 1-126 binding affinity was significantly lower than PBO, EN 1-14 and EN 1-16. EN 1-180 
which is structurally similar to PBO but has an oxygen atom (from the polyether chain) bound 
directly to the aromatic ring by removal of the methylene bridge group, -CH2-, (changing from 
a phenyl methyl structure to a phenyl structure i.e. from aromatic type A to aromatic type B) 
did not show any significant difference in binding potency compared to PBO. The last two 
Chapter 3                                              Use of PBO analogues to investigate the interactions between PBO and E4                                                      
63 
 
analogues in Table 3.4, EN 1-126 and EN 1-180, were used to generate further analogues 
presented in the next two sections 3.3.5.2 and 3.3.5.3. 
 
Table 3.4 Analogues with general modifications in the alkyl and polyether side chain 
(aromatic ring type A) and corresponding Index values, (I) with lower and upper 95% CL. 
 
 
 
 
 
Name 
Aromatic  
ring 
R1 R2 I (%) 
Lower 
95 %CL 
Upper 
95 %CL 
PBO  A CH2CH2CH3 (CH2OCH2)3CH2CH2CH3 5.86 5.14 6.60 
EN 1-14 A CH2CH2 CH2CH3 (CH2OCH2)3CH2CH2CH3 4.82 4.27 5.34 
EN 1-16 A CH2CH2 CH2 CH2CH2CH3 (CH2OCH2)3CH2CH2CH3 2.17 1.70 2.65 
EN 1-40 A H (CH2OCH2)3CH2CH2CH3 28.1 26.1 30.1 
EN 1-42 A (CH2OCH2)3CH2CH2CH3 (CH2OCH2)3CH2CH2CH3 10.3 9.11 11.5 
EN 1-101 A CH2CH2CH3 (CH2OCH2)3COOH 85.9 77.8 94.0 
EN 1-162 A CH2CH2CH3 (CH2OCH2)3COONa 84.0 78.2 89.8 
EN 1-93 A CH2CH2CH3 COOH 89.8 80.8 98.8 
EN 1-129 A H (CH2)11 CH3 61.1 56.2 66.0 
EN 1-126 A CH2CH2CH3 CH2O CH2C≡CCH3 12.8 10.9 14.7 
EN 1-180* A CH2CH2CH3 (OCH2CH2)3CH2CH3 4.67 4.07 5.27 
 
 
                    A   
O
O
R1
R2
 
* EN 1-180 is represented as an analogue having an aromatic ring type B in the following Tables and Figures. 
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Figure 3.6 Graphical representation of Index values of analogues with general modifications in 
the alkyl and polyether side chains (aromatic ring type A). Data are means ± SE, n=3 (refer to 
Table 3.4). 
 
3.3.5.2 Phenyl methyl and phenyl analogues (aromatic ring type A and B) 
When phenyl methyl and phenyl analogues (aromatic ring type A and B, respectively) were 
tested, EN 1-164 exhibited the highest binding affinity (Table 3.5 and Figure 3.7). Thus, it 
seems that an oxygen atom bound directly to the aromatic ring (by removing the -CH2- group) 
increases the binding affinity of EN 1-164 compared with EN 1- 126 which retains the -CH2- 
group (aromatic ring type A). Lack of an alkyl chain in EN 1-163 gave lower binding affinity 
than EN 1-164. Furthermore, reduced binding potency was also observed with EN 1-125, 
which is structurally similar to EN 1-126 but which also lacks the alkyl side chain. A similar 
trend was observed with EN 1-175 compared to EN 1-180. An analogue having an alkynyl 
moiety with the triple bond at the end of the side chain, as in EN 1-183, displayed high 
binding affinity and was similar to the binding potency of EN 1-164. However, when the alkyl 
side chain was absent as in EN 1-181 the affinity was reduced. EN 1-179, a compound having 
a polyether and an alkynyl ether chain, with both chains bound directly to the aromatic ring, 
showed higher binding potency than PBO or EN 1-180. Interestingly, EN 1-186 having the 
shortest polyether chain and a propyl side chain revealed higher binding potency than PBO, 
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EN 1-180 or EN 1-179. Finally EN 1-182, an analogue containing an alkynyl ether moiety and 
a branched methyl group (aromatic ring type A), exhibited slightly different binding affinity to 
EN 1-126. 
 
Table 3.5 Analogues with phenyl methyl or phenyl structure (aromatic ring type A and B, 
respectively) and corresponding Index values, (I) with lower and upper 95% CL.  
 
 
 
 
                                                      
                       A                                                B 
Name 
Aromatic  
ring 
R1 R2 I (%) 
Lower 
95 %CL 
Upper 
95 %CL 
PBO  A CH2CH2CH3 (CH2OCH2)3CH2CH2CH3 5.86 5.14 6.60 
EN 1-180 B CH2CH2CH3 (CH2CH2O)2CH2 CH2CH2CH3 4.67 4.07 5.27 
EN 1-186 B CH2CH2CH3 CH2CH2OCH3 2.31 1.78 2.84 
EN 1-175 B H (CH2CH2O)2CH2 CH2CH2CH3 26.5 24.3 28.7 
EN 1-179 B OCH2C≡CCH3 (CH2CH2O)2CH2 CH2CH2CH3 2.98 2.47 3.50 
EN 1-126 A CH2CH2CH3 CH2O CH2C≡CCH3 12.8 10.9 14.7 
EN 1-164 B CH2CH2CH3  CH2C≡CCH3 0.98 0.65 1.30 
EN 1-125 A H CH2O CH2C≡CCH3 37.1 31.7 42.6 
EN 1-163 B H CH2C≡CCH3 10.3 9.3 11.4 
EN 1-183 B CH2CH2CH3 CH2C≡CH 2.06 1.67 2.44 
EN 1-181 B H  CH2C≡CH 63.9 60.3 67.5 
EN 1-182 A H CH2 CH (CH3)CH2OCH2C≡CCH3 9.62 8.84 10.4 
 
 
O
O
R1
R2
 
O
O
R1
OR2
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Figure 3.7 Graphical representation of Index values of analogues with phenyl methyl and 
phenyl structure (aromatic ring type A and B, respectively). Data are means ± SE, n=3 (refer 
to Table 3.5). 
 
3.3.5.3 Analogues with modifications in the MDP moiety and side chains (aromatic ring 
type C, D, and E) 
The absence of one oxygen from the MDP moiety, as in EN 16/5-1 and EN 16-06, (Table 3.6 
and Figure 3.8) did not affect their binding affinities compared to PBO. In contrast, absence of 
both oxygen atoms, as in EN 14-05, resulted in reduced binding affinity. EN 16-17 containing 
a propyl side chain and an alkynyl ether moiety showed the highest binding affinity to E4. 
Nevertheless, an absence of the alkyl chain in EN 16-18 resulted in a significantly reduced 
binding affinity compared to EN 16-17.  
 
Verbutin, (common name for EN 25-10, Pap et al., 2001) showed lower binding affinity than 
PBO although a structurally similar compound, EN 25-35, gave a similar affinity as PBO. The 
absence of the propyl side chain in EN 25-37 could be correlated with low binding to E4 in the 
same way as previously seen for the presence/absence of the alkyl moiety. Similar to previous 
observations (Table 3.5 and Figure 3.7), a triple bond at the terminal position of the alkynyl 
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moiety affected the binding affinity and hence, EN 25-36 showed lower binding affinity than 
PBO. 
 
Table 3.6 Analogues with modifications in the MDP moiety, the side chains (aromatic ring 
type C, D, E) and PBO (aromatic ring type A) and corresponding Index values, (I), with lower 
and upper 95% CL. 
 
 
 
 
 
                       C                                                         D                                                               E 
Name 
Aromatic  
ring 
R1 R2 I (%) 
Lower 
95 %CL 
Upper 
95 %CL 
PBO  A CH2CH2CH3 (CH2OCH2)3CH2CH2CH3 5.86 5.14 6.60 
EN 16/5-1 C CH2CH2CH3 (CH2OCH2)3CH2CH2CH3 7.63 6.94 8.33 
EN 16-06 C (CH2OCH2)3CH2CH2CH3 H 6.89 6.13 7.64 
EN 14-05 D CH2CH2CH3 (CH2OCH2)3CH2CH2CH3 21.6 20.2 23.1 
EN 16-17 C CH2CH2CH3 OCH2 C≡CCH3 -1.17 -1.42 -0.94 
EN 16-18 C OCH2 C≡CCH3 H 28.6 24.7 32.4 
EN 25-10 E H CH (CH3)OCH2C≡CCH3 28.4 23.6 33.2 
EN 25-35 E CH2CH2CH3 OCH2 C≡CCH3 5.10 4.09 6.10 
EN 25-37 E H OCH2 C≡CCH3 39.1 36.1 42.1 
EN 25-36 E CH2CH2CH3 OCH2C≡CH 15.1 13.0 17.3 
O
R1
R2
R1
R2
CH3O
CH3O
R1
R2
 
 
 
 
 
Chapter 3                                              Use of PBO analogues to investigate the interactions between PBO and E4                                                      
68 
 
-10
0
10
20
30
40
50
60
70
80
90
100
PBO EN 16/5-1 EN 16-06 EN 14-05 EN 16-17 EN 16-18 EN 25-10 EN 25-35 EN 25-37 EN 25-36
In
d
e
x
 (
%
)
 
Figure 3.8 Graphical representation of Index values of analogues with modifications in the 
MDP moiety and side chains (aromatic ring type C, D, E) and PBO (aromatic ring type A). 
Data are the means ± SE, n=3 (refer to Table 3.6). 
 
3.3.6 Correlation between results obtained from the direct and indirect esterase assays 
for the inhibitory potency of PBO/analogues to E4  
The response (slopes) from the direct determination of E4 inhibition by PBO and analogues 
(conventional esterase assay, section 3.3.1) were plotted against the I values obtained from the 
esterase interference assay (Table 3.6, Table 3.7 and Table 3.8). The correlation of the results 
between the two biochemical assays is shown in Figure 3.9. There is a positive correlation 
between the slopes and the I values revealing that the smaller the I values (stronger the 
binding affinity) the less elevated the catalytic centre activity of the enzyme for the 1-NA (less 
activation). Statistical analysis showed that there was a significant regression (p=0.005) (the 
model being: Slope = 16.6 + 7.09×Index, SEs 15.7 and 1.76, respectively). However, three 
analogues EN 25-10, EN 1-40 and EN 1-129 do not fit this correlation and the common 
characteristic of these three analogues is the lack of the alkyl side chain. 
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Figure 3.9 Correlation between the slopes and Index values derived from the two biochemical 
assays (standard conventional assay and the esterase interference assay excluding EN 25-10, 
EN 1-40 and EN 1-129). 
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3.4 Discussion  
 
The mechanism by which PBO interacts with P450s is well-known (Dahl and Hodgson 1979; 
Wilkinson et al., 1984). In contrast, the mechanism by which PBO interacts with resistance- 
associated esterases has not been elucidated. In the present work, a series of biochemical 
assays including a SAR study was undertaken to determine the interaction(s) between PBO 
and E4, an esterase derived from the peach-potato aphid M. persicae, which is known to 
confer broad spectrum insecticide resistance (Devonshire and Moores, 1982).  
 
It has been observed that although PBO can act as an esterase inhibitor, it does not interact 
directly with the active site serine of the protein (Khot et al., 2008), as commonly reported for 
other esterase inhibitors such as PMSF (Fahrney and Gold, 1963). This was demonstrated by 
standard spectrophotometric assays using the model substrate 1-NA where homogenates 
derived from M. persicae, M. domestica and B. tabaci (Q-biotype) still hydrolysed 1-NA after 
incubation with PBO showing no detectable inhibition (Khot et al., 2008). In the present 
study, results from the conventional esterase assay with purified E4 in the presence of 
PBO/analogues and using the model substrate 1-NA, showed that PBO/analogues either did 
not affect substrate hydrolysis or increased the catalytic center activity of E4 (Figure 3.1 and 
Table 3.1). The former reaction where no inhibition was detected is in agreement with 
previous observations (Khot et al., 2008) and implies that these analogues do not react with 
the enzyme catalytic centre. However, in the same assay some analogues increased the 
catalytic activity and this implies that compounds such as EN 14-05 and PBO and to a lesser 
extent compounds such as EN 1-179, EN 16/5-1 and EN 1-42 are actually “helping” or 
“guiding” the substrate to reach and act at the catalytic centre at a higher rate. Nevertheless, it 
confirmed that the conventional assay fails to demonstrate inhibition of E4 activity by 
PBO/analogues. 
 
Results also show that the organophosphate ester, azamethiphos, acts directly on the E4 active 
site serine by forming initially a phosphoserine ester bond followed by enzyme 
dephosphorylation and finally recovery of E4 activity (Table 3.2 and Figure 3.2). However, 
the esterase interference assay showed that in the presence of PBO, azamethiphos is not 
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sequestered by E4. This suggests that PBO is preventing the azamethiphos reacting with the 
active site of the protein. Given that PBO prevents azamethiphos from interacting with the 
catalytic centre but allows 1-NA to reach and act on the active site, it seems that PBO is 
binding to the protein at an area that prevents the substrate reaching the active site.  
 
Carboxylesterases such as E4, AChE and butyrylcholinesterases (BuChE) are classified within 
the super family of serine esterases and into the B-esterase group (Aldridge, 1993). These 
esterases share a common structural framework with the active site containing a serine 
hydrolase catalytic triad which is composed of a serine (Ser), a histidine (His) and either an 
aspartate (Asp) or a glutamate (Glu) residue (Wheelock et al., 2005). For example E4’s 
catalytic triad consists of Ser191, His440 and Glu316 residues (Field et al., 1993). The 
catalytic triad of Torpedo californica AChE (TcAChE), one of the most extensively studied 
examples of a serine hydrolase, is composed of Ser200, His440 and Glu327 (TcAChE 
numbering). X-ray crystallography of the structure of TcAChE has also shown that its 
catalytic triad is located at the bottom of a deep and narrow cavity - the active site gorge (or 
aromatic gorge). The active site gorge is lined by 14 conserved aromatic residues and there is 
a site located close to the rim of the active site gorge, the so-called peripheral anionic site 
(PAS) (Sussman et al., 1991). The contribution of the 14 conserved aromatic amino acids in 
the active site gorge is fundamental since they provide both a substrate guidance system and 
flexibility in protein-ligand interactions (Xu et al., 2008). The arrangement of these residues 
accelerating the passage of substrate accounts for the extremely high turnover number of 
AChE (Ripoll et al., 1993). In particular, a tryptophan residue (Try279, TcAChE numbering) 
positioned at the lip of the aromatic gorge is responsible for directing substrate molecules 
towards the active site and removal of this residue by site-directed mutagenesis results in an 
enzyme with a decreased catalytic centre activity (Harel et al., 1995; Morel et al., 1999; Xu et 
al., 2008). Alignment of the amino acid sequences of TcAChE with E4 (23.7% sequence 
identity) shows that only 7 of the 14 conserved aromatic amino acids present in TcAChE are 
conserved in E4 (Figure 3.10). Taking account of the similarity between E4 and AChE and the 
findings in the present study showing that in the presence of the enzyme, PBO allows 
acylation by 1-NA but prevents phosphorylation by azamethiphos, it can be hypothesised that 
PBO (and analogues) bind to amino acid residues located near the rim of the active site gorge. 
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Furthermore, it is possible that analogues showing an increase in the catalytic centre activity 
of the enzyme in the conventional assay (e.g EN 14-05 and PBO) may bind in such a way that 
the aromatic moiety of these analogues acts similarly to the Try279 residue of TcAChE, i.e. 
guiding the substrate down the aromatic gorge. For analogues in which the catalytic centre 
activity is not increased (e.g EN 1-101, EN 1-162 and EN 1-129), the aromatic moiety is 
presumably not in the preferred configuration. Thus hindrance of azamethiphos may still be 
apparent, but passage of 1-NA is unchanged. 
 
Since the conventional spectrophotometric assay could not be used to study the inhibition of 
esterase activity by PBO and analogues, all further studies investigating the interactions of 
PBO and E4 were performed using the esterase interference assay.  
 
Results from the esterase interference assay using different incubation intervals of PBO with 
E4 showed that PBO acts as a reversible inhibitor (Figure 3.5). This suggests that PBO binds 
to the enzyme with non-covalent bonds such as hydrogen bonds, hydrophobic interactions, 
steric effects, etc. 
 
In an attempt to elucidate the interactions between PBO and E4, a SAR study was undertaken 
using a series of PBO analogues. Binding affinities of the analogues to E4 were used to give 
insights into the structural requirements of PBO to maximise the binding interactions in the 
protein-ligand complex. The SAR study could provide information about the future design of 
more potent and selective inhibitors.  
 
Results from the SAR study revealed that the presence of the alkyl chain may be of major 
importance for binding to the enzyme as shown with the analogues PBO/EN 1-40 (aromatic 
type A, Figure 3.6) and EN 1-180/EN 1-175 (aromatic type B, Figure 3.7) where the only 
difference in their structures is the presence or absence of the alkyl chain and the effects seem 
to be independent of other changes that have occurred to the structure. A similar trend was 
observed with two analogue groups where the polyether chain was replaced with an alkynyl 
moiety, EN 1-126/EN 1-125 (aromatic type A, Figure 3.7) and EN 1-164 /EN 1-163 (aromatic 
type B, Figure 3.7). With the triple bond at the end of the alkylnyl moiety and the propyl side 
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chain, EN 1-183 bound a greater amount of E4 compared to EN 1-181 (aromatic type B, 
Figure 3.7). Given the same presence/absence of an alkyl side chain, compounds having a 
modification in the MDP moiety and an alkynyl moiety, EN 16-17 and EN 25-35 showed 
higher binding potency than EN 16-18 and EN 25-37, respectively (aromatic type C and D, 
respectively, Figure 3.8). Additionally, increasing the length of the alkyl chain to a hexyl 
substituent in EN 1-16 is correlated with an increase of the binding potency to the esterase. 
These observations are in line with previous findings showing a positive correlation between 
the inhibitory potency of a series of compounds to mammalian carboxylesterases and an 
increased length in the alkyl chain (Wadkins et al., 2007). Results from the present study 
suggest that the presence of the hydrophobic alkyl substituent is of considerable importance 
and may interact with a corresponding hydrophobic region of the protein by hydrophobic 
effects. Assuming that E4 has a similar structure to TcAChE and possesses an aromatic gorge, 
(as described above) this would be relatively hydrophobic and provide a suitable binding area 
for the hydrophobic substituent of the analogues by hydrophobic interactions. The alkyl side 
chain is also likely to exert steric effects that may improve interactions with the amino acid 
residues of the binding area.  
 
The present results also demonstrate a significant contribution of the polyether chain to the 
binding affinity of the analogues to E4. This is best seen when the polyether chain is replaced 
with a dodecyl side chain (EN 1-129) resulting in a lower binding affinity compared to PBO 
(Figure 3.6). In this case, findings imply that the electron-donating effects of the oxygen atoms 
in the polyether chain play an additional role and affect the binding affinities. This suggests 
that electrostatic attraction/repulsions are important in improving the interactions with 
surrounding amino acids of the protein. Additionally, these lone pairs of electrons could 
support certain types of shapes of the structures or affect bond angles providing a better 
orientation of the compounds. 
 
A combination of an alkyl hydrophobic substituent and a polyether chain in analogue structure 
(as in PBO) provides a higher binding affinity than the presence of two polyether chains, as 
found in EN 1- 42 (Figure 3.6). The presence of two long and bulky polyether chains, 
containing lone pair electrons from oxygen atoms decreases the binding potency of EN 1-42 
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and this may occur because of extensive steric hindrance effects resulting from the 
electrostatic repulsions of the two chains. Thus both the alkyl chain and the polyether chain 
may be deemed necessary for close binding of the ligand to the esterase.  
 
For EN 1-101 and EN 1-93 both having a carboxyl group (-COOH), binding affinities were 
significantly low (Figure 3.6). Since the carboxyl group is a strong functional group, it may 
bind rapidly to an area of the protein before these analogues actually reach the appropriate 
binding area. Alternatively, this carboxyl group may prevent the analogues taking the same 
orientation as the other structures, even if bound to the same residues. This hypothesis is 
supported by Rebek (1987) who suggested that “Functional attached groups tend to diverge or 
become directed away from the cavity and from the substrates that are held inside”. It is also 
likely that a similar action occurs in the case of the EN 1-162 (Figure 3.6) since in an aquatic 
environment the -COONa group of EN 1-162 can react to form a –COOH group following the 
reaction: RCOONa + H2O → RCOOH 
- 
+ NaOH.  
 
When the oxygen atom is bound directly to the aromatic ring as in EN 1-180 (aromatic type B, 
Figure 3.7), results show there was no significant difference in the binding potency compared 
to PBO. This may imply that the oxygen’s contribution to the binding potency, by the 
presence of lone pair electrons, is not affected by their position in the polyether chain. 
Interestingly, EN 1-186 having the shortest polyether chain showed higher binding affinity 
than EN 1-180 (Figure 3.7). This may suggest that the structure of EN 1-186 is allowing a 
better configuration of the molecule and thus increasing the interactions in the suitable binding 
area.  
 
When the polyether chain was replaced by an alkynyl ether moiety with the oxygen bound 
directly to the aromatic ring (aromatic ring type B), the binding affinity increased dramatically 
in some analogues compared to PBO. A combination of an alkynyl ether moiety and the 
propyl chain as in EN 1-164 (aromatic ring type B), increased the binding potency compared 
to PBO, EN 1-126 or EN 1-125 (aromatic ring type A, Figure 3.7). This increase is possibly 
due to the delocalized electrons associated with the triple bond and the lone pair electrons 
spread across the oxygen which is bound directly to the aromatic ring. A combination of 
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delocalized electrons from the triple bond and those from the aromatic MDP moiety could 
form a conjugated system that interacts with aromatic rings from surrounding amino acid 
residues, providing further forces through aromatic stacking interactions. It is possible that 
these aromatic stacking interactions stimulate the insertion of the aromatic ring moiety into an 
aromatic pocket/binding area in the protein. This would explain the observation that analogues 
such as EN 1-164 and EN 1-183 exhibited high binding affinities. Similarly, delocalized 
electrons from the triple bond could occur in the alkynyl ether moiety of EN 1-179 (Figure 
3.7) in a combination with the lone pair electrons of the oxygen atoms in the polyether chain 
(as discussed above). However, the slightly lower binding affinity of EN 1-179 is likely to be 
due to the electrostatic effects in both side chains creating repulsion forces, thus contributing 
to a sub-optimal orientation of the molecule to the binding area.  
 
The presence of the branched methyl group in the alkynyl ether moiety of EN 1-182 (aromatic 
ring type A, Figure 3.7) is possibly correlated with the relatively high binding affinity to the 
protein. This structure may allow free rotation of the methyl group that could either provide a 
closer orientation of the molecule or the branched methyl group “wedged” between 
hydrophobic groups of the protein and improve the interaction with the binding area. 
Furthermore, the presence of the branched methyl group in the side chain gives additional 
hydrophobic properties to the molecule.  
 
Alteration of the MDP moiety by the removal of one oxygen atom in EN 16/5-1 and EN 16-06 
(aromatic ring type C) did not affect the binding affinities (Figure 3.8). Nevertheless, 
removing both oxygen atoms from the MDP moiety in EN 14-05 (aromatic ring type D), 
resulted in reduction of the binding potency compared to PBO (Figure 3.8). The requirement 
of an oxygen in the MDP ring to retain a high binding affinity could be explained by the 
electron donating effects and/or the provision of a bulky structure which could interact with 
the appropriate binding area. A lack of oxygen atoms in the MDP ring of EN 14-05 provides 
the molecule with a near-planar structure that is not easily retained within a binding pocket. 
EN 16-17 and EN 16-18 (aromatic type C, Figure 3.8)  both having an alkynyl side chain 
showed different binding affinities with the former revealing higher than the latter, probably 
due to the presence of the hydrophobic alkyl side chain (as discussed above).  
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Compounds where the MDP moiety was replaced by two bulky methoxy groups, similar to the 
verbutin structure (aromatic ring type E, verbutin analogues) first proposed by Pap et al., 
(2001), seem to affect the interaction with the protein (Figure 3.8). The two methoxy groups 
replacing the two oxygen atoms connected with the methylene carbon of the MDP moiety are 
relatively bulky and probably fit in a binding cavity like the MDP moiety. Although EN 25-10 
has an alkynyl ether moiety, the relatively low binding potency observed is possibly related to 
the absence of the hydrophobic propyl substituent and/or the position of the branched methyl 
group in the alkynyl ether chain. In contrast to the branched methyl group in EN 1-182, as 
discussed above (aromatic ring type A, Figure 3.7), where the methyl group is positioned 
between two -CH2- groups, the branched methyl group in EN 25-10 is between the oxygen of 
the alkynyl ether chain and the aromatic ring. This probably restricts its free rotation because 
of the free lone pair of electrons of the neighbouring oxygen atom (of the alkynyl ether 
moiety) and the delocalised electrons of the aromatic ring. EN 25-35 showed the highest 
binding potency compared to the rest of the verbutin analogues and it is likely to be correlated 
with the presence of the hydrophobic alkyl chain and the triple bond (as discussed above). The 
lower binding potency of EN 25-36 compared to EN 25-35 is probably due to the position of 
the triple bond, which in the former is located at the end of the chain (RC≡H+) and the active 
proton H+ (electric charge of +1) is acting as an attached functional group, giving acidic 
properties to the molecule. Subsequently, EN 25-36 could interact with surrounding amino 
acid residues before actually reaching the appropriate binding site or may settle in a different 
orientation.  
 
A final observation is that there is a positive correlation between the increased rate of the 
hydrolysis of 1-NA in the conventional assay (slopes) and the I values obtained from the 
interference assay (Figure 3.9). This suggests that the lower the binding affinity obtained from 
the interference assay the higher the increase of the catalytic centre activity. Furthermore, it is 
suggested that analogues such as EN 25-10, EN 1-40 and EN 1-129 lacking the propyl chain 
do not follow the above trend and are giving low binding affinities (high I values) with no 
increase of the catalytic centre activity. This again suggests that the alkyl side chain is 
important in the final orientation of the analogues. 
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3.5 Conclusions  
 
Results presented in this chapter suggest that the interactions between PBO/analogues and E4 
are based on a balance of non-covalent interactions. Several factors may contribute to the 
relative binding strength of inhibitors to the protein depending on the chemical and structural 
properties of both the ligands and the protein. Since the crystal structure of E4 is unknown, the 
binding properties with PBO/analogues can only be hypothesised. Considering that E4 has 
similarities with other carboxylesterases, AChE and BuChE (Xie et al., 2002; Imai, 2006), it is 
hypothesed that PBO and analogues are binding to a location near the active site gorge. 
Hypothetical aspects of the ligand-protein interaction have been discussed, involving 
conformation and flexibility of the inhibitors with amino acid residues of the binding site due 
to a combination of steric effects, hydrophobic bindings and aromatic stacking interactions.  
 
Using PBO analogues with specific organic groups such as alkyl and polyether chains, alkynyl 
moieties and functional groups such as -COOH and -COONa, some insights into esterase-PBO 
interactions have been suggested. Sizes and shapes of molecules, electrical charge distribution 
and geometry of bond angles of these organic groups seem to affect the properties of the 
interaction with the protein. Preliminary results revealed a significant contribution of the alkyl 
chain, suggesting that the presence of this hydrophobic substituent is orientating the ligand 
towards a hydrophobic area, possibly equivalent to the aromatic gorge of TcAChE (Sussman 
et al., 1991), by hydrophobic interactions and thus increasing the binding affinity. 
Furthermore, results suggest that increasing hydrophobicity by increasing the length of the 
alkyl side chain, leads to an increase in the binding affinity, as seen in EN 1-16. The length of 
the alkyl chain could also produce steric effects leading to a better orientation of the molecules 
in the binding area. The polyether chain is contributing to the binding affinity possibly by the 
lone pair of electrons of the oxygen atoms which are acting as electron-donating substituents. 
It may be that the polyether chain is also helping the molecule to a preferable orientation in the 
binding area. Additionally, replacement of the polyether chain with an alkynyl moiety 
suggests that the contribution of the delocalised electrons around a triple bond is also an 
important factor. Thus, either the charge derived from lone pairs of electrons on the oxygen 
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atoms of the polyether chain and/or delocalised electrons from the triple bond are likely to be 
contributing to the high binding affinity seen between the ligands and the protein.  
 
Overall, this study has identified possible parameters (such as the length of the alkyl chain and 
presence of the polyether chain) that are important for the binding potencies of PBO/ 
analogues to E4. Additionally, replacement of the polyether chain by an alkynyl chain in some 
cases increases the binding affinity of the analogues. Although conclusions at this stage can 
only be speculative, in the long term such study may contribute to the design of novel esterase 
inhibitors. Furthermore, since E4 can interact with several compounds, it is possible to search 
for a specific inhibitor for this protein. This would help in the characterisation of metabolic 
resistance which is not possible with the dual inhibitory ability of PBO on oxidases and 
esterases. Certainly, a crystal structure of E4 would contribute dramatically to the design of 
more potent and specific esterase inhibitors to overcome insecticide resistance problems 
arising from these metabolic enzymes. 
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Figure 3.10 Alignment of the Myzus persicae esterase (E4) and Torpedo californica AChE 
(TcAChE) showing the 14 conserved residues in TcAChE active site gorge (→) and the 7 
common conserved in E4 (    → ) [Using the Programme: AlignX (Vector NTI Advance 
10.1.1 2005 Invitrogen Corporation)] 
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Chapter 4  
Use of a piperonyl butoxide analogue, EN 16/5-1, to characterise metabolic 
resistance in two agricultural insect pests 
 
4.1 Introduction 
 
Metabolic resistance has often been inferred from correlations between resistance factors and 
enhanced enzyme activity when test insects are compared with their susceptible counterparts 
(Brown and Brogdon, 1987; Hemingway et al., 1996). The alternative has been to use a 
synergist and examine reductions in resistance factors due to inhibition of the enzymes 
conferring metabolic resistance (Raffa and Priester, 1985; Metcalf, 1989). 
 
Piperonyl butoxide, a MDP synergist was used for many years as a research tool to identify 
metabolic resistance resulting from elevated P450 activity (Sun and Johnson, 1960; Casida, 
1970). However, it was later reported that PBO not only inhibits microsomal oxidases, but 
also resistance-associated esterases in many insect pests (Gunning et al., 1998; Moores et al., 
1998; Young et al., 2005, 2006). The ability to inhibit both major metabolic enzyme systems 
makes PBO an ideal synergist for agricultural use, but negates its use as an indicator of 
resistance by P450 metabolism.  
 
Methylenedioxyphenyl compounds, such as PBO, exert their inhibitory effects on P450 
monooxygenases through the formation of a P450-MDP complex. This stable complex results 
from the interaction of the carbene with the haem iron of the cytochrome P450 (Dahl and 
Hodgson, 1979). Theoretically by altering the MDP ring, such a reaction could no longer take 
place due to the failure of carbene formation. An analogue of PBO, EN 16/5-1 (Figure 4.1), 
containing a modification in the MDP moiety, was synthesised. This analogue should no 
longer have the ability to form the P450-MDP inhibitory complex but retains its ability to 
inhibit esterases (as shown in the SAR study, Chapter 3). However, the analogue and PBO 
itself may well be able to inhibit oxidases other than the P450s. 
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The aims of the work reported in this chapter are to characterise the metabolic resistance 
mechanism(s) in a Greek M. persicae clone (clone 5191A) that exhibited resistance to 
imidacloprid and also to investigate the metabolic factor(s) conferring differential insensitivity 
to α–cypermethrin in four M. aeneus populations. The two insect species were examined in a 
series of in vitro and in vivo assays using PBO and the analogue (EN 16/5-1) and compared 
with insects possessing well-characterised resistance mechanisms. 
 
The in vitro assays described include the indirect determination of esterase binding using the 
esterase interference assay (Khot et al., 2008) and the ECOD assay (Ullrich and Weber, 1972). 
The esterase interference assay was used to study the interactions of semi-purified esterases 
derived from M. persicae clone 5191A and M. aeneus with two synergists, (PBO and EN 
16/5-1) and two insecticides (α-cypermethrin and imidacloprid). The ECOD assay was 
performed to measure the ability of the two synergists to inhibit O-deethylation activity in M. 
aeneus homogenates derived from the four populations with different resistance levels to α-
cypermethrin. 
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4.2 Materials and Methods  
 
4.2.1 Insects 
Five different M. persicae clones were used 4106A, TIV, 794JZ, 926B and 5191A (section 
2.1.2 and Appendix 1) and four M. aeneus populations UK, Stein, Rogalin and Lebork 
(section 2.1.3). The susceptible M. domestica strain, WHO, (section 2.1.4) was used as the 
AChE source for the esterase interference assay.  
 
4.2.2 Insecticides and synergists 
Two technical insecticides were used, imidacloprid and α-cypermethrin and two synergists, 
technical PBO (‘Ultra’, 94%) and its analogue, EN 16/5-1 (98%) (Figure 4.1).  
 
 
 
 
 
 
 
 
Figure 4.1 Structures of PBO and its analogue EN 16/5-1. 
 
4.2.3 Polyacrylamide gel electrophoresis  
Individual apterous M. persicae from each clone T1V, 926B, 5191A and 794JZ were 
homogenised in 25 µL of 0.02 M phosphate buffer, pH 7.0 and analysed by electrophoresis as 
described in section 2.3.1. 
 
4.2.4 Determination of Myzus persicae total esterase activity 
Esterase activity of aphids from clone 5191A was measured alongside four well-established 
aphid clones, 4106A, TIV, 794JZ and 926B using a colourimetric assay as described in section 
2.3.2.1.  
 
O
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4.2.5 Semi-purification of Myzus persicae and Meligethes aeneus esterases 
Aphids from clone 5191A (5 g) and pollen beetles from Lebork (1.5 g) (stored at -20ºC) were 
homogenised in 10 mL and 15 mL 0.02 M phosphate buffer, pH 7.0, respectively. The 
homogenates were used for the semi-purification of relevant esterases, as described in section 
2.3.4.2. 
 
4.2.6 Indirect determination of esterase binding  
Semi-purified esterase from M. persicae clone 5191A, (FE4), was pre-incubated with stock 
solutions of PBO, EN 16/5-1, α-cypermethrin and imidacloprid to give final concentrations of 
1 mM of synergists and insecticides (section 2.3.5.2). Aliquots (15 µL) of FE4, FE4+PBO, 
FE4+EN 16/5-1, FE4+α-cypermethrin and FE4+imidacloprid were used in the esterase 
interference assay as described in section 2.3.5.3. 
 
Semi-purified esterase(s) from M. aeneus (Epb) was pre-incubated with PBO, EN 16/5-1 and 
α-cypermethrin to give final concentrations of 1 mM of synergists and insecticide (section 
2.3.5.2). Aliquots (15 µL) of Epb, Epb+PBO, Epb+EN 16/5-1 and Epb+α-cypermethrin were 
used in the esterase interference assay as described in section 2.3.5.3. For this study, 
esterase(s) from the Lebork population was used as this population displayed the highest level 
of resistance to pyrethroid.  
 
4.2.7 Determination of O-deethylation activity 
4.2.7.1 Enzyme preparation  
Microsomal preparations from fresh rabbit liver and M. persicae aphid clone 5191A and M. 
aeneus homogenates were prepared as described in section 2.3.6.1. 
 
4.2.7.2 Determination of O-deethylation activity using microsomal enzymes from rabbit 
liver and Myzus persicae 
Aliquots (25 µL) of either liver or aphid microsomes were added to separate wells of a 
microplate followed by 25 µL 0.1 M sodium phosphate buffer, pH 7.6. Then, a mixture of 
liver and aphid microsomes (1:1, total volume 50 µL) was added to separate wells of the same 
plate and the assay performed as described in section 2.3.6.2. 
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4.2.7.3 Determination of O-deethylation inhibition in Meligethes aeneus homogenates by 
PBO and EN 16/5-1  
The anti-oxidase potency of PBO and EN 16/5-1 (10 mM stock solution) against pollen beetle 
homogenates was compared by measuring ECOD activity as described in section 2.3.6.3.   
 
4.2.8 Insect bioassays 
4.2.8.1 Full dose response and discriminating dose response bioassays (Myzus persicae) 
Apterous adults were individually dosed with either PBO or EN 16/5-1 in acetone. After 5 h 
the aphids were further treated with either imidacloprid or α-cypermethrin in acetone as 
described in section 2.4.1. 
 
To investigate response (mortality) to PBO alone, apterous aphids were topically treated with 
0.25 µL aliquots of PBO from stock solutions of 0.3 – 100 g L-1 in acetone. Controls were 
treated with acetone only.  
 
Discriminating dose response bioassays were carried out using the two synergists (PBO or EN 
16/5-1) and a single diagnostic concentration of either 1 ppm for imidacloprid against clone 
5191A or 100 ppm for α-cypermethrin against clone 794JZ as described in 2.4.2. Treated 
aphids were stored and scored as described in section 2.4.1. 
 
4.2.8.2 Full dose response and discriminating dose response bioassays (Meligethes 
aeneus) 
Full dose response bioassays were performed as described in section 2.4.3. Discriminating 
dose response bioassays using the two synergists (PBO or EN 16/5-1) and a single diagnostic 
concentration of 0.01 ppm for UK, 0.3 ppm for Stein and 1 ppm for Rogalin and Lebork α-
cypermethrin were carried out as described in section 2.4.4.  
 
4.2.9 Analysis of data 
4.2.9.1 Indirect determination of esterase binding by PBO and EN 16/5-1 
Concentrations of azamethiphos sufficient to inhibit 50% of AChE activity, (IC50 values, 
section 2.5.1) were tested for significance using one-way ANOVA analysis (GenStat 12th 
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Edition, VSN International). Following the ANOVA analysis, significance of the difference 
between selected pairs of means for treatments (IC50 mean of two or three replicates within 
each treatment) was assessed using the Least Significant Difference (LSD) at the 5% level.  
 
4.2.9.2 Determination of O-deethylation inhibition in Meligethes aeneus homogenates by 
PBO and EN 16/5-1  
The mean absorbance of three replicates at each time point was calculated and linear 
regressions plotted using Grafit 3.0 (Leatherbarrow, R.J., Erithacus Software). Then the 
efficacy of the inhibitors (PBO and EN 16/5-1) was estimated (section 2.5.2.). Standard errors 
for the ratios were estimated using the formula for the variance of a ratio (see Appendix 7). 
 
4.2.9.3 Insect bioassay data  
Full dose response and discriminating dose bioassay data were analysed as described in 
sections 2.5.3 and 2.5.4, respectively. 
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4.3. Results  
 
4.3.1 Polyacrylamide gel electrophoresis and total esterase activity 
The enhanced resistance-associated esterase present in clone 5191A was of the FE4 variant, 
commonly found in M. persicae samples from Mediterranean countries (Figure 4.2.) (Field 
and Devonshire, 1998). Both the mobility and intensity of staining of the esterase bands of 
clone 5191A were identical to those found in clone 926B. Additionally, clone 5191A had total 
esterase activity corresponding to category R3 (extremely high) similar to clones 926B and 
794JZ (Table 4.1). Aphid clones 794JZ (E4, R3) and T1V (E4, R2) were included to provide a 
reference for esterase mobility and intensities. 
 
Figure 4.2 Polyacrylamide gel electrophoresis showing presence of E4 in Myzus persicae 
clones T1V and 794JZ and FE4 in 926B and 5191A. 
 
Table 4.1 Myzus persicae esterase levels: absorbance values in mOD450min-1. 
Myzus persicae clone Esterase level* Mean ± SE 
926B R3 133 ± 7.13 
794JZ R3 113 ± 0.53 
T1V R2 34.1 ± 4.21 
4106A S 6.40 ± 3.35 
5191A R3 96.0 ± 2.41 
                           *S (susceptible), R2 (high), R3 (extremely high), n=19    
FE4 
E4 
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4.3.2 Indirect determination of esterase binding  
Since the interference assay depends on the action of unsequestered azamethiphos against 
housefly AChE, prior to the assays being performed the two insecticides (imidacloprid and α-
cypermethrin) were tested for direct inhibition of housefly AChE using the standard Ellman 
assay (Ellman et al., 1961). No inhibition was observed (data not shown). 
 
4.3.2.1 Indirect determination of esterase binding (Myzus persicae) 
The reduced protection of AChE against azamethiphos provided by FE4 following pre-
incubation with synergists or insecticides, is presented in Figure 4.3. Corresponding IC50 
values are presented in Table 4.2. 
 
Results of ANOVA analysis reveal significant differences among the treatments (p<0.001). 
The synergists, PBO and EN 16/5-1, were not significantly different in their action (p>0.05) 
and both bound greater amounts of FE4 than the insecticides (p<0.05). There was a significant 
difference in the esterase blockaded by the two insecticides, with α-cypermethrin binding 
more esterase than imidacloprid (p<0.05). 
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Figure 4.3 Indirect determination of Myzus persicae clone 5191A esterase (FE4) binding by 
synergists (PBO and EN 16/5-1) and insecticides (α-cypermethrin and imidacloprid). Data are 
means of triplicates ± SE, LSD (95%)=0.2301, df=20. 
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Table 4.2 Concentrations of azamethiphos required to give 50% inhibition of AChE activity 
(IC50) after pre-incubation of synergists (PBO and EN 16/5-1) and insecticides (α-
cypermethrin and imidacliprid) with FE4 from Myzus persicae clone 5191A (refer to Figure 
4.3). 
Sample IC50 (nM) SE ± 
AChE only (no FE4) 0.165 0.006 
FE4 only (FE4) 3.88 0.516 
FE4 + PBO 0.215 0.016 
FE4 + EN 16/5-1 0.197 0.007 
FE4 + α-cypermethrin 0.437 0.034 
FE4 + imidacloprid 0.908 0.087 
 
4.3.2.2 Indirect determination of esterase binding (Meligethes aeneus) 
Using the semi-purified esterases, Epb, from the Lebork population, results showed that PBO, 
EN 16/5-1 and α-cypermethrin were not significantly different in their action and bound 
similar amounts of semi-purified esterase (p>0.05) (Figure 4.4 and Table 4.3).  
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Figure 4.4 Indirect determination of Meligethes aeneus (Lebork population) semi-purified 
esterase (Epb) binding by synergists (PBO and EN 16/5-1) and insecticide (α-cypermethrin). 
Data are means of duplicates ± SE, LSD (95%)=0.04482, df=5. 
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Table 4.3 Concentrations of azamethiphos required to give 50% inhibition of AChE activity 
(IC50) after pre-incubation of synergists (PBO and EN 16/5-1) and insecticide (α-
cypermethrin) with semi-purified esterases Epb from Meligethes aeneus (Lebork population) 
(refer to Figure 4.4). 
 
 
 
 
 
 
 
 
4.3.3 Determination of O-deethylation activity using microsomal enzymes from rabbit 
liver and Myzus persicae 
Microsomal preparations from the aphid clone 5191A failed to exhibit any O-deethylation 
activity (Figure 4.5). Furthermore, when mixed with liver microsomes, which gave the 
expected high oxidase activity (Adams et al., 1993), the aphid microsomes inhibited the O-
deethylation activity of the liver.  
 
Figure 4.5 O-deethylation activity of the microsomal preparations from rabbit liver, Myzus 
persicae (clone 5191A) and liver + M. persicae (clone 5191A) mixture. Data are means of 
triplicates ± SE.  
Sample IC50 (nM) SE ± 
AChE only (no Epb) 0.10 0.0024 
Epb only (Epb) 0.42 0.0095 
Epb + PBO 0.31 0.006 
Epb + EN 16/5-1 0.26 0.0035 
Epb + α-cypermethrin 0.33 0.0147 
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4.3.4 Determination of O-deethylation inhibition in Meligethes aeneus homogenates by 
PBO and EN 16/5-1 
Pollen beetle homogenate was used in a fluorometric assay to measure the ability of PBO and 
EN 16/5-1 to inhibit the oxidation of 7-EC. The rate of 7-OH production reflects the activity 
of the oxidases (Table 4.4). Piperonyl butoxide was found to be a more potent inhibitor than 
EN 16/5-1 in all cases. The activity remaining (%) after inhibition by PBO varied according to 
the population. Thus, Lebork had the lowest oxidase activity remaining after inhibition by 
PBO (~19%) whilst the Rogalin population had the highest oxidase activity remaining 
(~35%). The percentage activity remaining after inhibition by the analogue was, in all cases, at 
least twice that after inhibition by PBO.  
Table 4.4 O-deethylation by Meligethes aeneus homogenates in the presence/absence of the 
two synergists, PBO and EN 16/5-1. 
Population 
Enzyme activity  
(FUs min-1) ± SE  
(%) Activity 
remaining  
PBO ± SE 
(%) Activity  
remaining 
EN 16/5-1 ± SE 
UK 250 ± 8.21 29.8 ± 3.61 99.7 ± 4.12 
Rogalin 147 ± 5.55 35.3 ±7.59 74.7 ± 6.99 
Lebork 138 ± 6.17 19.1 ± 4.76 73.4 ± 5.65 
Stein 90.0 ± 11.9 22.9 ± 11.1 61.5 ± 8.16 
         n=3 
4.3.5 Full dose response bioassays with Myzus persicae clones  
The results of the full dose response bioassays of M. persicae clone 5191A, together with 
other clones in which the resistance status has been characterised previously, are presented in 
Table 4.5 and Table 4.6 (see also Appendix 4). Considering the imidacloprid bioassay data 
(Table 4.5), the Greek clone 5191A had a considerably higher resistance factor (RF 56.5) than 
clone 926B (RF 4). The mechanism increasing the resistance of clone 5191A to imidacloprid 
did not confer cross-resistance to α-cypermethrin (Table 4.6) thus clones 5191A and 926B 
both had a similar response to the pyrethroid (RF 13 and RF 16.3, respectively). When PBO 
was used as a pre-treatment on clone 5191A, the LC50 was reduced substantially, indicating 
that the resistance is, at least partially, due to a metabolic mechanism. When EN 16/5-1 was 
used as the pre-treatment on clone 5191A, the LC50 was again reduced, although to a lesser 
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extent than with PBO (Table 4.5). Both clones 926B and 794JZ with esterase-based metabolic 
mechanisms (R3), were synergised by PBO and EN 16/5-1 resulting in similar SFs with both 
synergists (Table 4.6). As expected, 794JZ showed very high resistance against α-
cypermethrin due to the presence of target-site resistance, kdr (Martinez-Torres et al., 1999). 
However, the SF for this clone was found to be similar to 926B, illustrating that the metabolic 
resistance is comparable in both clones (Table 4.6). 
Table 4.5 Full dose response bioassays with Myzus persicae clones against imidacloprid using 
a 5h pre-treatment. 
Treatment Aphid Clone aLC50 (ppm) bCL 95% cRF dSF 
imidacloprid 4106A 1.55 1.18-1.99 1 -- 
 926B 6.53 5.32-8.03 4.21 -- 
 5191A 90.4 51.0-185 56.5 -- 
+ 1g L-1 PBO 5191A 6.22 4.04-8.70 -- 14.5 
+ 1g L-1 EN 16/5-1 5191A 12.2 8.80-16.4 -- 7.41 
aLC50=Lethal concentration to kill 50% of the clone, bCL= Confidence limits,  
c RF = resistance factor (LC50 resistant clone /LC50 susceptible clone),  
dSF = synergism factor (LC50 unsynergised clone /LC50 synergised clone) 
 
Table 4.6 Full dose response bioassays with Myzus persicae clones against α-cypermethrin 
using a 5h pre-treatment.* 
Treatment Aphid Clone aLC50 (ppm) bCL 95% cRF dSF 
α-cypermethrin 4106A 0.43 0.29-0.56 1 -- 
 5191A 5.60 5.94-6.33 13.0 -- 
 926B 7.08 5.63-8.70 16.3 -- 
 794JZ 1303 1060-1632 3030 -- 
+ 1g L-1 PBO 926B 2.10 1.24-2.88 -- 3.37 
+ 1g L-1 EN 16/5-1 926B 1.48 0.79-2.23 -- 4.78 
+ 1g L-1 PBO 794JZ 271 220-327 -- 4.80 
+ 1g L-1 EN 16/5-1 794JZ 264 215-321 -- 4.94 
* 
a, b, c, d,
 as per Table 4.5  
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4.3.6 Discriminating dose bioassays with Myzus persicae clones  
The effects of a 5 h pre-treatment with either PBO or EN 16/5-1 on clones 794JZ and 5191A, 
prior to exposure to a discriminating dose of insecticide, are presented in Figure 4.6 and 
Figure 4.7, respectively. Bioassays with clone 794JZ against α-cypermethrin revealed that 
PBO and EN 16/5-1 were not significantly different in their synergistic action (p>0.05) 
(Moores et al., 2009). The equal synergism was expected since it is known that the sole 
metabolic insecticide resistance mechanism in clone 794JZ is the enhanced esterase activity 
(Martine-Torres et al., 1999).  
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Figure 4.6 Synergistic effects of PBO and EN 16/5-1 (1 g L-1) on mortality against Myzus 
persicae clone 794JZ using a discriminating dose of α-cypermethrin (100 ppm) and a 5h pre-
treatment. Data are means ± SE, n=3 for acetone, EN 16/5-1 and PBO, n=15 to 17 for 
acetone/α-cypermethrin, EN 16/5-1/α-cypermethrin and PBO/α-cypermethrin, N=56, LSD 
(5%)=0.1188, df=44. 
 
Results from bioassays with clone 5191A against imidacloprid reveal that PBO and EN 16/5-1 
were significantly different in their synergistic action with PBO giving higher synergism 
(p<0.001). EN 16/5-1 gave a significant increase in mortality in comparison with insecticide 
alone (p<0.05). Results from the discriminating dose bioassays were therefore in accordance 
with the results obtained from full dose response bioassays (section 4.3.5). 
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Figure 4.7 Synergistic effects of PBO and EN 16/5-1 (1 g L-1) on mortality against Myzus 
persicae clone 5191A using a discriminating dose of imidacloprid (1 ppm) and a 5h pre-
treatment. Data are means ± SE, n=9 to 12 for acetone, EN 16/5-1 and PBO, n=24 to 30 for 
acetone/imidacloprid, EN 16/5-1/imidacloprid and PBO/imidacloprid, N=116, LSD 
(5%)=0.08065, df=98. 
 
4.3.7 Full dose response bioassays with Myzus persicae clones against PBO  
To investigate the response (mortality) to PBO only, high concentrations of the synergist were 
required. Three standard M. persicae clones were tested alongside clone 5191A. The LC50 
values obtained for clones 4106A, 794JZ and 926B were similar, however clone 5191A 
required approximately twice the dose of PBO to achieve equivalent mortality (Table 4.7, see 
also Appendix 4). 
 
    Table 4.7 Full dose response bioassays with Myzus persicae clones against PBO. 
Aphid Clone Esterase level aLC50 (ppm) bCL 95% 
4106A    S 14892 12527-18041 
794JZ R3 12196 8485-18788 
926B R2 10540 6865-17325 
5191A R3 25738 21570-30947 
             aLC50=Lethal concentration of PBO to kill 50% of the clone, bCL=Confidence limits.  
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4.3.8 Full dose response bioassays with Meligethes aeneus populations 
The response of the four pollen beetle populations to α-cypermethrin are presented in Table 
4.8 (see also Appendix 4). The LC50 value obtained from the UK population was considered to 
be representative of a susceptible population since it was found to be the most sensitive in 
comparison with the other populations. Rogalin and Lebork populations gave the highest RFs 
(~23 and ~34, respectively). The resistance level for Stein was lower with a RF of ~3.6.  
 
Table 4.8 Full dose response bioassays with Meligethes aeneus populations against 
α-cypermethrin. 
Population aLC50 (ηg/cm2) bCL 95% cRF 
UK 2.81 0.19-4.52 1 
Stein 10.0 6.01-17.0 3.57 
Rogalin 65.0 40.0-100 23.2 
Lebork 95.0 66.0-140 33.9 
              aLC50=Lethal concentration to kill 50% of the population, bCL= Confidence limits,   
                cRF =resistance factor (LC50 resistant population /LC50 susceptible population)  
 
4.3.9 Discriminating dose bioassays with Meligethes aeneus populations  
Different discriminating doses of α-cypermethrin were applied to each population, based on 
the results of the full-dose bioassay (section 4.3.8) and the effects of the synergists are 
presented in Figure 4.8. Results showed that PBO and EN 16/5-1 conferred different levels of 
synergism. In particular, PBO gave significantly higher synergism to α-cypermethrin in all 
populations (p<0.05), increasing the mortality to around 90%. Even in the susceptible UK 
population, PBO conferred high synergism to α-cypermethrin. In contrast, EN 16/5-1 did not 
significantly increase the mortality compared to the insecticide alone (p>0.05). No mortality 
was observed in treatments with acetone, PBO and EN 16/5-1 alone (data not shown). 
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Figure 4.8 Synergistic effects of PBO and EN 16/5-1 (0.01 g L-1) mixed with a discriminating 
dose of α-cypermethrin against Meligethes aeneus populations. Data are means ± SE. For UK 
n=5, N=15, LSD (95%)=0.1589 df=11; for Stein n=6, N=18, LSD (95%)=0.1827, df=15; for 
Rogalin* and Lebork* n=5, N=70,  LSD (95%)=0.1507, df=56 [*taken from the 7 treatment 
analysis (see Chapter 5, Figure 5.3)].  
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4.4 Discussion 
 
Piperonyl butoxide, a well known MDP insecticide synergist, has been used for many years to 
enhance insecticide efficacy in the presence of resistance due to oxidative mechanisms (Sun 
and Johnson, 1960; Casida, 1970; Bernard and Philogène, 1999). However, subsequent studies 
have reported that PBO can also inhibit resistance-associated esterases in many agricultural 
pests (Gunning et al., 1998; Moores et al., 1998; Young et al., 2005, 2006). This dual ability 
enables PBO to be an excellent synergist in the field, but negates its ability to be used as a 
research tool to identify which category of metabolic enzyme is conferring resistance. 
 
In this study, an analogue of PBO, EN 16/5-1, that maintains the ability to inhibit esterases 
(Chapter 3) but loses potency against P450s (due to a modification of the MDP ring) has been 
utilised. Using examples of insects where resistance mechanisms have been well-
characterised, in combination with resistant insects where their resistance-associated enzymes 
were under investigation, this analogue facilitated the characterisation of metabolic resistance 
(Moores et al., 2009). A series of in vivo and in vitro assays were applied to investigate 
possible contributions of metabolic enzymes conferring resistance. In vivo assays included full 
and discriminating dose bioassays incorporating the two synergists (PBO and the analogue) 
and in vitro assays included the esterase interference assay and ECOD assay. It is important to 
consider, at this stage which oxidative enzymes can contribute to the ECOD conversion. It is 
reported that some P450 enzymes will deethylate 7-EC (Hogdson, 1983) but other oxidative 
systems will also be capable of this interaction (Benedetii et al., 2006). The modification of 
the MDP ring will nullify the formation of the carbene complex and so P450 enzymes will be 
expected to remain active in the presence of the analogue, although inhibition of non-P450 
oxidases remains unclear. 
 
While earlier reports had indicated low levels of imidacloprid resistance in M. persicae, 
similar to that observed in clone 926B (Foster et al., 2008), clone 5191A possessed an 
additional degree of resistance, similar to that found previously in Greece, on tobacco 
(Margaritopoulos et al., 2007). This enhanced resistance of clone 5191A could be due to target 
site and/or metabolic resistance.   
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Synergism by PBO, as revealed in the full dose response (Table 4.5) and discriminating dose 
bioassays (Figure 4.7), suggested that the additional levels of imidacloprid resistance exhibited 
by M. persicae clone 5191A are due, at least partly, to metabolic enzyme activity. Since PBO 
is able to inhibit both esterases and oxidases, differential synergist bioassays were performed 
with PBO and EN 16/5-1 to identify the enzyme that contributed the major effect. In vitro 
studies were adapted using PBO and its analogue, EN16/5-1, to confirm the specificity of 
synergist action. 
 
Total esterase assay and PAGE showed that clone 5191A possessed a R3 esterase level and 
esterase pattern identical to 926B (FE4), a clone whose resistance profile had already been 
characterised (Moores et al., 1994). Subsequently, esterase(s) from clone 5191A were purified 
and used for the esterase interference assay. Results showed that FE4 bound equally to PBO 
and EN 16/5-1 (Figure 4.3). This equivalent interaction of PBO and its analogue with FE4 is 
in agreement with the α-cypermethrin bioassay results. These results showed very similar 
synergism factors (SF ~4) using either PBO or EN 16/5-1, against α-cypermethrin in both 
clones 926B (FE4) and 794JZ (E4) with full dose response bioassays (Table 4.6) and 
discriminating dose bioassays (Figure 4.6). Enhanced esterase activity has already been 
reported to be the metabolic mechanism conferring resistance to a broad spectrum of 
insecticides (Devonshire and Moores, 1982). The esterase interference assay also 
demonstrated that FE4 was capable of sequestering imidacloprid, though to a lesser extent 
than α-cypermethrin (Figure 4.3). The ability of FE4 to sequester imidacloprid could confer 
the 4-fold resistance of clone 926B against imidacloprid (Table 4.5). 
 
Measurement of O-deethylation of 7-EC by M. persicae has been recently reported (Kwon et 
al., 2009) however, there was no appreciable activity found in the clone 5191A microsomal 
preparation in the present study (Figure 4.5). This failure to measure the oxidase activity could 
be due to high levels of oxidase inhibitors present in M. persicae homogenates (Devonshire, 
1973; Devonshire and Moores, 1983). It was therefore impossible to assess the relative O-
deethylation inhibitory potencies of PBO and EN 16/5-1. However, it was found that EN 16/5-
1 had the expected decreased ability to inhibit oxidases using the ECOD assay with 
imidacloprid resistant whitefly B. tabaci (B-biotype) and this was in agreement with the 
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differential synergism found between PBO and EN 16/5-1, with the former revealing greater 
synergism (Moores et al., 2009). Synergism bioassays with clone 5191A against imidacloprid 
using full dose response (Table 4.5) and discriminating dose bioassays (Figure 4.7) revealed 
that PBO gave significantly higher synergism than EN 16/5-1. Following correction for 
control mortality there was a 5-fold increase in mortality with EN 16/5-1 and a 14-fold 
increase with PBO using the discriminating dose bioassay, showing good agreement with the 
full dose bioassays. Thus, both synergism bioassays and the esterase interference assay 
suggest the involvement of P450s as a major resistance mechanism in clone 5191A, similar to 
results obtained with imidacloprid resistant B. tabaci (Moores et al., 2009). The involvement 
of P450 in the imidacloprid resistant B. tabaci was also confirmed by recent studies (Karunker 
et al., 2008, 2009). However in the case of clone 5191A this cannot be absolutely confirmed 
since the in vitro oxidase assay was unable to validate the effect of PBO and EN 16/5-1. 
However, it is most likely that PBO inhibits M. persicae P450s whilst EN 16/5-1 does not. 
The difference in the two structures is unlikely to induce significant changes in other 
pharmaco-kinetic parameters, such as penetration. The resistance levels to α-cypermethrin in 
both clones 5191A and 926B (Table 4.6) further support enhanced esterases were not 
responsible for the additional difference in the imidacloprid response. 
 
An additional observation is the response of clone 5191A to PBO alone. It was found to have 
an ‘insensitivity’ of ~2-fold when compared to other M. persicae clones. This ‘resistance’ to 
PBO is not correlated to esterase content; hence the R3 clones 794JZ and 926B have the same 
response as the susceptible clone 4106A (Table 4.7). Previous reports of PBO resistance have 
suggested high levels of P450 activity in P. xylostella, although full characterisation of the 
mechanism was never carried out (Chen and Sun, 1986; Hung and Sun 1989). These same 
reports also noted a reduction in the ability of PBO to synergise, which could explain why 
complete susceptibility was not restored when clone 5191A was pre-treated with PBO. 
However, it is common in bioassay studies not to restore full susceptibility after application of 
a synergist, since the synergistic effect is correlated with the applied ratio of insecticide and 
synergist (Brindley and Selom, 1984; Bingham et al., 2007). An alternative explanation could 
be the possible involvement of another metabolic enzyme and/or target site resistance 
conferring low resistance levels. 
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Considering the M. aeneus results, in vivo synergistic bioassays demonstrated that PBO gave 
high synergism to α–cypermethrin in all tested populations (even in the most sensitive to the 
pyrethroid, UK population) (Figure 4.8). This would suggest that the different response to α–
cypermethrin in pollen beetles is, at least partially, due to metabolic mechanisms. In contrast, 
no significant increase in mortality was obtained when EN 16/5-1 was incorporated in a 
mixture with α-cypermethrin. Loss of synergistic activity following modification of the MDP 
ring has also been reported by Wilkinson et al., (1966) and more recently by Pap et al., 
(2001). 
 
To further preclude that M. aeneus esterases were not contributing to pyrethroid resistance, the 
interference assay was adapted using semi-purified esterase from the Lebork population, since 
this population was found to exhibit the highest resistance level to α-cypermethrin (Table 4.8). 
The protection afforded to the AChE against azamethiphos by M. aeneus esterase was found 
to be less than that afforded by FE4 derived from M. persicae per equivalent activity i.e. the 
catalytic centre activity of pollen beetle esterase is presumably higher, resulting in less moles 
of esterase present. Although the protection provided was lower, incubations with PBO and 
EN 16/5-1 showed an equal reduction of esterase protection.  
 
The ability of PBO and EN 16/5-1 to inhibit ECOD activity from M. aeneus was compared. 
As expected, modification of the MDP ring in EN 16/5-1 resulted in reduced inhibition of 
oxidase activity compared to PBO. The highest inhibition of ECOD activity by EN 16/5-1 was 
observed in the Stein population, followed to a lesser extent by Rogalin and Lebork (Table 
4.4). The O-deethylation inhibition by EN 16/5-1 must be presumed to be on non-P450 
enzymes present in the insect homogenates. Since EN 16/5-1 did not synergise insecticides in 
vivo (Figure 4.8), these enzymes are presumably not contributing to α-cypermethrin resistance. 
 
What might be considered surprising in this study is the observation that the susceptible UK 
M. aeneus population showed the highest ECOD activity. This finding is in contrast to most 
cases where enhanced enzyme activities using model substrates are correlated with resistance 
factors. However, it must be emphasised that oxidases are a large family of enzymes which 
can metabolise, to a different extent, an array of substrates (Wilkinson, 1983) and 
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consequently it is possible oxidases other than P450s are able to O-deethylate 7-EC (Beneditti 
et al., 2006). This example reinforces the necessity to fully characterise the contribution of 
enzyme systems conferring resistance, rather than simply looking for an increase in activity 
using a model substrate. Scott, (1999) stated that “it is possible that a similar phenomenon to 
the ‘mutant ali –esterase theory’ (Oppenoorth, 1985) could arise in the case of MFOs”. This 
statement is supported further since it has been shown that a single change in P450 amino acid 
sequence by site-directed mutagenesis can alter the substrate specificity of a P450 (Lindberg 
and Negishi, 1989). Qualitatively different P450s have also been reported in some housefly 
strains exhibiting diazinon and dimethoate resistance and this did not correlate to enhanced 
oxidase activity (Hogdson, 1983). 
 
Since the purpose of the present study was not to identify, or characterise, individual 
cytochrome P450s or specific oxidases involved in α-cypermethrin resistance, 7-EC was used 
as a model substrate, using whole insect homogenates. Results were interpreted following the 
hypothesis that an oxidative pyrethroid detoxification would be the result of a de -alkylation 
reaction similar to the O-deethylation of 7-EC by P450 (Roberts and Hutson, 1999; Hodgson, 
1983) and this hypothesis was supported by the correlation of the in vitro and the in vivo 
results. Pollen beetle homogenates were used in the ECOD assay, rather than microsomal 
preparations, to include the possible contribution of all oxidases that contributed to α-
cypermethrin resistance, not only membrane-bound examples such as microsomal P450s 
(Benedetii et al., 2006). 
 
4.5 Conclusions 
The results reported here demonstrate that PBO and its close analogue EN 16/5-1 may be used 
in parallel to characterise metabolic insecticide resistance. If both synergists show equal 
effect, it is likely that either esterases are the major metabolic resistance mechanism, or 
oxidases other than P450s are responsible. For this reason, the esterase interference assay 
should also be carried out to aid diagnosis. This is supported by the results with M. persicae 
clones in which esterase (E4/FE4) is known to confer resistance to a broad spectrum of 
insecticides and supports the findings of Moores et al., (2009). If PBO shows greater 
synergism than EN 16/5-1, it suggests that the difference between the two SFs is due to the 
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contribution of P450s. This premise is strengthened by the in vivo and in vitro assays 
presented here with clone 5191A against imidacloprid, where in vivo studies showed that PBO 
synergised to a greater extent than EN 16/5-1 whilst results of in vitro studies (esterase 
interference assay) showed both synergists bound equally with esterases. The latter results 
showed an esterase contribution in the imidacloprid resistant clone, 5191A. This esterase 
contribution is demonstrated when imidacloprid bound slightly to FE4 and conferred a RF of 
around 4 in clone 926B. In the case of M. aeneus investigations, synergism was achieved with 
PBO but not with EN 16/5-1 whilst in vitro both synergists bound equally with esterases 
(esterase interference assay), but the inhibitory potency of PBO upon oxidase was greater than 
the analogue (ECOD assay). This is in line with previous reports that imidacloprid resistance 
in B. tabaci is also synergised more strongly by PBO than the analogue, implying the 
contribution of P450s as the main metabolic enzyme conferring resistance (Moores et al., 
2009). Whitefly imidacloprid resistance due to an oxidative mechanism has also been 
supported by other reports based on correlations between enhanced ECOD activity and 
resistance factors (Rauch and Nauen, 2003; Roditakis, et al., 2009; Wang et al., 2009). 
However, recently it has been reported that overexpression of cytochrome P450 CYP6CM1 in 
B-biotype B. tabaci was associated with high level of imidacloprid resistance (Karunker et al., 
2008, 2009). Clearly, the analogous CYP6 in imidacloprod-resistant M. persicae would be 
worthy of further investigation. 
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Chapter 5  
In vivo and in vitro studies of piperonyl butoxide and analogues against four 
pollen beetle Meligethes aeneus Fabricius (Coleoptera: Nitidulidae) 
populations  
 
5.1 Introduction 
 
Insecticide synergists have been used for many years and have contributed significantly to 
improve the efficacy of insecticides, particularly when problems of resistance have arisen 
(Berhard and Philogènes, 1993). Although several chemicals have been produced, in earlier 
studies, for the specific purpose of enhancing the insecticidal properties of various toxicants 
(Beroza and Barthel, 1957; Moorefield, 1958; Metcalf and Fukuto, 1965), MDP compounds 
have been the most extensively studied due to their inhibitory effects against enzymes capable 
of oxidising insecticides (Casida, 1970). Piperonyl butoxide and a few closely related MDP 
compounds such as sesamex, sesame oil, isosafrole and safrole have demonstrated potent 
synergistic effects. However, only PBO is in commercial use and is the leading insecticide 
synergist (Jones, 1998; Keserú et al., 1999). Sesamex has a structure similar to PBO (Chapter 
1, Figure 1.3) and although it was one of the first potent synergists reported (Eldefrawi et al., 
1960; Farnham, 1971, 1973, 1974), it failed to achieve commercial use because in the 
presence of sunlight and moisture it decomposes to yield objectionably coloured products 
(Casida, 1970). 
 
In this chapter different PBO analogues have been examined for their ability to synergise the 
effects of α-cypermethrin against four M. aeneus populations that exhibited different 
sensitivity to this insecticide. The analogue structures studied in this chapter have 
modifications in the MDP moiety and/or the side chains and include phenyl methyl and phenyl 
ethers.  
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Of particular interest were four MDP analogues; two phenyl methyl but-2-ynyl ethers, EN 1-
126 and EN 1-125 and two phenyl but-2-ynyl ethers, EN 1-164 and EN 1-163 that were tested 
in conjunction with PBO (Figure 5.1). These two sets of analogues differed only in the 
presence/absence of the methylene bridge (-CH2-) between the aromatic ring and the oxygen 
atom of the alkynyl ether moiety. EN 1-164 and EN 1-163 lack the methylene bridge and the 
oxygen atom is bound directly to the aromatic ring (aromatic ring type B in Chapter 3) i.e in a 
similar position to sesamex, in an attempt to replicate its high synergism (the structures of EN 
1-164 and EN 1-163 have been presented in an European Patent Application, No 09168083.5, 
under the title “Substituted Alkynyl phenoxy compounds and their uses”, see Appendix 8). EN 
1-126 and EN 1-125 retain the methylene bridge between the aromatic ring and the oxygen 
atom of the alkynyl ether moiety (aromatic ring type A in Chapter 3). Structurally similar 
phenyl ethers have been reported in early studies for their synergistic effects with carbamate 
insecticides against susceptible houseflies (Barnes and Fellig, 1969; Fellig et al., 1970) and 
more recently phenyl methyl ethers (equivalent to EN 1-126 and EN 1-125) showed high 
synergism against pyrethroid and carbamate resistant houseflies (Pap et al., 2001; Bertók et 
al., 2003). Other compounds examined for their synergistic potency are compounds having 
alterations either in the MDP moiety (EN 16/5-1 and EN 14-05, aromatic ring type C and D 
respectively in Chapter 3) or in the side chains (EN 1-129 and EN 1-40 aromatic ring type A 
in Chapter 3). 
 
The aim of this chapter is to investigate the synergistic effects of these analogues and their 
ability to inhibit O-deethylation of 7-EC in comparison to PBO using four M. aeneus 
populations. Correlations between in vivo/in vitro investigations and analogue structures are 
discussed. 
 
 
 
 
 
 
 
Chapter 5                               In vivo and in vitro studies of PBO analogues against four pollen beetle populations  
105 
 
5.2 Materials and Methods 
 
5.2.1 Insects 
Four M. aeneus populations were used: Lebork, Leszno, Rogalin and UK (section 2.1.3). Due 
to insufficient insect numbers not all the analogues were tested with all populations. 
 
5.2.2 Insecticide and synergists 
Technical α-cypermethrin was used as the insecticide. Analytical grade PBO and analogues 
were used as synergists (Figure 5.1).  
 
 
                        EN 1-126                                                        EN 1-125 
 
 
 
                          EN 1-164                                                     EN 1-163 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                  Figure 5.1 Structures of PBO and analogues  
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5.2.3 Insect bioassays 
Different discriminating concentrations of α-cypermethrin were incorporated with 0.01g L-
1synergists in a mixture. Concentrations of insecticide used in the discriminating bioassays 
were derived from full dose response bioassays (Chapter 4, section 4.3.8, Table 4.8). 
Treatments including acetone and 0.01g L-1of synergists alone were used as controls.  
 
5.2.4 Determination of O-deethylation inhibition by PBO and analogues  
Pollen beetle homogenates were prepared as described in section 2.3.6.1 and O-deethylation 
inhibition by PBO and analogues was performed as described in section 2.3.6.3. 
 
5.2.5 Analysis of data 
5.2.5.1 Insect bioassay data 
Results from full dose and discriminating dose bioassays incorporating synergists were 
analysed as described in sections 2.5.3 and 2.5.4, respectively.  
 
5.2.5.2 Determination of O-deethylation inhibition by PBO and analogues 
The mean absorbance at each time point was calculated as described in section 2.5.2. Data 
were analysed using linear regression with correlated errors (GenStat 12th Edition, VSN 
International). O-deethylation inhibition by analogues was considered significantly different if 
the CL95% of the remaining activity (ratio) did not overlap.  
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5.3. Results  
 
5.3.1 Insect bioassays  
Full dose response bioassays with α-cypermethrin against the four M. aeneus populations are 
presented in Table 5.1 (see also Appendix 4). Data in Table 5.1 also includes LC50 values 
presented in Chapter 4 (section 4.3.8, Table 4.8) and repeated here for convenience. The 
additional data in Table 5.1 show the resistance level for the Leszno population which had a 
RF of 8 and therefore was less resistant than Rogalin and Lebork.  
 
Table 5.1 Full dose response bioassays with Meligethes aeneus populations against 
α-cypermethrin (including data from Chapter 4, Table 4.8). 
Population aLC5  (ηg/cm2) bCL 95% cRF 
UK  2.81 0.19-4.52 1 
Leszno 22.5 13.2-35.0 8.00 
Rogalin 65.0 40.0-100 23.2 
Lebork 95.0 66.0-140 33.9 
                                        aLC50=Lethal concentration to kill 50% of the population, bCL=Confidence limits,  
                                cRF=resistance factor (LC50 resistant population/LC50 susceptible population)  
 
In general, discriminating dose bioassays incorporating synergists showed that MDP 
compounds with the exception of EN 1-129 (Figure 5.2, Figure 5.3 and Figure 5.4) exhibited 
high synergistic activity against all studied pollen beetle populations (UK, Rogalin and 
Lebork). In contrast, analogues with alterations in the MDP ring (EN 16/5-1 and EN 14-05) 
did not show high synergism with any of the populations (see also Chapter 4 for synergism 
bioassays with PBO and EN 16/5-1). Treatments with acetone and 0.01 g L-1 of synergists 
alone did not confer mortality (data not shown).  
 
Considering firstly the susceptible UK population (Figure 5.2), EN 1-126 was significantly the 
most potent synergist compared to the other MDP compounds (p<0.05). Synergistic effects 
exhibited by PBO were not significantly different from EN 1-164, EN 1-163, EN 1-40 and EN 
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1-125 (p>0.05). Additionally, there was no significant difference in the synergistic effects 
between EN 16/5-1 and EN 1-129 (p>0.05) and both analogues were not significantly 
different from the insecticide alone (p>0.05).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Synergistic effects of PBO and analogues (0.01 g L-1) mixed with a discriminating 
dose of α-cypermethrin (0.3 ppm) against the UK population. Data are means ±SE, n=10 to 
15, N=106, LSD (95%)=0.2012, df=97. 
 
Overall, the synergistic effects shown from the most resistant populations, Rogalin and 
Lebork, were not significantly different (p=0.520) (Figure 5.3). EN 1-126 and EN 1-164 
exhibited no significant differences in their potency (p>0.05) and both were significantly more 
potent than PBO (p<0.05). 
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Figure 5.3 Synergistic effects of PBO and analogues (0.01 g L-1) mixed with a discriminating 
dose of α-cypermethrin (1 ppm) against the Rogalin and Lebork populations. Data are means 
±SE, n=5, N=70, LSD (95%)=0.1507, df=56. 
 
In order to distinguish clearly differences in the synergistic ability of PBO and analogues, a 
relatively low concentration of α-cypermethrin (0.3 ppm), sufficient to confer less than 10% 
mortality in the absence of synergist, was incorporated in a mixture with 0.01g L-1 of 
synergists and tested against the two most resistant populations, Rogalin and Lebork (Figure 
5.4). Overall, there was no statistically significant difference in response between the two 
populations (p=0.697). Analogues containing an alkynyl ether moiety showed higher 
synergistic activities than PBO. Overall, EN 1-126 was the more potent analogue when 
compared to the remaining analogues. The two phenyl ethers, EN 1-163 and EN 1-164, 
exhibited no significant difference in their synergistic effects (p>0.05) and both were more 
potent than PBO (p<0.05). Analogues with modifications in the MDP moiety, EN 16/5-1 and 
EN 14-05, showed no significant synergism when compared to insecticide only (p>0.05).  
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Figure 5.4 Synergistic effects of PBO and analogues (0.01 g L-1) mixed with a discriminating 
dose of α-cypermethrin (0.3 ppm) against the Rogalin and Lebork populations. Data are means 
±SE, n=5 to 11, N=110, LSD (95%)=0.2418, df=94. 
 
5.3.2 Determination of O-deethylation inhibition by PBO and its analogues  
The inhibition of ECOD activity by PBO and its analogues was measured in pollen beetle 
homogenates. The rate of the reaction product, 7-OH, reflects the oxidase activity. The ECOD 
activity remaining (%) after inhibition by PBO and its analogues with upper and lower limits 
for each population is presented in Table 5.2, Table 5.3, Table 5.4 and Table 5.5. It is 
important to consider at this stage that NADPH has a similar fluorometric profile to 7-OH 
(Chauret et al., 1999), thus if the amount of NADPH is reduced during the assay the 
fluorometric emission is reduced. Normally this reduction is ‘hidden’ by conversion of 7-EC 
to 7-OH, but if O-deethylation activity is completely inhibited the overall slope can be 
negative i.e. indicative of very high oxidase inhibition. A more appropriate ‘background’ 
activity to subtract would have been homogenate in the presence of NADPH and analogue, but 
absence of 7-EC. However, limitations on the amount of homogenate available precluded this 
procedure. The results are graphically presented in Figure 5.5.  
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Table 5.2 Inhibition of O-deethylation of 7-ethoxycoumarin activity (ECOD) by PBO and 
analogues in the UK population. 
 
UK population ECOD activity: 240 ± 8.28 FUs min-1 
Inhibitors  
Remaining  
activity (%) ± SE 
Lower 
CL 95 % 
Upper 
CL 95 % 
PBO 26.8 ± 4.38 18.2 35.3 
EN 1-126 1.15 ± 3.49 -5.69 8.00 
EN 1-164 10.4 ± 3.82 2.93 17.8 
EN 1-163 -9.30 ± 3.13 -15.4 -3.16 
EN 1-129 129 ± 7.90 113 144 
EN 16/5-1 101 ± 6.94 87.2 114 
EN 14-05 101 ± 6.93 87.0 114 
EN 1-40 41.0 ± 4.87 31.5 50.6 
EN 1-125 -1.04 ± 3.41 -7.73 5.66 
 
 
Table 5.3 Inhibition of O-deethylation of 7-ethoxycoumarin activity (ECOD) by PBO and 
analogues in the Leszno population. 
 
Leszno population ECOD activity:136 ± 8.47 FUs min-1  
Inhibitors  
Remaining 
activity (%) ± SE 
Lower  
CL 95 % 
Upper  
CL 95 % 
PBO 39.3 ± 8.64 22.3 56.2 
EN 1-126 23.7 ± 7.67 8.68 38.7 
EN 1-164 40.2 ± 8.70 23.1 57.2 
EN 1-163 19.9 ± 7.44 5.32 34.4 
EN 1-129 90.6 ± 11.8 67.4 114 
EN 16/5-1 85.6 ± 11.5 63.0 108 
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Table 5.4 Inhibition of O-deethylation of 7-ethoxycoumarin activity (ECOD) by PBO and 
analogues in the Rogalin population. 
 
Rogalin population ECOD activity: 137± 8.85 FUs min-1 
Inhibitors  
Remaining  
activity (%) ± SE 
Lower  
CL 95 % 
Upper  
CL 95 % 
PBO 20.4 ± 7.78 5.17 35.6 
EN 1-126 -6.76 ± 6.76 -18.5 5.05 
EN 1-164 27.5 ± 8.24 11.4 43.7 
EN 1-163 -11.2 ± 5.73 -22.4 0.00 
EN 1-129 114 ± 13.8 87.1 141 
EN 16/5-1 66.3 ± 10.7 45.2 87.4 
EN 14-05 88.2 ± 12.1 64.4 112 
 
 
Table 5.5 Inhibition of O-deethylation of 7-ethoxycoumarin activity (ECOD) by PBO and 
analogues in the Lebork population. 
 
Lebork population ECOD activity: 129 ± 6.93 FUs min-1 
Inhibitors  
Remaining  
activity (%) ± SE 
Lower 
CL 95 % 
Upper 
CL 95 % 
PBO 11.0 ± 5.94 -0.64 22.6 
EN 1-126 -15.4 ± 4.52 -24.2 -6.53 
EN 1-164 -2.24 ± 5.23 -12.5 8.02 
EN 1-163 -38.9 ± 3.26 -45.3 -32.5 
EN 1-129 90.9 ± 10.2 70.9 111 
EN 16/5-1 70.3 ± 9.12 52.4 88.2 
EN 14-05 71.4 ± 9.17 53.4 89.4 
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In general terms, the inhibition of ECOD activity varied among the tested compounds but 
results showed a consistent trend. Although widely used, PBO did not exhibit the highest 
inhibition of ECOD activity against any of the four pollen beetle homogenates. In contrast, 
MDP compounds having an alkynyl ether moiety in the side chain were found to be the most 
potent O-deethylation inhibitors, with EN 1-163 conferring the highest inhibition in all four 
populations.  
 
In the Lebork population, EN 1-163 was significantly the most potent O-deethylation inhibitor 
when compared to the rest of the analogues, followed by EN 1-126. Furthermore, EN 1-163 
and EN 1-126 inhibited ECOD activity in both the UK and Rogalin populations equally. EN 
1-125, an analogue having an alkynyl ether moiety but lacking the alkyl side chain, conferred 
equal inhibition as the above compounds (EN 1-126, EN 1-163) when tested against the UK 
population. Furthermore, EN 1-40 (an analogue lacking the alkyl chain) showed similar O-
deethylation inhibition to PBO against the UK population, indicating that an alkyl side chain 
may not be crucial for inhibiting ECOD activity in the MDP polyether compounds. EN 1-164 
was a relatively potent inhibitor of ECOD activity exhibiting similar inhibition to EN 1-126 
and PBO in UK and Rogalin/Lebork populations, respectively. Considering the intermediate 
resistant population, Leszno, analogues having the MDP moiety exhibited similar O-
deethylation inhibition except EN 1-129. Indeed, EN 1-129 despite having the MDP moiety, 
failed to inhibit ECOD activity to the same extent as the other MDP compounds and its 
potency appeared to be similar to EN 16/5-1 and EN 14-05 in all tested populations. EN 16/5-
1 and EN 14-05 are two analogues having either one or both oxygen atoms removed from 
their MDP rings, respectively. 
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Figure 5.5 O-deethylation activity remaining after inhibition by PBO and analogues in four 
Meligethes aeneus populations. Error bars represent ± SE (refer to Tables 5.2, 5.3, 5.4 and 
5.5). 
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5.4 Discussion  
 
Pyrethroid insecticides have been widely used because of their effectiveness and low 
mammalian toxicity (Casida et al., 1983). Subsequently, the extensive exposure of insects to 
pyrethroids has selected for resistance in many crop pest populations and human disease 
vectors (Liu et al. 2006; Jacobson et al., 2009; Kaufman et al., 2010; Komagata et al., 2010). 
There is now the threat of widespread pollen beetle populations resistant to pyrethroids, 
highlighting the danger of the frequent use of this, or any single class, of insecticides (Hansen, 
2003; Tiilikaninen and Hokkaanen, 2008; Wegorek et al., 2009). 
 
In this chapter the enhancement of pyrethroid insecticide potency against different pollen 
beetle populations using synergists such as PBO and its analogues was investigated using a 
combination of in vivo and in vitro assays. The mechanism conferring resistance to α-
cypermethrin in these pollen beetle populations has been proposed to be oxidase-based 
(Chapter 4). For the in vitro assays whole insect homogenates were used to ensure inclusion of 
all oxidases that may contribute to resistance to α-cypermethrin and could be potentially 
inhibited by the analogues. To interpret the in vivo results, ECOD activity was assayed as a 
measure of the dealkylation reaction often observed for pyrethroid detoxification (Roberts and 
Hutson, 1999) and because this assay has been widely used for biochemical characterisation of 
oxidative resistance (Yang et al., 2004; Audino et al., 2005; Marcombe et al., 2009; Wang et 
al., 2009). 
 
Inhibition of ECOD activity by PBO and its analogues generally correlated with results of the 
in vivo investigations. Results from both assays indicated that, at least in some cases, the 
classic MDP inhibitor, PBO, is not the most potent oxidase inhibitor and that analogues 
possessing a combination of the MDP ring and an alkynyl ether moiety exhibit the greatest 
inhibitory activities. This is best demonstrated in the case of the Rogalin and Lebork 
populations where a low concentration of pyrethroid insecticide was applied to separate 
inhibitors with the greatest potency (Figure 5.4). 
 
Chapter 5                               In vivo and in vitro studies of PBO analogues against four pollen beetle populations  
116 
 
Results of the present study show that replacement of the polyether side chain with an alkynyl 
ether moiety increases the inhibition of ECOD activity and synergism in the in vivo assays. 
These findings support previous in vivo investigations where structures equivalent to PBO 
analogues EN 1-125 and EN 1-126 were 6-fold and 4-fold respectively, more potent than PBO 
when used as synergists with carbofuran against resistant houseflies (Pap et al., 2001). The 
oxidative inhibitory potency of alkynyl groups was also evaluated in a series of alkylarenes 
against methoxyresorufin O-demethylation activity (MROD) using CYP6D1, a P450 isoform 
that has been found to be responsible for monooxygenase-mediated pyrethroid resistance in a 
housefly strain (Scott et al., 2000). 
 
Although it was shown previously that removal of the propyl side chain resulted in 
considerably lower inhibition of ECOD and MROD activity compared to PBO inhibition 
(Scott 1996; Scott et al., 2000), results in the present study showed that removal of the propyl 
chain in EN 1-40 had no effect upon the inhibition of ECOD activity (Figure 5.5) and this is 
supported further by the bioassay results with the UK population (Figure 5.2). Results, here 
are also consistent with previous in vivo investigations with permethrin against houseflies (Pap 
et al., 2001). 
 
Sesamex (Figure 1. 3, Chapter 1) was one of the first potent synergists reported (Eldefrawi et 
al., 1960; Farnham, 1971, 1973, 1974). Its structure contains a MDP ring and a polyether side 
chain similar to the structure of PBO, but having the first oxygen atom of the polyether chain 
bound directly to the aromatic ring instead of via a methylene bridge. In view of this, two 
phenyl but-2-ynyl ethers (EN 1-163 and EN 1-164) that had the oxygen atom bound directly to 
the aromatic ring (similar to sesemex) and also carried a triple bond, were synthesised. 
Bioassays and ECOD assays incorporating EN 1-163 and EN 1-164 showed, in some cases, 
significantly greater inhibition than PBO, similar to EN 1-126, a phenyl methyl but-2-ynyl 
ether compound which retains a methylene bridge between the aromatic ring and the oxygen 
atom of the alkynyl ether chain. A similar improvement of MDP alkynyl ethers over PBO was 
demonstrated in an earlier study where a phenyl prop-2-ynyl ether similar to EN 1-163 
showed 2-3 fold greater synergism than PBO when tested with carbaryl against houseflies 
(Barnes and Fellig, 1969). An additional observation is that EN 1-126 showed greater 
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synergistic effects with all populations, although in some cases EN 1-163 was a significantly 
more potent inhibitor of ECOD activity. This may be the result of EN 1-126 being a more 
lipophilic compound and thus able to penetrate the insect cuticle more rapidly when applied as 
a mixture with the insecticide. 
 
It was initially surprising that the MDP compound EN 1-129 was unable to synergise α-
cypermethrin in vivo or exhibit inhibitory potency in the ECOD assay. This finding suggests 
that the absence of a polyether chain, in contrast to the absence of an alkyl chain, within MDP 
compounds, is critical for synergism and O-deethylation of 7-EC. However, potency can be 
regained if it is replaced by an alkynyl ether moiety. The contribution of a polyether chain 
with MDP compounds for synergistic activity has been suggested in an earlier report where it 
was proposed that “a side chain with at least one or more oxygen atoms incorporated into an 
ether group is considered of major importance in preventing insecticide detoxification” (Esaac 
and Casida, 1969). Nonetheless, the presence of polyether and alkyl side chains, but an 
absence of the MDP ring, is not sufficient to enable synergistic activity in bioassays and 
inhibition of O-deethylation of 7-EC, as revealed with EN 16/5-1 and EN 14-05. This failure 
was expected since the fundamental contribution of the MDP ring of (methylenedioxyphenyl) 
polyether compounds to synergistic activity was established previously (Wilkinson et al., 
1966; Casida, 1970).  
 
Compounds with modifications to the MDP ring, such as EN 16/5-1 and EN 14-05, were 
previously evaluated as synergists with carbamate insecticides. Results revealed a lack of 
synergism, although replacement of one oxygen with sulphur resulted in only a slight decrease 
in the synergistic effect (Wilkinson et al., 1966). Furthermore, high synergism was reported 
following replacement of the MDP ring with a 1,2 dimethoxybenzene group and incorporation 
of an alkynyl ether side chain (forming the known synergist verbutin) (Pap et al., 2001; Bertok 
et al., 2003).  
 
Due to the extensive application of many conventional insecticide groups i.e. pyrethroids, 
OPs, carbamates, many insect pests have developed resistance. Results from the in vivo and in 
vitro investigations in the present study clearly indicate that it is possible to design new 
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insecticide synergists that can effectively increase the toxicity to pest insects and prolong the 
use of existing pesticides (Moores et al., 2005). 
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Chapter 6  
In vivo synergistic effects of piperonyl butoxide analogues using two Myzus 
persicae clones with different metabolic resistance mechanisms  
 
6.1 Introduction 
 
Bioassays using live insects play a crucial role in investigating insecticide resistance and such 
in vivo assays are the most reliable method of estimating resistance levels and evaluating the 
potency of toxicants against resistant insects. Therefore, a complete evaluation of either 
current insecticide resistance or new strategies for using insecticides and/or synergists must 
include in vivo tests alongside in vitro studies. However, difficulties can arise in interpreting 
comparative results obtained from in vivo and in vitro studies. 
 
Following in vitro investigations discussed in previous chapters, different analogues together 
with PBO were used as insecticide synergists in vivo against two M. persicae clones which 
have different metabolic resistance mechanisms. The analogues have different alterations in 
the MDP moiety and the side chains. Piperonyl butoxide was used as the standard synergist 
for comparison. The synergistic efficacy of the analogues derived from in vivo studies are 
compared with the in vitro assays described in previous chapters.  
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6.2 Materials and Methods 
 
6.2.1 Insects 
Two M. persicae aphid clones were used: 5191A and 794JZ (section 2.1.2 and Appendix 1).  
 
6.2.2 Insecticides and synergists 
Two technical insecticides were used: imidacloprid and α-cypermethrin. Analogues and PBO 
were used as synergists (section 2.2 and for analogue’ structures see Appendix 2). 
 
6.2.3 Insect bioassays (full dose response bioassays) 
Individual apterous adult aphids were dosed with either PBO or analogues in acetone and were 
further treated 5 h later with either imidacloprid or α-cypermethrin in acetone, as described in 
section 2.4.1.  
 
6.2.4 Analysis of data 
Full dose response bioassay data were analysed as described in section 2.5.3. 
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6.3 Results 
 
6.3.1 Full dose response bioassays with imidacloprid and Myzus persicae clone 5191A  
Results from full dose response bioassays using imidacloprid against the resistant M. persicae 
clone 5191A are presented in Table 6.1 (see also Appendix 4). The results show that the 
analogues conferred a range of synergistic potencies with EN 1-126 giving the highest SF 
(292) and EN 14-05 the lowest SF (2.17). The classic MDP synergist PBO gave a SF of 14.5.  
 
Table 6.1 Synergism factors of analogues with imidacloprid in full dose response bioassays 
against Myzus persicae clone 5191A using a 5h pre-treatment. 
Treatment aLC50  (ppm) bCL95% cSF 
imidacloprid* 90.4 51.0-185 -- 
+ 1g L-1 PBO* 6.22 4.04-8.70 14.5 
+ 1g L-1 EN 16/5-1* 12.2 8.80-16.4 7.41 
+ 1g L-1 EN 1-164 1.25 0.75-1.97 72.4 
+ 1g L-1 EN 1-126 0.31 0.21-0.43 292 
+ 1g L-1 EN 1-163 2.98 1.90-4.51 30.3 
+ 1g L-1 EN 25-10 4.88 1.20-11.0 18.5 
+ 1g L-1 EN 1-129 28.4 13.6-45.8 3.18 
+ 1g L-1 EN 16-17 7.11 5.12-9.53 12.7 
+ 1g L-1 EN 16-18 18.4 9.69-29.5 4.91 
+ 1g L-1 EN 14-05 41.5 26.1-62.6 2.17 
*Data from Chapter 4 
aLC50=Lethal concentration to kill 50% of the clone, bCL= Confidence limits, 
cSF = synergism factor (LC50 unsynergised clone/ LC50 synergised clone) 
 
Analogues containing the MDP moiety gave different potencies with EN 1-129 showing the 
lowest SF (3.18) and EN 1-126 showing the highest SF (292). Generally, the highest 
synergism was observed with analogues having a combination of the MDP ring and an alkynyl 
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ether chain, EN 1-126, EN 1-164 and EN 1-163. Of these, EN 1-126 had a LC50 value of 0.31 
ppm which is even lower than the LC50 value obtained from the susceptible aphid clone 
(4106A) treated with imidacloprid, which had a LC50 value of 1.55 ppm (Chapter 4, Table 
4.5). 
 
Considering EN 1-126, which has a bridging -CH2- group connecting the aromatic ring and 
the alkynyl ether side chain, the SF was 4-fold higher than EN 1-164 in which the bridging -
CH2- group is absent. The presence of a propyl side chain in EN 1-164 increased the SF 2.38-
fold compared to EN 1-163 where the propyl side chain is absent. Similarly, EN 16-17 gave a 
2.58–fold higher SF than EN 16-18 which lacks the propyl side chain. Both of these analogues 
had one oxygen atom removed from the MDP ring and synergism was decreased compared 
with analogues that retained the complete MDP moiety. The lowest SF was seen for EN 14-05 
which had both oxygen atoms removed from the MDP ring. EN 25-10 (verbutin), a compound 
lacking the MDP ring, gave a SF of 18.54, higher than some MDP compounds including PBO 
and EN 1-129. 
 
6.3.2 Full dose response bioassays with α-cypermethrin and Myzus persicae clone 794JZ  
Results from full dose response bioassays using α-cypermethrin against the resistant M. 
persicae clone 794JZ are presented in Table 6.2 (see also Appendix 4). Synergistic factors of 
the analogues fall within a narrow range with only a 4.28-fold difference between the highest 
(EN 1-16, SF 8.87) and the lowest (EN 1-129, SF 2.07). Piperonyl butoxide showed an 
intermediate synergistic effect (SF 4.8).  
 
Analogues with an increased length of the alkyl side chain, EN 1-16 and EN 1-14, gave the 
highest SFs with values of 8.87 and 6.35, respectively followed by the aryl alkynyl ether EN 
25-10 with a SF of 6.07. The two other aryl alkynyl ethers with a MDP moiety, EN 1-126 and 
EN 1-164, gave 1.65-fold difference in their synergistic potency. Compounds such as PBO, 
EN 16/5-1 and EN 1-40 exhibited similar SFs (~5) and the lowest SFs were obtained with EN 
14-05, EN 1-129 and EN 1-93 with SFs between 2 and 3. 
 
 
Chapter 6        In vivo synergistic effects of PBO analogues using two M. persicae clones with different metabolic 
resistance mechanisms  
123 
 
Table 6.2 Synergism factors of analogues with α-cypermethrin in full dose response bioassays 
against Myzus persicae clone 794JZ using a 5h pre-treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Data from Chapter 4 
aLC50=Lethal concentration to kill 50% of the clone, bCL= Confidence limits, 
cSF = synergism factor (LC50 unsynergised clone/ LC50 synergised clone) 
 
 
 
 
 
 
 
 
Treatment aLC50 (ppm) bCL95% cSF 
α-cypermethrin* 1303 1061-1632 ---- 
+ 1g L-1 PBO* 271 220-327 4.80 
+ 1g L-1 EN 16/5-1* 264 215-321 4.94 
+ 1g L-1 EN 1-14 205 162 -258 6.35 
+ 1g L-1  EN 1-126 218  139-335 5.97 
+ 1g L-1  EN 1-164 361 211-473 3.60 
+ 1g L-1  EN 1-93 507 370-675 2.57 
+ 1g L-1  EN 1-40 259 207-313 5.03 
+ 1g L-1  EN 25-10  215 157-276 6.07 
+ 1g L-1  EN 14-05 569 377-898 2.29 
+ 1g L-1  EN 1-129 629 484-878 2.07 
+ 1g L-1  EN 1-16 147 101-195 8.87 
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6.4 Discussion 
 
In vivo synergism with PBO and its analogues was investigated with two insecticides, 
imidacloprid and α-cypermethrin and two aphid clones, 5191A and 794JZ respectively.  
 
As shown previously, clone 5191A exhibited a 56.5-fold resistance to imidacloprid. In vivo 
and in vitro assays suggest that although clone 5191A has high levels of esterase (FE4 variant, 
R3), imidacloprid resistance was primarily due to an oxidative based mechanism (Chapter 4). 
The bioassay results reported in this chapter show that MDP compounds with an alkynyl ether 
side chain, EN 1-126, EN 1-164 and EN 1-163, are the most potent synergists when used with 
imidacloprid (Table 6.1). Similarly, bioassay results with the pyrethroid resistant pollen beetle 
populations showed that EN 1-126 was the most potent synergist followed by EN 1-164 and 
EN 1-163 (Chapter 5, Figure 5.4). It is of note that the oxidative mechanism in clone 5191A 
does not exhibit enhanced levels of pyrethroid resistance (only a RF of 13, due to FE4 -R3, 
Chapter 4) compared to the high level of imidacloprid resistance (RF of 56.5, Chapter 4). 
Furthermore, pollen beetle populations from Europe that have exhibited pyrethroid resistance 
(as also found in Chapter 5) have not exhibited cross-resistance to imidacloprid (Slater and 
Nauen, 2007). This implies that the oxidase enzyme systems responsible for imidacloprid 
resistance in clone 5191A and pyrethroid resistance in pollen beetles have different substrate 
profiles. This is perhaps unsurprising, given that oxidases show a large variation in substrate 
specificity (Wilkinson, 1983). However, the three aryl alkynyl ethers (EN 1-126, EN 1-164 
and EN 1-163) are potent synergists with both insecticides against the two insect species 
which exhibited oxidative metabolic resistance. This suggests that these analogues have broad 
spectrum activity and are capable of inhibiting a variety of oxidase enzymes.  
 
Another observation is that EN 1-129 and EN 14-05 gave low SFs when tested with the 
imidacloprid resistant aphid clone 5191A (Table 6.1) and also low synergism in the 
discriminating dose bioassays with pyrethroid resistant pollen beetles (Chapter 5, Figure 5.3 
and Figure 5.4). This implies that the presence of only the MDP moiety or only the polyether 
chain is not sufficient for high synergistic efficacy. This is further supported by the in vitro 
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results with pollen beetle homogenates where EN 1-129 and EN 14-05 failed to inhibit the 
ECOD activity to the same extent as the other compounds tested.  
 
The significant contribution of the MDP moiety is also demonstrated by the lower synergistic 
effects of two other analogues with modifications in the MDP moiety (EN 16-17 and EN 16-
18) when compared to EN 1-126. The low synergism exhibited by EN 16-17 and EN 16-18 
further supports the finding that imidacloprid resistance is associated with an oxidative 
mechanism (Chapter 4).  
 
Of particular note is the significance of the propyl side chain in the analogue’s structure. EN 
1-164 and EN 1-163 both of which contain a MDP moiety and alkynyl side chain differ only 
in that EN 1-164 has a propyl side chain. Bioassay results revealed that EN 1-164 exhibited a 
2.4-fold higher SF than EN 1-163. Furthermore, two other analogues, EN 16-17 and EN 16-
18, differ again in that the former carries a propyl side chain and exhibited a 2.6 –fold higher 
SF than EN 16-18. This relatively constant difference between analogues with and without the 
propyl side chain implies that the presence of the alkyl chain provides specific properties to 
the synergists. The presence of the alkyl side chain in both cases increases the lipophilicity of 
the compounds and consequently may help penetration of the synergist through the insect 
cuticle. Since the optimum pre-treatment times for individual analogues were not defined and 
all experiments used a 5 h delay (shown to be the optimal for PBO against M. persicae – Khot, 
2009), it could be that this pre-treatment time is more appropriate for analogues having a 
propyl side chain, similar to PBO. This would also explain the observation that although EN 
1-163 was the significantly more potent inhibitor against ECOD activity, followed by EN 1-
126 and EN 1-164, it did not exhibit significantly different synergism from EN 1-164 when 
both were tested in vivo in a mixture with α-cypermethrin against pollen beetles (Chapter 5). 
Similarly with the imidacloprid resistant clone 5191A, EN 1-163 had a lower synergistic 
effect than EN 1-164 (Table 6.1). This could be due to the 5 h pre-treatment being insufficient 
for EN 1-163 and other similar analogues which lack the propyl side chain. However, the 
inhibitory potency of EN 1-163 upon oxidative systems derived from different insect species 
remains unclear. The importance of inhibiting the enhanced metabolic enzymes prior to the 
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active ingredient being applied (‘temporal synergism’) has been demonstrated previously 
(Young et al., 2005, 2006; Bingham et al., 2007, 2008).  
 
Bioassays with the aphid clone 5191A showed that EN 25-10 (verbutin), a compound with an 
alkynyl ether moiety and two methoxy groups instead of the MDP moiety, showed synergistic 
effects similar to PBO. EN 25-10 has previously been reported to synergise pyrethroid and 
carbamate insecticides against housefly strains possessing enhanced oxidases (Pap et al., 
2001; Bertók et al., 2003).  
 
In contrast to the synergism observed for the analogues with the imidacloprid resistant clone 
5191A, the bioassay results for the pyrethroid resistant clone 794JZ showed relatively low SFs 
(Table 6.2). Additionally, results showed that SFs obtained from analogues tested against 
clone 794JZ were uniform. However, a common observation with both of these resistant aphid 
clones and with the pyrethroid resistant pollen beetles is the low synergism with EN 1-129, 
EN 1-93 and EN 14-05. Synergistic effects derived from these analogues also concur with the 
SAR study results (Chapter 3) where the two MDP compounds EN 1-129 and EN 1-93 
exhibited very low binding affinities against E4 (Chapter 3, Figure 3.6) and EN 14-05 had a 
significantly lower binding affinity than PBO (Chapter 3, Figure 3.8). The highest synergism 
was observed with EN 1-16 followed by EN 1-14 (Table 6.2). In both these analogues the 
propyl chain has been replaced by a hexyl or butyl chain, respectively. These two analogues 
also exhibited high binding affinities in the SAR study, with the former showing a 
significantly higher binding affinity than the latter (Chapter 3, Figure 3.6). As discussed 
previously, the presence of the alkyl side chain gives the compounds a more lipophilic profile 
and may be an important factor for the high synergistic effects exhibited by these analogues. 
Additionally, as discussed for the in vitro studies, increasing lipophilicity is positively 
correlated with high binding potency to E4, possibly due to hydrophobic interactions between 
the alkyl chain and a hydrophobic area of the enzyme (Chapter 3, SAR study).  
 
The relatively low SFs from the pyrethroid resistant aphid clone 794JZ (Table 6.2) compared 
to the high SFs obtained from the imidacloprid resistant aphid 5191A clone (Table 6.1) could 
result from the different resistance profiles of the two aphid clones. The pyrethroid resistant 
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794JZ aphid clone possessed enhanced metabolic enzyme (E4 variant, R3) and a target site 
mutation (kdr) and this combination is reported to increase insensitivity to pyrethroid 
compounds (Martinez-Torres et al., 1999). Although not all analogues were tested in vivo 
against clone 794JZ, the SFs obtained were low and not appreciably different. This implies 
that the target site mutation (kdr) is the major resistance mechanism in clone 794JZ and the 
contribution of E4 is relatively minor. In contrast, when the same analogues were tested in 
vitro (Chapter 3, SAR study) differences in their binding affinities were clearly evident. The 
difference in results between the SAR study and the in vivo assays may be due to the esterase 
interference assay being optimised for this purpose and thus being capable of distinguishing 
any differences in binding affinities towards the enzyme (E4). Since with in vivo studies this 
separation was not possible, the fine differences observed in the SAR study would not be 
found. However, use of a more potent insecticide with the in vivo assays may help to define 
distinguishable differences among the analogues and thus provide a better correlation with the 
binding affinities displayed by the SAR study. Nevertheless, the extreme responses (the most 
potent and the weakest synergists) are still evident in the in vivo assays and are in agreement 
with the binding affinities obtained in the in vitro study.  
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Chapter 7  
General discussion 
 
7.1 Summary of the main findings 
The main findings from this study have been summarised below: 
• The conventional spectrophotometric assay using the model substrate 1-NA, confirmed 
previous findings that PBO does not inhibit substrate hydrolysis when incubated with 
insect esterases. Additionally, it has been shown that PBO and some of its analogues 
increased the catalytic centre activity when incubated with purified E4 (activation). 
This implies that some compounds are actually “helping” or “guiding” the substrate to 
reach and act at the catalytic centre at a higher rate (Chapter 3). 
• Incubations of PBO with purified E4 at different intervals showed that PBO acts as a 
reversible inhibitor suggesting that it binds to the enzyme with non-covalent bonds 
such as hydrogen bonds, hydrophobic interactions, steric effects etc (Chapter 3). 
• The alkyl and the polyether side chains of the analogues make significant contributions 
to their binding affinity to E4 (Chapter 3). 
• High binding affinities to E4 were found with analogues where the polyether chain was 
replaced by an alkynyl ether chain, especially with the oxygen atom bound directly to 
the aromatic ring (aromatic type B), or where the length of the alkyl chain was 
increased (Chapter 3). 
• Alterations to the MDP moiety, by removing one oxygen atom (aromatic ring type C) 
did not affect the binding affinities; however, removal of both oxygen atoms (aromatic 
ring type D) resulted in a reduction of the binding potency of the analogues compared 
to PBO (Chapter 3). 
• There was a positive correlation between the slopes and Index values derived from the 
two biochemical assays (conventional esterase assay and the interference assay, 
respectively) with the exception of analogues lacking the alkyl side chain. This 
correlation shows that the stronger the binding affinity, the less the catalytic centre 
activity of the enzyme for 1-NA was increased (less activation) (Chapter 3). 
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• An analogue of PBO, EN 16/5-1, that retains the ability to inhibit esterases (Chapter 3) 
but loses potency against oxidase activity (due to a modification of the MDP ring), was 
used in parallel with PBO (using in vivo and in vitro assays) to characterise metabolic 
enzymes conferring resistance in two different insect species (Chapter 4). 
• MDP compounds containing the alkynyl ether side chain conferred high synergism in 
vivo and were potent inhibitors of ECOD activity when tested against pyrethroid 
resistant pollen beetles (Chapter 5). 
• Synergist bioassays results showed that MDP compounds with the alkynyl ether side 
chain were the most potent synergists when tested against the imidacloprid resistant 
aphid clone 5191A. Furthermore, results with clone 5191A suggested a 5 h pre-
treatment time to be a more appropriate time delay for analogues containing a propyl 
side chain, similar to PBO (Chapter 6). 
• Synergist bioassays with analogues against the pyrethroid resistant aphid clone 794JZ 
gave relatively low and uniform SFs (Chapter 6) in contrast to the SAR study where 
binding affinities were easily distinguishable (Chapter 3). However, analogues with an 
increased length of the alkyl side chain exhibited high synergism in agreement with 
findings from the SAR study (Chapter 6). 
• Generally, analogues with the MDP and the alkynyl ether moieties exhibited high SFs 
against both species, aphids and pollen beetles, carrying oxidative resistance 
mechanisms. If the alkyl side chain is also present the synergistic effects are even 
greater (Chapter 5 and 6). Similar responses with these compounds were observed with 
in vitro assays, i.e. the SAR study and the ECOD assay (Chapter 3, 5). In contrast, 
results from in vivo and in vitro assays with analogues having modifications in the 
MDP ring, showed that the response depended upon the resistance mechanism present 
in the insect population studied (Chapter 3, 4, 5 and 6). 
 
7.2 Discussion and future work  
The widespread occurrence of insecticide resistance is a serious threat for the control of many 
important agricultural pests and vectors of human diseases. Resistance to different classes of 
insecticides has developed and over 500 species of insects and mites are resistant to one or 
more insecticides. As a result, the destruction and limitation of food supplies caused by the 
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failure to control insect infestations causes annual economic losses of several billion dollars 
worldwide (Elzen and Hardee, 2003). Economic losses by insect control failure are further 
increased by the high cost of inventing and developing new active ingredients with novel 
modes of action. Since few classes of insecticides are available for insect control and few new 
insecticides are being produced, increasing our understanding and/or improving the efficacy of 
existing insecticides is essential. Insecticide synergists such as PBO are capable of prolonging 
the use of the existing insecticides and overcoming insecticide resistance (Bernard and 
Philogène, 1993).  
 
In the present study the interactions between PBO/analogues and metabolic enzymes 
conferring insecticide resistance have been investigated using insect species with different 
insecticide resistance mechanism profiles. Piperonyl butoxide, probably the most well-known 
synergist, has been used in the field to reduce resistance factors. Additionally, it has been used 
for research purposes to characterise metabolic resistance, since it was considered to be a 
specific inhibitor of MFOs. Subsequent studies, however, showed that PBO can also interact 
with resistance-associated esterases.   
 
This study supports the previous findings that PBO can inhibit both phase 1 metabolic 
enzymes, namely oxidases and esterases. In an attempt to gain a better understanding of the 
mechanism by which PBO interacts with resistance-associated esterases, a SAR study was 
undertaken using PBO analogues which have different modifications in the MDP moiety and 
side chains. This SAR study, incorporating the interference assay, showed that different levels 
of binding affinity to E4 occur when the PBO molecule is modified. The extent of these 
differences was dependent upon the changes made to the analogue molecule. Although the 
exact mechanism by which PBO interacts with E4 remains unclear, preliminary results from 
the present study gave some insights into this interaction. The presence of the alkyl chain and 
the polyether chain made a significant contribution to the binding affinity of analogues to E4. 
Furthermore, replacement of the polyether side chain by an alkynyl ether chain with the 
oxygen bound directly to the aromatic ring and the presence of an alkyl chain, increased the 
binding affinity to E4. These findings suggest parameters that are fundamental for the high 
binding potency to E4 and may contribute to the design of potent inhibitors of this esterase. 
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Although conclusions at this stage can only be speculative, design of specific compounds for 
inhibiting E4 would prolong the use of existing insecticides controlling aphid populations and 
eliminate synergistic effects against non-target insects, thus contributing to integrated pest 
management (IPM) strategies.  
 
Analogues combining the MDP ring and the alkynyl ether chain, such as EN 1-164, EN 1-126, 
showed high binding affinities to E4, inhibition of ECOD activity from insect homogenates 
and excellent synergistic effects in in vivo tests against both M. persicae and M. aeneus. These 
analogues could be used to enhance the efficacy of existing insecticides from different classes 
and inhibit relevant metabolic enzymes. Such analogues could be used as insecticide 
synergists in insect resistance management (IRM) programmes in order to maintain utility of 
current insecticides by slowing, preventing or reversing development of resistance.  
 
Alterations to the MDP moiety, by removal of one oxygen atom, did not affect the binding 
affinities to esterases from M. persicae and M. aeneus, but significantly reduced the inhibition 
of oxidative enzymes in the latter. Unfortunately in this study, assessment of aphid 
microsomal oxidase activity was not possible and thus in vitro investigations for evaluation of 
analogue potency against oxidative enzymes could not be completed. However, the analogue 
EN 16/5-1 could be used as a first indication of which metabolic resistance mechanism is 
present in a resistant population and consequently, the appropriate synergist could be applied 
to overcome the resistance.  
 
Previous work had shown that the efficacy of PBO as an insecticide synergist can be enhanced 
by using an appropriate pre-treatment time between the application of the synergist and the 
insecticide. Additionally, it has been shown that PBO pre-treatment time differs between 
insect species (Young et al., 2005, 2006). Synergism in the present study was investigated 
using either a 5 h pre-treatment time (the optimal time delay for PBO against M. persicae), or 
a mixture of the synergist with the insecticide. However, analogues may have a different 
optimal pre-treatment time compared to PBO. Hence, synergist efficacies could be increased 
by using the appropriate pre-treatment time for each analogue. Results here indicated that 
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analogues having the alkyl side chain to increase analogue lipophilicity may have similar pre-
treatment times to PBO.  
 
Microencapsulated formulations have been developed to give a burst release of PBO several 
hours prior to a second burst release of the active ingredient (Bingham et al., 2007, 2008). It is 
probable that similar microencapsulated formulations containing a PBO analogue could 
produce more potent synergistic effects, provided the pre-treatment times were optimised.  
Furthermore, by manipulating this parameter it is possible to reduce undesirable effects 
against non-targeted insects, such as beneficial insects. 
 
The contribution of metabolic inhibitors such as synergists to reduce resistance factors in the 
fields is unquestioned (Bernard and Philogène, 1993). As shown in previous reports and 
confirmed in the present study, PBO and analogues could be used to prolong the use of 
existing insecticides. However, their use needs to be considered with caution. It is likely that 
target insects would resist metabolic inhibitor treatment as they resist other xenobiotics, such 
as insecticides and plant toxicants and genetic changes will occur, perhaps with a concomitant 
increase in target-site resistance. Careful design for their application is also needed to meet 
IPM strategies. The frequency and rate of synergist application in combination with the 
ecology and biology of the target insects are fundamental factors for the successful used of 
synergists. A similar programme for the control of H. armigera in Australian cotton fields 
where the use of PBO is restricted to once per season with a single pyrethroid (Forrester et al., 
1993) could be adapted for the long-term successful management of synergists in field 
resistance situations contributing to  IPM  and IRM strategies.  
 
Further investigation of the interactions between metabolic enzymes (esterases and oxidases) 
and PBO analogues would help to clarify the role of different chemical moieties and allow the 
synthesis of potent synergists, similar to analogues having an alkynyl ether moiety in the 
present study. Although investigations were undertaken using purified E4 and semi-purified 
esterases from pollen beetles, other enzymes e.g different P450 isozymes need to be evaluated 
in the presence of analogues in appropriate assays. Differences in enzyme structures could be 
Chapter 7                                                                                                                                        General discussion  
133 
 
the key to the design of specific synergists for specific insects, thus minimising undesired 
effects on beneficials such as honeybees.  
 
Preliminary investigations were made to find specific inhibitors to characterise the different 
metabolic enzymes confirming insecticide resistance, since PBO inhibits both, esterases and 
oxidases. Although EN 16/5-1 can be used as an esterase inhibitor, the need for a specific 
oxidase inhibitor still remains. Furthermore, since assessment of aphid microsomal oxidase 
activity was not possible in the present study, further studies need to be undertaken to obtain 
information on this enzyme group and clarify its contribution to insecticide resistance.  
 
Design of a systemic synergist is of major importance to contribute further to IPM strategies. 
In the present study, EN 1-101 was designed specifically for this purpose by adding a -COOH 
group at the end of the polyether chain to achieve high water solubility. However, EN 1-101 
gave low binding affinity to E4 and could be considered an ineffective esterase inhibitor. It 
would be interesting to evaluate the inhibitory potency of EN 1-101 against ECOD activity, 
since this analogue retains the MDP moiety and the polyether chain. If it retains inhibitory 
effects upon ECOD activity, it could be tested further in systemic studies as a specific 
systemic oxidase inhibitor. 
 
It can be concluded from this study that some analogues of the insecticide synergist PBO have 
potential to enhance insecticide efficacies. Compounds within a given structural family such 
as PBO analogues, may exhibit varying biological activities depending on their interactions 
with different enzymes (esterases and oxidases). By altering chemical moieties or functional 
groups of a lead compound, in this case PBO, its interactions against target proteins and other 
properties (e.g physicochemical) can be modified and improved. Further investigations are 
needed to design analogues to act as insecticide synergists with high potency and specificity. 
Such compounds will improve crop production and contribute to IPM and IRM strategies. 
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Appendices  
 
Appendix 1. Resistance mechanisms and origins of Myzus persicae clones  
 
Clone 1Esterase 2kdr Origin 
Date of 
collection 
Crop of 
collection 
4106A S SS Scotland, UK August, 2000 Potato 
T1V R2- E4 SS Beds, UK  June, 1975 Sugar beet 
794JZ R3 -E4 RR Evesham, UK March, 1982 Chrysanth 
926B R3 -FE4 SS Greece July,1990 Tobacco 
5191A*   Greece July, 2007 Tobacco 
1Determinate by immunoassay: S/R1 (susceptible), R2 (high), R3 (extreme resistant) (Devonshire et al., 1986). 
2Based on direct DNA sequencing of PCR-amplified sodium channel gene fragments from aphid genomic 
DNA (Martinez-Torres et al., 1999). 
* Resistance mechanisms of clone 5191A were under investigation in the present study. 
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Appendix 2. Analogue structures (in numerical order)  
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                                                                                                                    EN 1-163 
 
 
 
 
 
                                                                                                                    EN 1-164 
 
 
 
 
 
                                                                                                                    EN 1-175 
 
 
 
 
 
                                                                                                                    EN 1-179 
 
 
 
 
 
O
O
O
O
O
O
ONa
sodium 2-(2-(2-((6-propylbenzo[d][1,3]dioxol-5-yl)methoxy)ethoxy)ethoxy)acetate
O
O O
5-(but-2-ynyloxy)benzo[d][1,3]dioxole
O
O
O
O O
5-(2-(2-butoxyethoxy)ethoxy)benzo[d][1,3]dioxole
O
O O
O
O
O
5-(but-2-ynyloxy)-6-(2-(2-butoxyethoxy)ethoxy)benzo[d][1,3]dioxole
O
O O
5-(but-2-ynyloxy)-6-propylbenzo[d][1,3]dioxole
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                                                                                                                    EN 1-180 
 
 
 
 
 
                                                                                                                    EN 1-181 
 
 
 
 
 
                                                                                                                    EN 1-182 
 
 
 
 
 
                                                                                                                    EN 1-183 
 
 
 
 
 
                                                                                                                 EN 1-186 
 
 
 
 
 
O
O
O
O
O
5-(2-(2-butoxyethoxy)ethoxy)-6-propylbenzo[d][1,3]dioxole
O
O
O
5-(prop-2-ynyloxy)benzo[d][1,3]dioxole
O
O O
5-(3-But-2-ynyloxy-2-methyl-propyl)-benzo[1,3]dioxole
O
O O
5-(prop-2-ynyloxy)-6-propylbenzo[d][1,3]dioxole
O
O O
O
5-(2-methoxyethoxy)-6-propylbenzo[d][1,3]dioxole
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                                                                                                                    EN 14-05 
 
 
 
 
 
                                                                                                                   EN 16/5-1 
 
 
 
 
 
                                                                                                                    EN 16-06 
 
 
 
 
 
                                                                                                                    EN 16-17 
 
 
 
 
 
                                                                                                                    EN 16-18 
 
 
 
 
 
O
O
O
O
6-((2-(2-butoxyethoxy)ethoxy)methyl)-5-propyl-2,3-dihydrobenzofuran
O
O
O
5-((2-(2-butoxyethoxy)ethoxy)methyl)-6-propyl-2,3-dihydro-1H-indene
O
O
O
O
5-((2-(2-butoxyethoxy)ethoxy)methyl)-2,3-dihydrobenzofuran
O O
6-(but-2-ynyloxy)-5-propyl-2,3-dihydrobenzofuran
O
O
5-(but-2-ynyloxy)-2,3-dihydrobenzofuran
Appendices______________________________________________________________ 
161 
 
 
 
 
                                                                                                   EN 25-10 (Verbutin) 
 
 
 
 
 
                                                                                                                    EN 25-35 
 
 
 
 
 
                                                                                                               EN 25-36 
 
 
 
 
 
                                                                                                                    EN 25-37 
 
 
 
 
 
 
 
 
 
 
 
O
O (R)
O
(R)-4-(1-(but-2-ynyloxy)ethyl)-1,2-dimethoxybenzene
O
O
O
1-(but-2-ynyloxy)-4,5-dimethoxy-2-propylbenzene
O
O
O
1,2-dimethoxy-4-(prop-2-ynyloxy)-5-propylbenzene
O
O
O
4-(but-2-ynyloxy)-1,2-dimethoxybenzene
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Appendix 3. Buffers, substrates and electrophoresis recipes  
 
Buffers 
• 0.02 M phosphate buffer, pH 7.0 
3.58 g di-sodium hydrogen orthophosphate dodecahydrate (Na2HPO4.12H2O) and 1.36 g 
(KH2PO4) potassium dihydrogen orthophosphate dissolved in1 L distilled water (d H2O). 
 
• 0.1 M sodium phosphate buffer,  pH 7.6, containing 1 mM EDTA, 1 mM DTT, 1 mM 
PTU, 1 mM PMSF and 1.46  mM sucrose 
6.23 g Na2HPO4.12H2O, 0.406 g KH2PO4, 0.074 g EDTA, 0.03 g DTT, 0.03 g PTU, 0.034 g 
PMSF and 100 g sucrose were dissolved in 200 mL dH2O. The PTU and PMSF were firstly 
dissolved in 1mL ethanol (absolute high, 100%).  
 
• 0.1 M sodium phosphate buffer, pH 7.8 
3.3 g Na2HPO4.12H2O and 0.133 g KH2PO4, were dissolved in 100 mL dH2O. 
 
• 0.02M Tris/HCl, pH 8.5 
0.884 g Trizma hydrochloride and 1.744 g Trizma Base were dissolved in 1 L dH2O 
 
Substrates 
• 30 mM 1-naphthyl acetate (MW= 186.21) 
0.558 g of 1-napthyl acetate in 100 mL of acetone 100% AR 
 
• 5, 5’ DiThio-bis (2-NitroBenzoic Acid) – DTNB (MW: 396.3) 
0.015 g DTNB in 25mL 0.02 M phosphate buffer, pH 7.0 to give a concentration of 1.5 mM 
 
• AcetylThioCholine Iodide–ATChI– (MW: 289.2) 
0.022 g ATChI in 50 mL 0.02 M phosphate buffer, pH 7.0 to give a concentration of 1.5 mM 
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Polyacrylamide Gel Electrophoresis (PAGE) 
 
Small pore gel (for approximately 15 gels) 
Solution 1:  Potassium ferricyanide 12 mg 
Acrylamide (40%)  60 mL 
Bis-acrylamide (2%)  32 mL 
Tris-base   534 mg 
Tris-HCL   2.873 mg 
Temed (Electran)  180 µL 
Made up to 250 mL with dH2O   
Solution 2: 224 mg ammonium persulphate were dissolved in 30 mL d H2O 
Mix solution 1 and solution 2 
Solution 3: 40 mL 1.6% Triton in dH2O           
Pour into moulds and seal with 2-methyl-2-butanol 
Allow to 1-2 h to set before adding large pore gel 
 
Large pore gel (for approximately 15 gels) 
Solution 1:  Acrylamide (40%)             8 mL  
Bis-acrylamide (2%)  19 mL  
Tris-base   33 mg 
Tris-HCl    180 mg 
Temed (Electran)  35 µL 
Made up to 45 mL with dH2O 
Solution 2:  Riboflavin 0.004% in dH2O 7.5 mL 
1.6% Triton X-100 in dH2O 7.5 mL 
Mix solutions 1 and 2. 
Wash 2-methyl-2- butanol off small pore gel with dH2O 
Pour large pore gel and add combs, leave them in front of light to set (1-2h) 
 
Barbitone buffer (Tank buffer) 
27.6 g Barbitone and 5g Tris-base were dissolved in 5 L dH2O 
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0.2 M phosphate buffer, pH 6.0 (Staining buffer) 
8.81 g Na2HPO4.12H2O and 23.85 g KH2PO4 were dissolved in 1 L dH2O 
 
0.2% Fast Blue RR (FBRR) 
100 mg FBRR made up to 50 mL with 0.2 M phosphate buffer, pH 6.0 and filtered 
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Appendix 4. Polo Plus analysis outputs 
 
Table 7.1 Full dose response bioassays with Myzus persicae clones against imidacloprid using a 5h pre-treatment (Chapter 4, refer to 
Table 4.5). 
Treatment Aphid Clone aLC50 (ppm) bCL 95% Slope ±SE cdf dχ2 eRF fSF 
Number of 
insects  
imidacloprid 4106A 1.55 1.18-1.99 1.90 ±0.16 60 82.9 1 -- 658 
 926B 6.53 5.32-8.03 1.41 ±0.08 82 78.08 4.21 -- 877 
 5191A 90.4 51.0-185 0.93 ±0.07 58 192.9 56.5 -- 667 
+ 1g L-1 PBO 5191A 6.22 4.04-8.70 1.50 ±0.14 86 154.1 -- 14.5 980 
+ 1g L-1 EN 16/5-1 5191A 12.2 8.80-16.4 1.24 ±0.09 89 105.4 -- 7.41 956 
aLC50=Lethal concentration to kill 50% of the population, bCL=Confidence limits, cdf=degrees of freedom,  dχ2=chi-square, 
e RF=resistance factor (LC50 resistant strain/LC50 susceptible strain), fSF=synergism factor (LC50 unsynergised/LC50 synergised) 
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Full dose response bioassays with Myzus persicae clones against α-cypermethrin using a 5h pre-treatment (Chapter 4, refer to Table 
4.6.). 
Treatment Aphid Clone aLC50 (ppm) bCL 95% Slope ±SE cdf dχ2 eRF fSF 
Number 
of insects 
α-cypermethrin 4106A 0.43 0.29-05.6 2.98 ±0.40 36 64.4 1 -- 408 
 5191A 5.60 5.94-6.33 3.14 ±0.24 102 88.2 13.0 -- 539 
 926B 7.08 5.63-8.70 2.91 ±0.32 65 70.0 16.3 -- 731 
 794JZ 1303 1060-1632 1.71±0.18 63 56.2 3030 -- 760 
+ 1g L-1 PBO 926B 2.10 1.24-2.88 2.49 ±0.51 42 21.79 -- 3.37 824 
+ 1g L-1 EN 16/5-1 926B 1.48 0.79-2.23 1.53 ±0.20 102 117.7 -- 4.78 1092 
+ 1g L-1 PBO 794JZ 271 220-327 2.26 ±0.24 81 96.02 -- 4.80 1106 
+ 1g L-1 EN 16/5-1 794JZ 264 215-321 2.16 ±0.21 100 113.7 -- 4.94 1131 
aLC50=Lethal concentration to kill 50% of the population, bCL=Confidence limits, cdf=degrees of freedom, dχ2=chi-square, 
e RF=resistance factor (LC50 resistant strain/LC50 susceptible strain), fSF=synergism factor (LC50 unsynergised/LC50 synergised) 
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Full dose response bioassays with Myzus persicae clones against PBO (Chapter 4, refer to Table 4.7). 
Aphid Clone aLC50 (ppm) bCL 95% Slope ±SE cdf dχ2 
Number 
of insects 
4106A 14892 12527-18041 2.95 ±0.31 41 41.4 489 
794JZ 12196 8485-18788 1.72 ±0.17 36 75.7 440 
926B 10540 6865-17325 1.42 ±0.15 45 125 512 
5191A 25738 21570-30947 2.25 ±0.20 100 140 838 
aLC50=Lethal concentration of PBO to kill 50% of the population, bCL=Confidence limits, cdf=degrees of freedom, dχ2=chi-square 
 
Full dose response bioassays with Meligethes aeneus against α-cypermethrin (Chapter 4 and 5, refer to Table 4.8 and 5.1). 
Population aLC50 (ηg/cm2) bCL 95% Slope ±SE cdf dχ2 eRF 
Number 
of insects 
UK  2.81 0.19-4.52 1.58 ±0.18 26 42.3 1 293 
Stein 10.0 6.01-17.0 0.84 ±0.08 27 14.9 3.57 343 
Rogalin 65.0 40.0-100 1.40 ±0.20 18 11.9 23.2 148 
Lebork 95.0 66.0-140 2.55 ±0.48 18 6.23 33.9 135 
Leszno 22.5 13.2-35.0 1.23 ±0.18 18 17.3 8.00 118 
aLC50=Lethal concentration to kill 50% of the population bCL= Confidence limits, cdf=degrees of freedom, dχ2=chi-square 
 
eRF=resistance factor (LC50 resistant strain/LC50 susceptible strain) 
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Synergism factors of analogues with imidacloprid in full dose response bioassays against Myzus persicae clone 5191A using a 5h pre-
treatment (Chapter 6, refer to Table 6.1). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aLC50=Lethal concentration to kill 50% of the population, bCL=Confidence limits, cdf=degrees of freedom, dχ2=chi-square, 
eSF=synergism factor (LC50 unsynergised/LC50 synergised)  
Treatment aLC50 (ppm) bCL 95% Slope ±SE cdf dχ2 eSF 
Number 
of insects 
imidacloprid 90.4 51.0-185 0.93 ±0.07 58 193 -- 667 
+ 1g L-1 PBO 6.22 4.04-8.70 1.50 ±0.14 86 154 14.5 980 
+ 1g L-1 EN 16/5-1 12.2 8.80-16.4 1.24 ±0.09 89 105 7.41 956 
+ 1g L-1 EN 164 1.25 0.74-1.97 1.23 ±0.08 77 266 72.4 869 
+ 1g L-1 EN 126 0.31 0.21-0.43 1.69 ±0.14 87 154 292 911 
+ 1g L-1 EN 163 2.98 1.90-4.51 0.81 ±0.05 80 138 30.3 954 
+ 1g L-1 EN 25-10 4.88 1.20-11.0 1.13 ±0.15 33 84.8 18.5 389 
+ 1g L-1 EN 129 28.4 13.6-45.8 1.39 ±0.19 42 70.0 3.18 499 
+ 1g L-1 EN 16-17 7.11 5.12-9.53 1.13 ±0.06 146 265 12.7 1600 
+ 1g L-1 EN 16-18 18.4 9.69-29.5 1.14 ±0.11 79 156 4.91 862 
+ 1g L-1 EN 14-5 41.5 26.1-62.6 1.12 ± 0.13 42 42.1 2.17 506 
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Synergism factors of analogues with α-cypermethrin in full dose response bioassays against Myzus persicae clone 794JZ using a 5h 
pre-treatment (Chapter 6, refer to Table 6.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aLC50=Lethal concentration to kill 50% of the population, bCL=Confidence limits, cdf=degrees of freedom, dχ2=chi-square, 
eSF=synergism factor (LC50 unsynergised/LC50 synergised) 
Treatment aLC50 (ppm) bCL 95% Slope ±SE cdf dχ2 eSF 
Number of 
insects 
α- cypermethrin 1303 1061-1632 1.70 ±0.20 63 56.2 ---- 760 
+ 1g L-1 PBO 271 220-327 2.26 ±0.24 81 96.0 4.81 1106 
+ 1g L-1 16/5-1 264 215-321      2.17 ±0.21 100 114 4.94 1131 
+ 1g L-1 1-14 205 162 -258 2.67 ±0.33 54 67.5 6.35 684 
+ 1g L-1 126 218 139-335 1.45 ±0.25 47 67.2 5.97 547 
+ 1g L-1 164 361 211-473 3.46 ±0.84 43 63.6 3.60 494 
+ 1g L-1 1-93 507 370-675 2.44 ±0.46 62 80.7 2.57 540 
+ 1g L-1 1-40 259 207-313 2.18 ±0.31 87 80.3 5.03 971 
+ 1g L-1 25-10 215 157-276 1.71±0.22 107 155 6.07 1147 
+ 1g L-1 14-05 569 377-898 2.27 ±0.49 52 92.0 2.29 590 
+ 1g L-1 129 629 484-878 1.70 ±0.29 76 73.3 2.07 868 
+ 1g L-1 1-16 147 101-194 1.74 ±0.25 71 81.2 8.87 806 
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Appendix 5. Analysis of discriminating dose bioassay data  
 
Generalized Linear Model (GLM) was fitted to the data calculated as proportions (number of 
dead aphids out of the total) assuming a Binomial distribution for the probability of death and 
using a logit link function. 
 
The general model was: 
log(Pijk/(1 − Pijk)) = µ + Dayi + (Control vs Treatment)j +  
[(Control vs Treatment).Treatment]jk  + [Day.(Control vs Treatment)]ij  +   
(Day.Treatment )ik + [Day.(Control vs Treatment).Treatment]ijk 
 
where Pijk is the probability of death, i = 1, 2, 3 days (this refers to temporal replicates),  
j = 1, 2 (control or treated) and  
k = 1, 2, 3….. (for the treatments: e.g. imidacloprid, imidacloprid + PBO and imidacloprid +  
EN 16/5-1). 
 
The model accounted for:  
the effects of day of assay – Day; 
the control compared with the treated situation as a whole – (Control vs Treatment);  
the different effects of the treatments having accounted for the control – [(Control vs 
Treatment).Treatment];  
and the interactions of control and treated situations with time – [Day.(Control vs Treatment)] 
and (Day.Treatment )ik + [Day.(Control vs Treatment).Treatment].  
 
On examination of residuals, the model was found to fit well, with no problem of 
overdispersion (variability over and above that which would be expected for the binomial 
distribution assumed). Following the fit of the model, the predicted probabilities of death were 
output with standard errors. The least significant difference (LSD) at the 5% level of 
significance between any pair of predictions was used to compare the treatments. 
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Appendix 6. Analysis of data for the esterase interference assay  
 
The IC50 value found using Grafit was converted into a percentage and given a new 
terminology: I (for “Index value”). The IC50 for ‘E4’ was taken as 100 % activity and for ‘no 
E4’ taken as 0% activity. 
 
The IC50 of the synergist sample, (I), was converted into a percentage by the following 
formula: 
I =  I (synergist) – I (no E4)   ×   100 = y – x1   ×   100 
      I (E4) – I (no E4)    x2 – x1 
Variance of the index (I) was approximated using the following expression: 
var (I) =    1002  [var(y) + var(x1)] 
    (x2-x1)2 
 
It is important to note that this calculation often gives an underestimated value for the variance 
because the denominator is taken as a fixed quantity in the formula. 
 
Here, var(y) = (se(y))2 where se(y) is the standard error for the IC50 (for the synergist) as given 
by the fit provided using Grafit; and similarly for x1 (‘no E4’). 
Following this, 
se (I)  =  √[var(I)]   
        ____   __ 
= √    1002      .  [var(y) + var(x1)]  
       (x2-x1)2 
The 95% Confidence Interval, denoted CI (95%), is given by 
I ± t0.05, 21 × se(I) 
where t0.05, 21 is the t-value at the p = 0.05 level of significance on 21 degrees of freedom (df). 
These are 21 because there are 33 data points (11 data points for each curve and 3 curves (no 
E4, E4, E4+synergist), less 12 parameters for fitting the 3 logistic curves. 
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Appendix 7. Formula for the variance of the ratio  
 
Given the means and standard errors for all the compounds, the ratios of analogues to the 
control were calculated. The formula for the variance of this ratio is: 
 
var(a/b) = (a2/b2)[(var(a)/a2)+(var(b)/b2)] 
 
where a is the mean and var(a) is the square of the standard error of the mean for an analogue 
and where b is the mean and var(b) is the square of the standard error of the mean for the 
control. 
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Appendix 8. Publications arising from this thesis  
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